{"id":43155,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-xoom-com-inc-and-liquidmarket.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-xoom-com-inc-and-liquidmarket","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-xoom-com-inc-and-liquidmarket.html","title":{"rendered":"Agreement and Plan of Merger &#8211; Xoom.com Inc. and LiquidMarket Inc."},"content":{"rendered":"<pre>\n================================================================================\n\n\n\n\n\n\n\n                          AGREEMENT AND PLAN OF MERGER\n\n\n                                  by and among\n\n\n                                 XOOM.COM, INC.\n                             a Delaware corporation\n\n\n                               LIQUIDMARKET, INC.\n                             a Delaware corporation\n\n\n                                       and\n\n\n                          XOOM ACQUISITION SUB II, INC.\n                             a Delaware corporation\n\n\n\n\n\n                           Dated as of July 26, 1999\n\n\n\n\n\n================================================================================\n\n\n\n<\/pre>\n<table>\n<caption>\n<p>                                TABLE OF CONTENTS<\/p>\n<p>                                                                                 PAGE<br \/>\n                                                                                 &#8212;-<br \/>\n      <s>                                                                           <c><br \/>\n1.    The Merger; Effective Time&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.1<\/p>\n<p>      1.1      The Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..1<\/p>\n<p>      1.2      Effective Time of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..2<\/p>\n<p>      1.3      The Merger Consideration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;2<\/p>\n<p>      1.4      Escrow&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;2<\/p>\n<p>2.    Purchaser and the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;3<\/p>\n<p>      2.1      Certificate of Incorporation of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;3<\/p>\n<p>      2.2      Bylaws of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<\/p>\n<p>      2.3      Directors and Officers of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;3<\/p>\n<p>3.    Treatment of Stock and Company Options&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<\/p>\n<p>      3.1      Exchange of Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<\/p>\n<p>      3.2      Mechanics of Exchange&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;5<\/p>\n<p>      3.3      No Further Rights in Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.6<\/p>\n<p>      3.4      Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..6<\/p>\n<p>      3.5      Supplementary Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.6<\/p>\n<p>      3.6      Dissenting Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.6<\/p>\n<p>4.    Closing Conditions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;7<\/p>\n<p>      4.1      Conditions Precedent to Obligations of Purchaser<br \/>\n               and Merger Sub&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.7<\/p>\n<p>      4.2      Conditions Precedent to Obligations of the Company<br \/>\n               and the Selling Stockholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.10<\/p>\n<p>5.    Representations and Warranties of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..11<\/p>\n<p>      5.1      Organization, Good Standing, Qualification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..11<\/p>\n<p>      5.2      Certificate of Incorporation and Bylaws; Records&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..11<\/p>\n<p>      5.3      Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;12<\/p>\n<p>      5.4      Authority; Binding Nature of Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..12<\/p>\n<p>      5.5      Non-Contravention; Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..13<\/p>\n<p>      5.6      Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..14<\/p>\n<p>      5.7      Proceedings; Orders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.15<\/p>\n<p>      5.8      Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;16<\/p>\n<p>                                       1<\/p>\n<p>                                                                                 PAGE<br \/>\n                                                                                 &#8212;-<br \/>\n      <s>                                                                          <c><br \/>\n      5.9      Title to Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..16<\/p>\n<p>      5.10     Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..17<\/p>\n<p>      5.11     Employees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..17<\/p>\n<p>      5.12     Compliance with Legal Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.18<\/p>\n<p>      5.13     Governmental Authorizations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..18<\/p>\n<p>      5.14     Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;19<\/p>\n<p>      5.15     Securities Laws Compliance; Registration Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;21<\/p>\n<p>      5.16     Finders and Brokers; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<\/p>\n<p>      5.17     Environmental Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<\/p>\n<p>      5.18     Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<\/p>\n<p>      5.19     Related Party Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;22<\/p>\n<p>      5.20     Absence of Changes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..23<\/p>\n<p>      5.21     Powers of Attorney&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..24<\/p>\n<p>      5.22     Benefit Plans; ERISA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;24<\/p>\n<p>      5.23     HSR Act Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..26<\/p>\n<p>      5.24     Full Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..26<\/p>\n<p>      5.25     Due Diligence Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.27<\/p>\n<p>6.    Representations and Warranties of Purchaser and Merger Sub&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.27<\/p>\n<p>      6.1      Organization, Good Standing, Authority;<br \/>\n               Binding Nature of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..27<\/p>\n<p>      6.2      Investment Representations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;27<\/p>\n<p>      6.3      Purchaser Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..28<\/p>\n<p>      6.4      Authority; Binding Nature of Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..28<\/p>\n<p>      6.5      Non-Contravention; Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..28<\/p>\n<p>      6.6      Finders and Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.29<\/p>\n<p>      6.7      Reports and Financial Statements; Absence of Certain Changes&#8230;&#8230;..29<\/p>\n<p>      6.8      Compliance with Applicable Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..30<\/p>\n<p>      6.9      Complete Copies of Requested Reports&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..30<\/p>\n<p>      6.10     Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..31<\/p>\n<p>      6.11     Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;31<\/p>\n<p>7.    Pre-Closing Covenants of the Company and the Selling Stockholders&#8230;&#8230;&#8230;&#8230;32<\/p>\n<p>      7.1      Corporate Proceedings; Stockholder Approval&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.32<\/p>\n<p>                                       2<\/p>\n<p>                                                                                 PAGE<br \/>\n                                                                                 &#8212;-<br \/>\n      <s>                                                                          <c><br \/>\n      7.2      Access and Investigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<\/p>\n<p>      7.3      Operation of Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<\/p>\n<p>      7.4      Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<\/p>\n<p>      7.5      Notification; Updates to Company Disclosure Schedule&#8230;&#8230;&#8230;&#8230;&#8230;.35<\/p>\n<p>      7.6      No Negotiation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;35<\/p>\n<p>      7.7      Best Efforts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..36<\/p>\n<p>8.    Pre-Closing Covenants of Purchaser&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.36<\/p>\n<p>      8.1      Corporate Proceedings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..36<\/p>\n<p>      8.2      Access and Investigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..37<\/p>\n<p>      8.3      Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;37<\/p>\n<p>      8.4      Notification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..38<\/p>\n<p>      8.5      Best Efforts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..38<\/p>\n<p>9.    Other Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.38<\/p>\n<p>      9.1      Registration of Company Options&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.38<\/p>\n<p>      9.2      Confidentiality&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..38<\/p>\n<p>      9.3      Public Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;38<\/p>\n<p>      9.4      Valuation Report&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.39<\/p>\n<p>      9.5      No Inconsistent Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.39<\/p>\n<p>      9.6      Terms of Employment of Critical Employees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;39<\/p>\n<p>      9.7      Patent Opinions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..39<\/p>\n<p>      9.8      Effect of Pre-Closing Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.39<\/p>\n<p>10.   Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;39<\/p>\n<p>      10.1     Termination Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..39<\/p>\n<p>      10.2     Termination Procedures&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.40<\/p>\n<p>      10.3     Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..40<\/p>\n<p>      10.4     Exclusivity of Termination Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..40<\/p>\n<p>11.   Indemnification, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;40<\/p>\n<p>      11.1     Survival of Representations and Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;40<\/p>\n<p>      11.2     Indemnification by the Selling Stockholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.41<\/p>\n<p>      11.3     Tax Indemnification by Purchaser&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;43<\/p>\n<p>      11.4     No Contribution&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..43<\/p>\n<p>                                       3<\/p>\n<p>                                                                                 PAGE<br \/>\n                                                                                 &#8212;-<br \/>\n      <s>                                                                          <c><br \/>\n      11.5     Setoff&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..43<\/p>\n<p>      11.6     Defense of Third Party Claims&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;43<\/p>\n<p>      11.7     Sole Remedy&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<\/p>\n<p>      11.8     Exercise of Remedies by Indemnitees Other than Purchaser and<br \/>\n               by Selling Stockholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<\/p>\n<p>12.   Miscellaneous&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.45<\/p>\n<p>      12.1     Further Assurances&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..45<\/p>\n<p>      12.2     Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;45<\/p>\n<p>      12.3     Attorneys&#8217;Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;45<\/p>\n<p>      12.4     Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;45<\/p>\n<p>      12.5     Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.46<\/p>\n<p>      12.6     Successors and Assigns&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<\/p>\n<p>      12.7     Entire Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<\/p>\n<p>      12.8     Separability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..47<\/p>\n<p>      12.9     Amendments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<\/p>\n<p>      12.10    Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<\/p>\n<p>      12.11    Publicity and Use of Confidential Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..49<\/p>\n<p>      12.12    Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..49<\/p>\n<p>      12.13    Delays or Omissions; Waivers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.49<\/p>\n<p>      12.14    Remedies Cumulative; Specific Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;50<\/p>\n<p>      12.15    Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;50<\/p>\n<p>      12.16    Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..50<br \/>\n<\/c><\/s><\/c><\/s><\/c><\/s><\/c><\/s><\/caption>\n<\/table>\n<p>                                       4<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>         THIS AGREEMENT AND PLAN OF MERGER (the &#8220;AGREEMENT&#8221;) is entered into<br \/>\nas of July 26, 1999, by and among XOOM.COM, INC., a Delaware corporation<br \/>\n(&#8220;PURCHASER&#8221;), LIQUIDMARKET, INC., a Delaware corporation (the &#8220;COMPANY&#8221;),<br \/>\nXOOM ACQUISITION SUB II, INC., a Delaware corporation and a wholly-owned<br \/>\nsubsidiary of Purchaser (&#8220;MERGER SUB&#8221;), the Company and Merger Sub sometimes<br \/>\nbeing hereinafter collectively referred to as the &#8220;CONSTITUENT CORPORATIONS,&#8221;<br \/>\nand the undersigned individuals and Entities (collectively, the &#8220;SELLING<br \/>\nSTOCKHOLDERS&#8221;), acting through Rajesh Parekh (the &#8220;HOLDER REPRESENTATIVE&#8221;).<br \/>\nCertain capitalized terms in this Agreement are defined in EXHIBIT A.<\/p>\n<p>                                    RECITALS<\/p>\n<p>      A. The Board of Directors of Purchaser, Merger Sub and the Company each<br \/>\n         have determined that it is in the best interests of their respective<br \/>\n         stockholders, as the case may be, for Purchaser to acquire the<br \/>\n         Company by the merger of Merger Sub with and into the Company upon<br \/>\n         the terms, and subject to the conditions, set forth herein (the<br \/>\n         &#8220;MERGER&#8221;).<\/p>\n<p>      B. For federal income tax purposes, it is intended that the Merger<br \/>\n         constitute a &#8220;reorganization,&#8221; within the meaning of Section 368(a)<br \/>\n         of the Internal Revenue Code of 1986, as amended (the &#8220;CODE&#8221;), and<br \/>\n         that each of Purchaser, Merger Sub and the Company be a &#8220;party to a<br \/>\n         reorganization,&#8221; within the meaning of Section 368(b) of the Code,<br \/>\n         in respect of the Merger.<\/p>\n<p>                                    AGREEMENT<\/p>\n<p>         Purchaser, the Company, Merger Sub and the Selling Stockholders,<br \/>\nintending to be legally bound, agree as follows:<\/p>\n<p>1.       THE MERGER; EFFECTIVE TIME.<\/p>\n<p>         1.1      THE MERGER.<\/p>\n<p>         Subject to the terms and conditions of this Agreement, at the<br \/>\nEffective Time (as defined in Section 1.2 hereof), Merger Sub shall be merged<br \/>\nwith and into the Company, with the Company as the surviving corporation in<br \/>\nsuch Merger (the &#8220;SURVIVING CORPORATION&#8221;), and the separate existence of<br \/>\nMerger Sub shall thereupon cease. The Merger shall have the effects set forth<br \/>\nin Section 251 of the General Corporation Law of the State of Delaware.<br \/>\nWithout limiting the generality of the foregoing, and subject thereto, at the<br \/>\nEffective Time all property, rights, powers, privileges and franchises of<br \/>\nMerger Sub shall vest in the Company as the Surviving Corporation, and all<br \/>\ndebts, liabilities and duties of Merger Sub shall become the debts,<br \/>\nliabilities and duties of the Surviving Corporation. Immediately following<br \/>\nthe Effective Time, the Surviving Corporation shall be a wholly-owned<br \/>\nsubsidiary of Purchaser.<\/p>\n<p>                                       1<\/p>\n<p>         1.2      EFFECTIVE TIME OF THE MERGER.<\/p>\n<p>         The Merger shall become effective upon the completion of the filing<br \/>\nof a properly executed Certificate of Merger (the &#8220;CERTIFICATE OF MERGER&#8221;)<br \/>\nwith the Secretary of State of the State of Delaware, which filing shall be<br \/>\nmade as soon as practicable after the Closing (as defined below). When used<br \/>\nin this Agreement, the term &#8220;EFFECTIVE TIME&#8221; with respect to the Merger shall<br \/>\nmean the date and time at which such Certificate of Merger has been accepted<br \/>\nfor filing by the Secretary of State of Delaware.<\/p>\n<p>         1.3      THE MERGER CONSIDERATION.<\/p>\n<p>                  (a) Subject to Section 1.3(b), Purchaser shall acquire all<br \/>\nof the outstanding shares of Common Stock and Company Preferred Stock, and<br \/>\nassume all of the Company Options, for an aggregate consideration equal to<br \/>\n1,061,008 shares of Purchaser Stock (the &#8220;MERGER CONSIDERATION&#8221;). Each<br \/>\nSelling Stockholder shall be allocated the portion of the Merger<br \/>\nConsideration set forth next to each such Selling Stockholder&#8217;s name on<br \/>\nSCHEDULE I attached hereto in exchange for the shares of Common Stock (as<br \/>\ndefined below) held by such Selling Stockholder.<\/p>\n<p>                  (b) Notwithstanding the provisions of Section 1.3(a):<\/p>\n<p>                      (i) if the product of (x) 1,061,008 times (y) the<br \/>\nAverage Purchaser Stock Price exceeds $60,000,000, then the aggregate number<br \/>\nof shares of Purchaser Stock payable as Merger Consideration shall equal the<br \/>\nquotient of $60,000,000 and the Average Purchaser Stock Price;<\/p>\n<p>                      (ii) if the product of (x) 1,061,008 times (y) the<br \/>\nAverage Purchaser Stock Price is less than $40,000,000, then the aggregate<br \/>\nnumber of shares of Purchaser Stock payable as Merger Consideration shall<br \/>\nequal the quotient of $40,000,000 and the Average Purchaser Stock Price; and<\/p>\n<p>                      (iii) if the Average Purchaser Stock Price is less than<br \/>\n$28.57, then Purchaser shall have the right, but not the obligation, to pay<br \/>\nthe Merger Consideration calculated in accordance with Section 1.3(b)(ii),<br \/>\nbut if Purchaser does not choose to do so, then either:<\/p>\n<p>                           (A) the Selling Stockholders shall receive from<br \/>\n         Purchaser a Merger Consideration consisting of, in the aggregate,<br \/>\n         1,400,000 shares of Purchaser Stock; or<\/p>\n<p>                           (B) the Company may terminate the Agreement<br \/>\n         pursuant to the terms of Section 10.<\/p>\n<p>         1.4      ESCROW.<\/p>\n<p>         As a source for the payment of the Selling Stockholders&#8217;<br \/>\nindemnification obligations set forth herein and in the Escrow Agreement, and<br \/>\nas security for the completion of certain product development and other tasks<br \/>\nthat are essential to the value of the assets of the Company, Purchaser will<br \/>\ndeliver to Escrow Agent under an Escrow Agreement (the &#8220;ESCROW AGREEMENT&#8221;) <\/p>\n<p>                                       2<\/p>\n<p>in substantially the form attached as EXHIBIT B, an amount equal to twenty<br \/>\npercent (20%) of the Merger Consideration (the &#8220;HOLDBACK AMOUNT&#8221;).<\/p>\n<p>2.       PURCHASER AND THE SURVIVING CORPORATION.<\/p>\n<p>         2.1      CERTIFICATE OF INCORPORATION OF THE SURVIVING CORPORATION.<\/p>\n<p>         The Certificate of Incorporation of Merger Sub as in effect at the<br \/>\nEffective Time shall be the Certificate of Incorporation of the Surviving<br \/>\nCorporation until duly amended in accordance with applicable law.<\/p>\n<p>         2.2      BYLAWS OF THE SURVIVING CORPORATION.<\/p>\n<p>         The Bylaws of Merger Sub as in effect at the Effective Time shall be<br \/>\nthe Bylaws of the Surviving Corporation until thereafter amended in<br \/>\naccordance with applicable law.<\/p>\n<p>         2.3      DIRECTORS AND OFFICERS OF THE SURVIVING CORPORATION.<\/p>\n<p>                  (a) The directors of Merger Sub at the Effective Time shall<br \/>\nbe the initial directors of the Surviving Corporation and shall hold office<br \/>\nfrom the Effective Time until their respective successors are duly elected or<br \/>\nappointed and qualified in the manner provided in the Certificate of<br \/>\nIncorporation and Bylaws of the Surviving Corporation, or as otherwise<br \/>\nprovided by law.<\/p>\n<p>                  (b) The officers of the Company at the Effective Time shall<br \/>\nbe the initial officers of the Surviving Corporation and shall hold office<br \/>\nfrom the Effective Time until removed or until their respective successors<br \/>\nare duly elected or appointed and qualified in the manner provided in the<br \/>\nCertificate of Incorporation and Bylaws of the Surviving Corporation, or as<br \/>\notherwise provided by law.<\/p>\n<p>3.       TREATMENT OF STOCK AND COMPANY OPTIONS.<\/p>\n<p>         3.1      EXCHANGE OF STOCK.<\/p>\n<p>         At the Effective Time, by virtue of the Merger and without any<br \/>\nfurther action on the part of the holders thereof:<\/p>\n<p>                  (a) The shares of Merger Sub common stock, $.0001 par<br \/>\nvalue, which shall be outstanding immediately prior to the Effective Time of<br \/>\nthe Merger, shall be converted into the number of shares of common stock of<br \/>\nthe Surviving Corporation equal to the number of shares of common stock of<br \/>\nMerger Sub then outstanding.<\/p>\n<p>                  (b) Each share of common stock of the Company, par value<br \/>\n$0.001 per share (the &#8220;COMMON STOCK&#8221;), and each share of Company Preferred<br \/>\nStock outstanding immediately prior to the Effective Time (such outstanding<br \/>\nshares hereinafter referred to collectively as the &#8220;STOCK&#8221;) shall at the<br \/>\nEffective Time, by virtue of the Merger and without any action on the part of<br \/>\nthe holder thereof, be converted into the right to receive a portion of the<br \/>\nMerger Consideration equal to the number of shares of Purchaser Stock derived<br \/>\nby obtaining the quotient equal to (i) the Merger Consideration divided by<br \/>\n(ii) the sum of (x) the number of shares of Stock and (y) the <\/p>\n<p>                                       3<\/p>\n<p>number of shares of Common Stock that may be issued upon the exercise of the<br \/>\noutstanding Company Options (including Additional Employee Option Grants)<br \/>\n(such quotient, the &#8220;EXCHANGE RATIO&#8221;).<\/p>\n<p>                  (c) At the Effective Time, all Company Options shall be<br \/>\nassumed by Purchaser in accordance with provisions described below.<\/p>\n<p>                           (i)      At the Effective Time, each Company<br \/>\nOption, whether vested or unvested, shall be, in connection with the Merger,<br \/>\nassumed by Purchaser. Each Company Option so assumed by Purchaser under this<br \/>\nAgreement shall continue to have, and be subject to, the same terms and<br \/>\nconditions set forth in the Company&#8217;s 1998 Stock Incentive Plan (the &#8220;OPTION<br \/>\nPLAN&#8221;), which Purchaser shall also assume, and\/or as provided in the<br \/>\nrespective option agreements governing such Company Option immediately prior<br \/>\nto the Effective Time, provided that (A) such Company Option shall be<br \/>\nexercisable for that number of whole shares of Purchaser Stock equal to the<br \/>\nproduct of the number of shares of Common Stock that were issuable upon<br \/>\nexercise of such Company Option immediately prior to the Effective Time<br \/>\nmultiplied by the Exchange Ratio, rounded down to the nearest whole number of<br \/>\nshares of Purchaser Stock and (B) the per share exercise price for the<br \/>\nPurchaser Stock issuable upon exercise of such assumed Company Option shall<br \/>\nbe equal to the quotient determined by dividing the exercise price per share<br \/>\nof Common Stock at which such Company Option was exercisable immediately<br \/>\nprior to the Effective Time by the Exchange Ratio, rounded up to the nearest<br \/>\nwhole cent.<\/p>\n<p>                           (ii)     Notwithstanding anything in this<br \/>\nAgreement to the contrary, in the event that the parties mutually agree that<br \/>\nadditional incentives are necessary to ensure retention of certain Company<br \/>\nemployees after the Effective Time, the Company and Purchaser shall, prior to<br \/>\nthe Closing Date, make additional grants of Company Options (&#8220;ADDITIONAL<br \/>\nEMPLOYEE OPTION GRANTS&#8221;) to such employees prior to the determination of the<br \/>\nExchange Ratio; provided, HOWEVER, that the number of shares subject to<br \/>\nAdditional Employee Option Grants granted pursuant to this Section 3.1(c)(ii)<br \/>\nshall not exceed two hundred twenty-five thousand (225,000) shares of Common<br \/>\nStock.<\/p>\n<p>                           (iii)    It is the intention of the parties that<br \/>\nthe Company Options assumed by Purchaser qualify following the Effective Time<br \/>\nas incentive stock options as defined in Section 422 of the Code to the<br \/>\nextent the Company Options qualified as incentive stock options immediately<br \/>\nprior to the Effective Time.<\/p>\n<p>                           (iv)     Following the Effective Time, Purchaser<br \/>\nwill issue to each holder of an outstanding Company Option a document<br \/>\nevidencing the foregoing assumption of such Company Option by Purchaser.<\/p>\n<p>                  (d) The Holdback Amount shall be held by the Escrow Agent<br \/>\nas provided for in Section 1.4 hereof and in the Escrow Agreement, and each<br \/>\nSelling Stockholder shall be paid such Selling Stockholder&#8217;s allocable<br \/>\nportion of the Merger Consideration less such Selling Stockholder&#8217;s pro rata<br \/>\nportion of the Holdback Amount upon the surrender of the certificates<br \/>\nformerly representing the Stock in accordance with Section 3.2 of this<br \/>\nAgreement.<\/p>\n<p>                                       4<\/p>\n<p>                  (e) No fraction of a share of Purchaser Stock shall be<br \/>\nissued in the Merger. In lieu of fractional shares, the Selling Stockholders,<br \/>\nupon surrender of their Certificates as set forth in Section 3.2, shall be<br \/>\npaid an amount in cash, without interest, rounded to the nearest cent,<br \/>\ndetermined by multiplying the fractional interest to which such Stockholder<br \/>\nwould otherwise be entitled by the Average Purchaser Stock Price.<\/p>\n<p>                  (f) The shares of Purchaser Stock issued in connection with<br \/>\nthe Transactions will not be registered under the Securities Act. Such shares<br \/>\nmay not be transferred or resold thereafter, except in compliance with the<br \/>\nterms of this Agreement and the other Transactional Agreements and following<br \/>\nregistration under the Securities Act or in reliance on an exemption from<br \/>\nregistration under the Securities Act.<\/p>\n<p>         3.2      MECHANICS OF EXCHANGE.<\/p>\n<p>                  (a) At the Effective Time, each Selling Stockholder shall<br \/>\nbe entitled to surrender the certificate or certificates that immediately<br \/>\nprior to the Effective Time represented the Stock (the &#8220;CERTIFICATES&#8221;), and<br \/>\nthat were converted into the right to receive a portion of the Merger<br \/>\nConsideration, to Purchaser for cancellation in exchange for such Selling<br \/>\nStockholder&#8217;s allocable portion of the Merger Consideration as set forth on<br \/>\nSCHEDULE I attached hereto. It shall be a condition of payment that the<br \/>\nCertificates so surrendered shall be properly endorsed or otherwise in proper<br \/>\nform for transfer to Purchaser.<\/p>\n<p>                  (b) From and after the Effective Time, there shall be no<br \/>\ntransfers on the stock transfer books of the Company of the shares which were<br \/>\noutstanding immediately prior to the Effective Time. If, after the Effective<br \/>\nTime, Certificates formerly representing the Stock set forth on SCHEDULE I<br \/>\nattached hereto are presented to the Surviving Corporation for payment, they<br \/>\nshall be cancelled and exchanged for the applicable portion of the Merger<br \/>\nConsideration in accordance with the procedures set forth in this Section.<\/p>\n<p>                  (c) At or prior to the Effective Time of the Merger,<br \/>\nPurchaser shall deliver to the Escrow Agent pursuant to the terms of the<br \/>\nEscrow Agreement shares of Purchaser Stock in an aggregate amount equal to<br \/>\nthe Holdback Amount.<\/p>\n<p>                  (d) In the event that any Certificate shall have been lost,<br \/>\nstolen or destroyed, upon the making of an affidavit of that fact by the<br \/>\nSelling Stockholder claiming such Certificate to be lost, stolen or<br \/>\ndestroyed, Purchaser will issue or cause to be issued in exchange for such<br \/>\nlost, stolen or destroyed Certificate the portion of the Merger Consideration<br \/>\nfor which the shares of Stock represented by the Certificate are exchanged in<br \/>\naccordance with this Section 3. When authorizing such issuance in exchange<br \/>\ntherefor, Purchaser may, in its discretion and as a condition precedent to<br \/>\nthe issuance thereof, require such Selling Stockholder to give Purchaser a<br \/>\nbond in such sum as it may direct as indemnity, or such other form of<br \/>\nindemnity, as it shall reasonably direct, against any claim that may be made<br \/>\nagainst Purchaser with respect to the Certificate alleged to have been lost,<br \/>\nstolen or destroyed.<\/p>\n<p>                  (e) Purchaser may, at its option, meet its obligations<br \/>\nunder this Section 3.2 through a bank or trust company selected by Purchaser<br \/>\nto act as exchange agent in connection with the Transactions.<\/p>\n<p>                                       5<\/p>\n<p>                  (f) If any certificate for Purchaser Stock is to be issued<br \/>\nin a name other than that in which the Certificate surrendered in exchange<br \/>\ntherefor is registered, it shall be a condition of such exchange that the<br \/>\nperson requesting such exchange shall (i) pay to Purchaser any transfer or<br \/>\nother taxes required by reason of the issuance of certificates for such<br \/>\nsecurities in a name other than that of the registered holder of the<br \/>\nCertificate surrendered or (ii) establish to the satisfaction of Purchaser<br \/>\nthat such tax has been paid or is not applicable.<\/p>\n<p>                  (g) Notwithstanding anything in this Agreement to the<br \/>\ncontrary, neither Purchaser nor any other party hereto shall be liable to a<br \/>\nholder of shares of Stock for any portion of the Merger Consideration, or<br \/>\ndividend on shares of Purchaser Stock issued as part of the Merger<br \/>\nConsideration, or in accordance with Section 3.1 the cash payment for any<br \/>\nfractional interests, that (i) is delivered to a public official pursuant to<br \/>\napplicable escheat laws following the passage of time specified therein or<br \/>\n(ii) has not been claimed by the holder pursuant to the procedures set forth<br \/>\nin this Section 3.2 by the second anniversary of the Closing Date.<\/p>\n<p>         3.3      NO FURTHER RIGHTS IN STOCK.<\/p>\n<p>                  All cash, cash equivalents or securities received by each<br \/>\nSelling Stockholder pursuant to this Agreement shall be deemed to have been<br \/>\ndelivered and received in full satisfaction of all rights pertaining to such<br \/>\nSelling Stockholder&#8217;s shares of Stock. At the Effective Time of the Merger,<br \/>\nthe Selling Stockholders shall cease to have any rights with respect to<br \/>\nshares of Stock, and their sole right shall be to receive the Merger<br \/>\nConsideration.<\/p>\n<p>         3.4      CLOSING.<\/p>\n<p>         The closing of the Transactions (the &#8220;CLOSING&#8221;) shall take place at<br \/>\nthe offices of Morrison &amp; FOERSTER LLP, 425 Market Street, San Francisco,<br \/>\nCalifornia 94105-2482 at 9:00 a.m., local time, on the later of (x) July 28,<br \/>\n1999 or (y) the second business day after the day on which all of the<br \/>\nconditions set forth in Sections 4.1 and 4.2 hereof are satisfied or waived,<br \/>\nor at such other date, time and place as the parties shall otherwise agree<br \/>\n(the date of such Closing, the &#8220;CLOSING DATE&#8221;).<\/p>\n<p>         3.5      SUPPLEMENTARY ACTION.<\/p>\n<p>         If at any time after the Effective Time, any further assignments or<br \/>\nassurances in law or any other things are necessary or desirable to vest or<br \/>\nto perfect or confirm of record in the Surviving Corporation the title to any<br \/>\nproperty or rights of either Constituent Corporation, or otherwise to carry<br \/>\nout the provisions of this Agreement, the officers and directors of the<br \/>\nSurviving Corporation are hereby authorized and empowered on behalf of the<br \/>\nConstituent Corporations, in the name of and on behalf of either Constituent<br \/>\nCorporation as appropriate, to execute and deliver any and all things<br \/>\nnecessary or proper to vest or to perfect or confirm title to such property<br \/>\nor rights in the Surviving Corporation, and otherwise to carry out the<br \/>\npurposes and provisions of this Agreement.<\/p>\n<p>         3.6      DISSENTING SHARES<\/p>\n<p>                  (a) If holders of Stock are entitled to dissent from the<br \/>\nMerger and demand appraisal of the Stock under applicable law (each person<br \/>\nelecting to exercise such rights, a <\/p>\n<p>                                       6<\/p>\n<p>&#8220;DISSENTING HOLDER&#8221;), any shares of Stock held by a Dissenting Holder as to<br \/>\nwhich appraisal has been so demanded in accordance with applicable law<br \/>\n(&#8220;DISSENTING SHARES&#8221;) shall not be exchanged as described in Section 3.1, but<br \/>\nshall from and after the Effective Time represent only the right to receive<br \/>\nsuch consideration as may be determined to be due such Dissenting Holder<br \/>\npursuant to applicable law; PROVIDED, that each share of Stock held by a<br \/>\nDissenting Holder who shall, after the Effective Time, withdraw its demand<br \/>\nfor appraisal or lose its rights of appraisal with respect to such shares of<br \/>\nStock, in either case pursuant to applicable law, shall not be deemed a<br \/>\nDissenting Share, but shall be deemed to be converted, as of the Effective<br \/>\nTime, into the applicable portion of the Merger Consideration.<\/p>\n<p>                  (b) The Company shall give Purchaser prompt notice of any<br \/>\nwritten demands for appraisal of any shares of Stock, withdrawals of such<br \/>\ndemands or failures to perfect appraisal rights resulting in a loss of such<br \/>\nrights, and any other instruments received by the Company which relate to any<br \/>\nsuch demand for appraisal. The Company shall not voluntarily make any payment<br \/>\nwith respect to any demands or potential demands for appraisal of Stock or<br \/>\noffer to settle or settle any such demands or potential demands. Purchaser<br \/>\nshall be responsible for any settlement of claims with respect to any<br \/>\nDissenting Shares, which settlements may be paid in cash, Purchaser Stock or<br \/>\nsuch other consideration as Purchaser may determine, except as otherwise<br \/>\nrequired under applicable law.<\/p>\n<p>4.       CLOSING CONDITIONS.<\/p>\n<p>         4.1      CONDITIONS PRECEDENT TO OBLIGATIONS OF PURCHASER AND MERGER<br \/>\nSUB.<\/p>\n<p>         Purchaser&#8217;s and Merger Sub&#8217;s obligations to consummate the Merger<br \/>\nand to take the other actions required to be taken by Purchaser and Merger<br \/>\nSub at the Closing are subject to the satisfaction, at or prior to the<br \/>\nClosing, of each of the following conditions (any of which may be waived by<br \/>\nPurchaser, in whole or in part, in accordance with Section 12.13):<\/p>\n<p>                  (a) the representations and warranties made by the Holder<br \/>\nRepresentative, the Selling Stockholders and the Company in Section 5 hereof<br \/>\nor in any other Transactional Agreement shall have been true and accurate in<br \/>\nall material respects as of the date of this Agreement and as of the Closing<br \/>\nDate as though made on and as of the Closing Date, without giving effect to<br \/>\nany Disclosure Schedule update;<\/p>\n<p>                  (b) all covenants, agreements and conditions contained in<br \/>\nthis Agreement or in any other Transactional Agreement to be observed by the<br \/>\nHolder Representative, the Selling Stockholders and\/or the Company on or<br \/>\nprior to the Closing shall have been performed or complied with in all<br \/>\nmaterial respects;<\/p>\n<p>                  (c) the Selling Stockholders, the Holder Representative or<br \/>\nthe Company, as the case may be, shall have delivered the following documents<br \/>\nto Purchaser:<\/p>\n<p>                           (i)      the Escrow Agreement, duly executed by<br \/>\nthe Holder Representative;<\/p>\n<p>                           (ii)     a Registration Rights Agreement in the<br \/>\nform of EXHIBIT C (the &#8220;RIGHTS AGREEMENT&#8221;), duly executed by the Holder<br \/>\nRepresentative;<\/p>\n<p>                                       7<\/p>\n<p>                           (iii)    the Employment and Non-Competition<br \/>\nAgreements substantially in the form of EXHIBIT D, duly executed by each of the<br \/>\nCritical Employees named therein;<\/p>\n<p>                           (iv)     one Investment Agreement, in the form of<br \/>\nEXHIBIT E hereto (the &#8220;INVESTMENT AGREEMENT&#8221;) and one Stockholder Questionnaire,<br \/>\nin the form of EXHIBIT F hereto (the &#8220;STOCKHOLDER QUESTIONNAIRE&#8221;), from each<br \/>\nrespective Selling Stockholder, duly executed and delivered by such Selling<br \/>\nStockholder and the Holder Representative, together with such evidence as is<br \/>\nacceptable to Purchaser, in its sole discretion, confirming the status of each<br \/>\nSelling Stockholder as an &#8220;accredited investor&#8221; (as such term is used in the<br \/>\nSecurities Act and the rules promulgated thereunder) or, in the case of a<br \/>\nSelling Stockholder who does not meet such criteria, the status of each Selling<br \/>\nStockholder&#8217;s representative or advisor with respect to the investment in<br \/>\nPurchaser Stock as a &#8220;purchaser representative&#8221; (as that term is defined in the<br \/>\nSecurities Act and the rules promulgated thereunder);<\/p>\n<p>                           (v)      one Voting Agreement (the &#8220;VOTING<br \/>\nAGREEMENT&#8221;) from each of the four individuals who beneficially owns the greatest<br \/>\nnumber of shares of Stock, in a form to be mutually agreed upon by the parties<br \/>\nhereto, pursuant to which each such Selling Stockholder agrees, subject to<br \/>\ncertain conditions, to vote such Selling Stockholder&#8217;s shares of Purchaser Stock<br \/>\nin favor of the NBC Transactions;<\/p>\n<p>                           (vi)     the legal opinion of Hale and Dorr, LLP,<br \/>\ncounsel to the Selling Stockholders and the Company, dated the Closing Date, in<br \/>\nsubstantially the form of EXHIBIT G;<\/p>\n<p>                           (vii)    a certificate (the &#8220;SELLING STOCKHOLDERS<br \/>\nCLOSING CERTIFICATE&#8221; and the &#8220;COMPANY CLOSING CERTIFICATE,&#8221; respectively)<br \/>\nexecuted by the Holder Representative and a senior executive officer of the<br \/>\nCompany, respectively, dated as of the Closing, and certifying to the<br \/>\nsatisfaction of the conditions specified in Sections 4.1(a) and (b);<\/p>\n<p>                           (viii)   the written resignations of the members of<br \/>\nthe Company Board;<\/p>\n<p>                           (ix)     written evidence reasonably satisfactory to<br \/>\nPurchaser and its counsel of the grant of Company Options (including any<br \/>\nAdditional Employee Option Grants) to the employees of the Company as set forth<br \/>\non SCHEDULE II attached hereto;<\/p>\n<p>                           (x)      written evidence reasonably satisfactory to<br \/>\nPurchaser and its counsel of the consent of all holders of the Company Preferred<br \/>\nStock to a waiver of their rights to any liquidation or other preference to<br \/>\nwhich such holders would be entitled as a result of the Merger and an agreement<br \/>\nto receive pursuant to the Merger the same Merger Consideration per share as<br \/>\nholders of Common Stock;<\/p>\n<p>                           (xi)     written evidence reasonably satisfactory to<br \/>\nPurchaser and its counsel of the agreement by all Company Option holders to be<br \/>\nbound by the restrictions on sale of Purchaser Stock contained in Section 3.1 of<br \/>\nthe Registration Rights Agreement.<\/p>\n<p>                           (xii)    written evidence reasonably satisfactory to<br \/>\nPurchaser and its counsel of the waiver by all Company Option holders and<br \/>\nholders of restricted Common Stock or other similar securities of the Company of<br \/>\ntheir right(s), if any, to acceleration of the vesting of their Company Options<br \/>\nor restricted Common Stock or other similar securities of the Company, <\/p>\n<p>                                       8<\/p>\n<p>as the case may be, as a result of the Transactions or any other event or<br \/>\ncircumstance, and the acceptance in consideration of such waiver of (i) a six<br \/>\n(6) month acceleration in vesting of the Merger Consideration to be received<br \/>\nby such persons and (ii) such additional consideration as the Company and<br \/>\nPurchaser shall mutually agree; and<\/p>\n<p>                           (xiii)   such other documents reasonably satisfactory<br \/>\nto Purchaser as Purchaser may request in good faith for the purpose of (A)<br \/>\nevidencing the accuracy of any representation or warranty made by the Company or<br \/>\nthe Selling Stockholders, (B) evidencing the compliance by the Company or the<br \/>\nSelling Stockholders with, or the performance by the Company or the Selling<br \/>\nStockholders of, any covenant or obligation set forth in this Agreement or any<br \/>\nother Transactional Agreement, (C) evidencing the satisfaction of the conditions<br \/>\nset forth in this Section 4.1, or (D) otherwise facilitating the consummation or<br \/>\nperformance of any of the Transactions;<\/p>\n<p>                  (d) each of the Critical Employees shall have accepted<br \/>\nemployment with Purchaser;<\/p>\n<p>                  (e) to the satisfaction of Purchaser and its counsel, the<br \/>\noffer and sale of the Purchaser Stock pursuant to the terms of this Agreement<br \/>\nshall comply with an exemption from registration under the Securities Act and\/or<br \/>\nany applicable federal or state securities laws and regulations;<\/p>\n<p>                  (f) all corporate and other proceedings required to be taken<br \/>\non the part of the Company and the Selling Stockholders in connection with this<br \/>\nAgreement, the Transactional Agreements and the Transactions, and all documents<br \/>\nincident thereto, shall be reasonably satisfactory in form and in substance to<br \/>\nPurchaser and its counsel;<\/p>\n<p>                  (g) there shall not be Dissenting Shares constituting more<br \/>\nthan one percent (1%) of the capital stock of the Company calculated on a<br \/>\nfully-diluted basis;<\/p>\n<p>                  (h) Purchaser&#8217;s Board of Directors and the Company&#8217;s Board of<br \/>\nDirectors and stockholders shall have ratified or approved the execution of this<br \/>\nAgreement and the other Transactional Agreements by Purchaser and shall have<br \/>\napproved the consummation of the Transactions;<\/p>\n<p>                  (i) each of the Consents identified or required to be<br \/>\nidentified in Part 5.5 of the Disclosure Schedule shall have been obtained and<br \/>\nshall be in full force and effect;<\/p>\n<p>                  (j) there shall have been no material adverse change in the<br \/>\nCompany&#8217;s business, condition, assets, liabilities, operations, financial<br \/>\nperformance or prospects, or any aspect or portion thereof (any such change or<br \/>\nsimilar effect, as the context requires, a &#8220;MATERIAL ADVERSE CHANGE&#8221; or<br \/>\n&#8220;MATERIAL ADVERSE EFFECT&#8221;) since the date of this Agreement; and<\/p>\n<p>                  (k) no Person shall have made or expressly threatened any<br \/>\nclaim asserting that such Person (i) may be the holder or the beneficial owner<br \/>\nor, or may have the right to acquire or to obtain beneficial ownership of, any<br \/>\ncapital stock or other securities of the Company, or (ii) may be entitled to all<br \/>\nor any portion of the Merger Consideration.<\/p>\n<p>                                       9<\/p>\n<p>         4.2      CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY AND THE<br \/>\nSELLING STOCKHOLDERS.<\/p>\n<p>         The Company&#8217;s obligation to take the actions required to be taken by<br \/>\nthe Company at the Closing is subject to the satisfaction, at or prior to the<br \/>\nClosing, of each of the following conditions (any of which may be waived by the<br \/>\nCompany, in whole or in part, in accordance with Section 12.13):<\/p>\n<p>                  (a) the representations and warranties made by Purchaser and<br \/>\nMerger Sub in Section 6 and in any other Transactional Agreement shall have been<br \/>\ntrue and correct in all material respects as of the date of this Agreement and<br \/>\nas of the Closing Date as though made on and as of the Closing Date;<\/p>\n<p>                  (b) all covenants, agreements and conditions contained in this<br \/>\nAgreement or in any other Transactional Agreement to be observed by Purchaser<br \/>\nand Merger Sub on or prior to the Closing shall have been performed or complied<br \/>\nwith in all material respects;<\/p>\n<p>                  (c) Purchaser shall have delivered the following documents to<br \/>\nthe Selling Stockholders, the Holder Representative and\/or the Company, as the<br \/>\ncase may be, duly executed by Purchaser:<\/p>\n<p>                           (i)      the Escrow Agreement;<\/p>\n<p>                           (ii)     the Rights Agreement;<\/p>\n<p>                           (iii)    the Employment and Non-Competition<br \/>\n                                    Agreements;<\/p>\n<p>                           (iv)     the Investment Agreement;<\/p>\n<p>                           (v)      the legal opinion of Morrison &amp; Foerster<br \/>\nLLP, counsel to Purchaser, dated the Closing Date, in substantially the form of<br \/>\nEXHIBIT H; and<\/p>\n<p>                           (vi)     a certificate (the &#8220;PURCHASER CLOSING<br \/>\nCERTIFICATE&#8221;) executed by a senior executive officer of Purchaser, dated the<br \/>\nClosing Date and certifying to the satisfaction of the conditions specified in<br \/>\nSections 4.2(a) and (b);<\/p>\n<p>                  (d) all corporate and other proceedings required to be taken<br \/>\non the part of Purchaser and Merger Sub in connection with the Transactions, and<br \/>\nall documents incident thereto, shall be reasonably satisfactory in form and in<br \/>\nsubstance to the Company and its counsel;<\/p>\n<p>                  (e) there shall have been no change that would have a material<br \/>\nadverse effect on the business, condition assets, liabilities, operations,<br \/>\nfinancial performance or prospects, or any aspect or portion thereof, of<br \/>\nPurchaser and its subsidiaries, taken as a whole (any such change or similar<br \/>\neffect, as the context requires, a &#8220;PURCHASER MATERIAL ADVERSE CHANGE&#8221; or<br \/>\n&#8220;PURCHASER MATERIAL ADVERSE EFFECT&#8221;) since the date of this Agreement; and<\/p>\n<p>                  (f) Purchaser&#8217;s Board of Directors, Company&#8217;s Board of<br \/>\nDirectors and the holders of all of the outstanding capital stock of the Company<br \/>\nshall have ratified or approved the <\/p>\n<p>                                       10<\/p>\n<p>execution of this Agreement and the other Transactional Agreements by the<br \/>\nCompany, the Holder Representative and\/or the Selling Stockholders, as the<br \/>\ncase may be, and shall have approved the consummation of the Transactions.<\/p>\n<p>5.       REPRESENTATIONS AND WARRANTIES OF THE COMPANY.<\/p>\n<p>         Except as specifically set forth in the disclosure schedule provided by<br \/>\nthe Company and attached hereto as SCHEDULE III (the &#8220;COMPANY DISCLOSURE<br \/>\nSCHEDULE&#8221;), the parts of which are numbered to correspond to the Section numbers<br \/>\nof this Agreement, the Company hereby represents and warrants to each Indemnitee<br \/>\nas follows:<\/p>\n<p>         5.1      ORGANIZATION, GOOD STANDING, QUALIFICATION.<\/p>\n<p>                  (a) The Company is a corporation duly organized, validly<br \/>\nexisting and in good standing under the laws of the State of Delaware, is<br \/>\nqualified to conduct business and is in both corporate and tax good standing<br \/>\nunder the laws of each jurisdiction in which the nature of its business or the<br \/>\nownership or leasing of its properties requires such qualification. The Company<br \/>\nhas the requisite corporate power and authority to own and operate its<br \/>\nproperties and assets, and to carry out the provisions hereof and thereof, and<br \/>\nto carry on its business as currently conducted.<\/p>\n<p>                  (b) The Company has never approved, or commenced any<br \/>\nproceeding, or made any election contemplating, the dissolution or liquidation<br \/>\nof the Company or the winding up or cessation of the Company&#8217;s business or<br \/>\naffairs.<\/p>\n<p>                  (c) The Company has no subsidiaries and does not own,<br \/>\nbeneficially or otherwise, any shares or other securities of, or any other<br \/>\ndirect or any other indirect interest of any nature in, any Entity.<\/p>\n<p>         5.2      CERTIFICATE OF INCORPORATION AND BYLAWS; RECORDS.<\/p>\n<p>                  (a) The Company has delivered to Purchaser accurate and<br \/>\ncomplete copies of:<\/p>\n<p>                           (i)      the Company&#8217;s Certificate of Incorporation<br \/>\nand bylaws, including all amendments thereto, as presently in effect;<\/p>\n<p>                           (ii)     the stock records of the Company; and<\/p>\n<p>                           (iii)    the minutes and other records of the<br \/>\nmeetings and other proceedings (including any actions taken by written consent<br \/>\nor otherwise without a meeting) of the stockholders of the Company, the Company<br \/>\nBoard and all committees of the Company Board.<\/p>\n<p>There have been no meetings or other proceedings of the stockholders of the<br \/>\nCompany, the Company Board or any committee of the Company Board that are not<br \/>\nmemorialized in such minutes or other records.<\/p>\n<p>                                       11<\/p>\n<p>                  (b) The Company has never conducted any business under or<br \/>\notherwise used, for any purpose or in any jurisdiction, any fictitious name,<br \/>\nassumed name, trade name or other name, other than the names listed on Part 5.2<br \/>\nof the Company Disclosure Schedule.<\/p>\n<p>                  (c) There has not been any material violation of the<br \/>\nCompany&#8217;s Certificate of Incorporation or bylaws.<\/p>\n<p>         5.3      CAPITALIZATION.<\/p>\n<p>                  (a) The authorized capital stock of the Company consists of<br \/>\n20,450,000 shares of capital stock, comprised of 15,000,000 shares of Common<br \/>\nStock, of which 3,600,000 shares are issued and outstanding, and 5,450,000<br \/>\nshares of Preferred Stock, of which 3,200,000 are designated Series A<br \/>\nConvertible Preferred Stock, all of which are issued and outstanding, and<br \/>\n2,250,000 shares of Series B Convertible Preferred Stock, all of which are<br \/>\nissued and outstanding (collectively, the &#8220;COMPANY PREFERRED STOCK&#8221;). No other<br \/>\nshares of capital stock are issued or outstanding. All issued and outstanding<br \/>\nshares of the Company&#8217;s capital stock have been duly authorized and validly<br \/>\nissued, are fully paid and nonassessable, and have been issued in full<br \/>\ncompliance with all applicable securities laws and other applicable legal<br \/>\nrequirements. SCHEDULE II accurately sets forth (i) the names of the<br \/>\nemployees\/consultants who have been granted Company Options (including<br \/>\nAdditional Employee Option Grants); (ii) the number of Company Options held by<br \/>\nsuch employees as of the date of this Agreement; and\/or (iii) the number of<br \/>\nCompany Options to be granted to such employees\/consultants prior to the<br \/>\nClosing.<\/p>\n<p>                  (b) Except as set forth on SCHEDULE II or Part 5.3 of the<br \/>\nCompany Disclosure Schedule, there is no:<\/p>\n<p>                           (i)      outstanding subscription, option, call,<br \/>\nwarrant or right (whether or not currently exercisable) to acquire any shares of<br \/>\nthe capital stock or other securities of the Company;<\/p>\n<p>                           (ii)     outstanding security, instrument or<br \/>\nobligation that is or may become convertible into or exchangeable for any shares<br \/>\nof the capital stock or other securities of the Company; or<\/p>\n<p>                           (iii)    to the knowledge of the Company, condition<br \/>\nor circumstance that would reasonably be expected to result in a claim by any<br \/>\nPerson to the effect that such Person is entitled to acquire or receive any<br \/>\nshares of capital stock or other securities of the Company.<\/p>\n<p>                  (c) Except as set forth in Part 5.3 of the Company Disclosure<br \/>\nSchedule, the Company has never repurchased, redeemed or otherwise reacquired<br \/>\n(or agreed, committed or offered (in writing or otherwise) to repurchase, redeem<br \/>\nor otherwise reacquire) any shares of capital stock or other securities, except<br \/>\nfrom employees of the Company pursuant to the terms of the Option Plan and the<br \/>\nCompany&#8217;s forms of option agreement.<\/p>\n<p>         5.4      AUTHORITY; BINDING NATURE OF AGREEMENTS.<\/p>\n<p>         The Company has the corporate power and authority to enter into and to<br \/>\nperform its obligations under this Agreement and the other Transactional<br \/>\nAgreements to which it is or is <\/p>\n<p>                                       12<\/p>\n<p>contemplated to be a party, and the execution, delivery and performance by<br \/>\nthe Company of this Agreement and such Transactional Agreements have been<br \/>\nduly authorized by all necessary action on the part of the Company Board and<br \/>\nits stockholders. This Agreement and the other Transactional Agreements<br \/>\nconstitute, or upon execution and delivery will constitute, the legal, valid<br \/>\nand binding obligations of the Company, enforceable against the Company in<br \/>\naccordance with their respective terms, except to the extent that<br \/>\nenforceability may be limited by applicable bankruptcy, reorganization,<br \/>\ninsolvency, moratorium or other laws affecting the enforcement of creditor&#8217;s<br \/>\nrights generally and by general principles of equity regardless of whether<br \/>\nsuch enforceability is considered in a proceeding in law or equity.<\/p>\n<p>         5.5      NON-CONTRAVENTION; CONSENTS.<\/p>\n<p>         Subject to the filing of the Certificate of Merger as required by the<br \/>\nGeneral Corporation Law of the State of Delaware and compliance by Purchaser<br \/>\nwith applicable securities laws in connection with the offer and sale of the<br \/>\nPurchaser Stock, the execution and delivery of this Agreement and the other<br \/>\nTransactional Agreements, and the consummation of the Transactions, by the<br \/>\nCompany will not, directly or indirectly (with or without notice or lapse of<br \/>\ntime):<\/p>\n<p>                  (a) contravene, conflict with or result in a material<br \/>\nviolation of (i) the Company&#8217;s Certificate of Incorporation or bylaws, or (ii)<br \/>\nany resolution adopted by the Company Board or any committee thereof or the<br \/>\nstockholders of the Company;<\/p>\n<p>                  (b) contravene, conflict with or result in a material<br \/>\nviolation of, or give any Governmental Body or other Person the right to<br \/>\nexercise any remedy or obtain any relief (other than statutory dissenters&#8217;<br \/>\nrights) under, any legal requirement or any Order to which the Company or any<br \/>\nmaterial assets owned or used by it are subject;<\/p>\n<p>                  (c) cause any material assets owned or used by the Company to<br \/>\nbe reassessed or revalued by any taxing authority or other Governmental Body;<\/p>\n<p>                  (d) contravene, conflict with or result in a material<br \/>\nviolation of any of the terms or requirements of, or give any Governmental Body<br \/>\nthe right to revoke, withdraw, suspend, cancel, terminate or modify, any<br \/>\nGovernmental Authorization that is held by the Company or any of its employees<br \/>\nor that otherwise relates to the Company&#8217;s business or to any of the material<br \/>\nassets owned or used by the Company;<\/p>\n<p>                  (e) contravene, conflict with or result in a material<br \/>\nviolation or material breach of, or material default under, any Company<br \/>\nContract;<\/p>\n<p>                  (f) give any Person the right to any payment by the Company or<br \/>\ngive rise to any acceleration or change in the award, grant, vesting or<br \/>\ndetermination of options, warrants, rights, severance payments or other<br \/>\ncontingent obligations of any nature whatsoever of the Company in favor of any<br \/>\nPerson, in any such case as a result of the change in control of the Company or<br \/>\notherwise resulting from the Transactions; or<\/p>\n<p>                  (g) result in the imposition or creation of any encumbrance<br \/>\nupon or with respect to any material asset owned or used by the Company.<\/p>\n<p>                                       13<\/p>\n<p>Except as set forth in Part 5.5 of the Company Disclosure Schedule and as<br \/>\ncontemplated in this Agreement and the other Transactional Agreements, the<br \/>\nCompany will not be required to make any filing with or give any notice to,<br \/>\nor obtain any Consent from, any Person in connection with the execution and<br \/>\ndelivery of this Agreement and the other Transactional Agreements or the<br \/>\nconsummation or performance of any of the Transactions.<\/p>\n<p>         5.6      INTELLECTUAL PROPERTY.<\/p>\n<p>                  (a) Part 5.6 of the Company Disclosure Schedule sets forth a<br \/>\ncomplete list, in all material respects, of all patents, trademarks, copyrights,<br \/>\nregistered maskworks, trade names and service marks, and any applications<br \/>\ntherefor in respect of any of the foregoing, included in the Company&#8217;s<br \/>\nProprietary Assets, and specifies, where applicable, the jurisdictions in which<br \/>\neach such Proprietary Assets has been issued or registered or in which an<br \/>\napplication for such issuance and registration has been filed, including the<br \/>\nrespective registration or application numbers and the names of all registered<br \/>\nowners. Part 5.6 also sets forth a complete list of all material licenses,<br \/>\nsublicenses and other agreements as to which the Company is a party and pursuant<br \/>\nto which the Company or any other Person is currently authorized to use any of<br \/>\nthe Company&#8217;s Proprietary Assets (excluding object code and end-user licenses<br \/>\ngranted to the Company as an end-user in the ordinary course of business that<br \/>\npermit use of software products without a right to modify, distribute or<br \/>\nsublicense the same (&#8220;END-USER LICENSES&#8221;)) or other trade secret material to the<br \/>\nCompany, and includes the identity of all parties thereto, a description of the<br \/>\nnature and subject matter thereof, the applicable royalty and the term thereof.<br \/>\nThe Company is not in material violation of any license, sublicense or agreement<br \/>\ndescribed on such list except such violations as do not materially impair the<br \/>\nCompany&#8217;s rights under such license, sublicense or agreement. Except as set<br \/>\nforth in Part 5.6 of the Company Disclosure Schedule, and except for any<br \/>\nconsents to transfer required under any Company Contract, the execution and<br \/>\ndelivery of this Agreement by the Company, and the consummation of the<br \/>\ntransactions contemplated hereby, (i) will not cause the Company to be in<br \/>\nviolation or default under any such license, sublicense or agreement, (ii) will<br \/>\nnot entitle any other party to any such license, sublicense or agreement to<br \/>\nterminate or modify such license, sublicense or agreement or (iii) will not<br \/>\nrequire the Company to repay any funds already received by it from a third<br \/>\nparty, except where the occurrence of any of (i) through (iii) would not have a<br \/>\nMaterial Adverse Effect.<\/p>\n<p>                  (b) Except as set forth in Part 5.6 of the Company Disclosure<br \/>\nSchedule, the Company has all right, title and interest in and to and is the<br \/>\nsole and exclusive owner or licensee of (free and clear of any liens or<br \/>\nencumbrances), the Company&#8217;s Proprietary Assets, and has sole and exclusive<br \/>\nrights (and is not contractually obligated to pay any compensation to any third<br \/>\nparty in respect thereof) to the use thereof or the material covered thereby in<br \/>\nconnection with the services or products in respect of which the Company&#8217;s<br \/>\nProprietary Assets are being used.<\/p>\n<p>                  (c) Except as set forth in Part 5.6 of the Company Disclosure<br \/>\nSchedule, no claims with respect to the Company&#8217;s Proprietary Assets have been<br \/>\nasserted or, to the knowledge of the Company, are threatened by any person nor<br \/>\nare there any valid grounds, to the knowledge of the Company, for any bona fide<br \/>\nclaims: (i) to the effect that the manufacture, sale, licensing or use of any of<br \/>\nthe products of the Company as now manufactured, sold, licensed or used or<br \/>\nproposed in written form for manufacture, sale, licensing or use by the Company<br \/>\ninfringes on any third party&#8217;s Proprietary Assets; (ii) against the use by the<br \/>\nCompany used in the Company&#8217;s business <\/p>\n<p>                                       14<\/p>\n<p>as currently conducted; or (iii) challenging the ownership by the Company,<br \/>\nvalidity or effectiveness of any of the Company&#8217;s Proprietary Assets. To the<br \/>\nCompany&#8217;s knowledge, all registered patents, trademarks, service marks and<br \/>\ncopyrights held by the Company, if any, are valid and subsisting.<\/p>\n<p>                  (d) To the knowledge of the Company, there is no material<br \/>\nunauthorized use, infringement or misappropriation of any of the Company&#8217;s<br \/>\nProprietary Assets by any third party, including any employee or former employee<br \/>\nof the Company.<\/p>\n<p>                  (e) None of the Company&#8217;s Proprietary Assets or product of the<br \/>\nCompany is subject to any outstanding decree, order, judgment, or stipulation<br \/>\nrestricting in any manner the licensing thereof by the Company.<\/p>\n<p>                  (f) The Company has not entered into any agreement under which<br \/>\nthe Company is restricted from selling, licensing or otherwise distributing any<br \/>\nof its current or anticipated products to any class of customers, in any<br \/>\ngeographic area, during any period of time or in any segment of the market.<\/p>\n<p>                  (g) Each of the Company&#8217;s current and former employees,<br \/>\nconsultants and other agents with access to any of the Company&#8217;s Proprietary<br \/>\nAssets has executed the Company&#8217;s form of proprietary information and invention<br \/>\nagreement in substantially the form provided to Purchaser and its counsel.<\/p>\n<p>         5.7      PROCEEDINGS; ORDERS.<\/p>\n<p>                  (a) There is no pending Proceeding, and, to the Company&#8217;s<br \/>\nknowledge, no Person has threatened to commence any Proceeding:<\/p>\n<p>                            (i)      that names the Company as a party or as<br \/>\na result of which the Company or its property or assets are reasonably likely<br \/>\nto be bound; or<\/p>\n<p>                            (ii)     that challenges, or that may have the<br \/>\neffect of preventing, delaying, making illegal or otherwise interfering with,<br \/>\nany of the Transactions or the Company&#8217;s ability to comply with or perform<br \/>\nits obligations and covenants under the Transactional Agreements, and, to the<br \/>\nknowledge of the Company, no event has occurred, and no claim, dispute or<br \/>\nother condition or circumstance exists, that might directly or indirectly<br \/>\ngive rise to or serve as a basis for the commencement of any such Proceeding.<\/p>\n<p>                  (b) The Company has delivered to Purchaser accurate and<br \/>\ncomplete copies of all pleadings, correspondence and other written materials to<br \/>\nwhich the Company has access that relate to the Proceedings identified in Part<br \/>\n5.7 of the Company Disclosure Schedule, if any.<\/p>\n<p>                  (c) There is no Order to which the Company, or any of the<br \/>\nassets owned or used by the Company, is subject.<\/p>\n<p>                  (d) To the Company&#8217;s knowledge, no officer or employee of the<br \/>\nCompany is subject to any Order that prohibits such officer or employee from<br \/>\nengaging in or continuing any conduct, activity or practice relating to the<br \/>\nCompany&#8217;s business.<\/p>\n<p>                                       15<\/p>\n<p>         5.8      FINANCIAL STATEMENTS.<\/p>\n<p>                  (a) The Company has delivered to Purchaser the following<br \/>\nfinancial statements and notes (collectively, the &#8220;FINANCIAL STATEMENTS&#8221;), which<br \/>\nare attached as EXHIBIT I:<\/p>\n<p>                           (i)      the audited balance sheet of the Company as<br \/>\nof December 31, 1998, and the related audited statement of operations, changes<br \/>\nin stockholders&#8217; equity and cash flows of the Company for the period ended<br \/>\nDecember 31, 1998, together with the notes thereto; and<\/p>\n<p>                           (ii)     the unaudited balance sheet of the Company<br \/>\nas of June 30, 1999 (the &#8220;UNAUDITED INTERIM BALANCE SHEET&#8221;), and the related<br \/>\nunaudited statement of operations, changes in stockholders&#8217; equity and cash<br \/>\nflows of the Company for the three (3) months then ended.<\/p>\n<p>                  (b) All the Financial Statements are accurate and complete in<br \/>\nall material respects, and the dollar amount of each line item included in the<br \/>\nFinancial Statements is accurate in all material respects. The Financial<br \/>\nStatements are in accordance with the books and records of the Company and<br \/>\npresent fairly the financial position of the Company as of the respective dates<br \/>\nthereof and the results of operations, changes in stockholders&#8217; equity and cash<br \/>\nflows of the Company for the periods covered thereby. The Financial Statements<br \/>\nhave been prepared in accordance with GAAP applied on a consistent basis<br \/>\nthroughout the periods covered, subject, in the case of the unaudited financial<br \/>\nstatements, to normal recurring year-end adjustments, the effect of which will<br \/>\nnot be material, and the absence of notes thereto.<\/p>\n<p>                  (c) As of the date of this Agreement, the Company has no<br \/>\nLiabilities in excess of $25,000, individually or in the aggregate, except for<br \/>\nLiabilities identified as such in the &#8220;liabilities&#8221; column of the Unaudited<br \/>\nInterim Balance Sheet.<\/p>\n<p>         5.9      TITLE TO ASSETS.<\/p>\n<p>                  (a) The Company owns all assets purported to be owned by it,<br \/>\nfree and clear of any material encumbrances, except liens for current taxes and<br \/>\nassessments not delinquent.<\/p>\n<p>                  (b) Each of the Company&#8217;s assets is free of material defects<br \/>\nand deficiencies and in good condition and repair, consistent with its age and<br \/>\nintended use (ordinary wear and tear excepted).<\/p>\n<p>                  (c) The Company does not own any real property or any interest<br \/>\nin real property, except for the leaseholds created under the real property<br \/>\nleases identified in Part 5.9(c) of the Company Disclosure Schedule (the &#8220;LEASED<br \/>\nPREMISES&#8221;). Part 5.9(c) of the Company Disclosure Schedule lists the premises<br \/>\ncovered by said leases. The Company enjoys peaceful and undisturbed possession<br \/>\nof such premises.<\/p>\n<p>                  (d) Part 5.9(d) of the Company Disclosure Schedule identifies<br \/>\nall tangible assets that are leased to the Company that have a value in excess<br \/>\nof $25,000. All leases pursuant to which the Company leases real or personal<br \/>\nproperty are valid and in full force and effect in <\/p>\n<p>                                       16<\/p>\n<p>accordance with their respective terms and, to the knowledge of the Company,<br \/>\nthere exists no default thereunder.<\/p>\n<p>         5.10     CONTRACTS.<\/p>\n<p>                  (a) Part 5.10 of the Company Disclosure Schedule identifies<br \/>\nand describes each material Company Contract. The Company has delivered to<br \/>\nPurchaser accurate and complete copies of all Company Contracts identified in<br \/>\nPart 5.10 of the Company Disclosure Schedule, including all amendments thereto.<\/p>\n<p>                  (b) Each Company Contract is currently valid and in full force<br \/>\nand effect, and is enforceable by the Company in accordance with its terms,<br \/>\nexcept to the extent that enforceability may be limited by applicable<br \/>\nbankruptcy, reorganization, insolvency, moratorium or other laws affecting the<br \/>\nenforcement of creditor&#8217;s rights generally and by general principles of equity<br \/>\nregardless of whether such enforceability is considered in a proceeding in law<br \/>\nor equity.<\/p>\n<p>                  (c) The Company is not in material default under any Company<br \/>\nContract, and, to the knowledge of the Company, (i) no Person has materially<br \/>\nviolated or breached, or declared or committed any material default under, any<br \/>\nCompany Contract; and (ii) the Company has not waived any of its rights under<br \/>\nany Company Contract.<\/p>\n<p>                  (d) (i) The Company has never guaranteed or otherwise agreed<br \/>\nto cause, insure or become liable for, and has never pledged any of its assets<br \/>\nto secure, the performance or payment of any obligation or other Liability of<br \/>\nany other Person; and (ii) the Company has never been a party to or bound by any<br \/>\nmaterial joint venture agreement, partnership agreement, profit-sharing<br \/>\nagreement, cost-sharing agreement, loss-sharing agreement or similar Contract.<\/p>\n<p>                  (e) No Person is renegotiating any amount paid or payable to<br \/>\nthe Company under any Company Contract or any other material term or provision<br \/>\nof any Company Contract.<\/p>\n<p>                  (f) Part 5.10(f) of the Company Disclosure Schedule identifies<br \/>\nand provides an accurate and complete description of each proposed Company<br \/>\nContract as to which any bid, offer, written proposal, term sheet or similar<br \/>\ndocument has been submitted to or received by the Company and is outstanding and<br \/>\nwhich would be material to the business or prospects of the Company.<\/p>\n<p>                  (g) No party to any Company Contract has notified the Company<br \/>\nto the effect that the Company has failed to perform a material obligation<br \/>\nthereunder.<\/p>\n<p>         5.11     EMPLOYEES.<\/p>\n<p>                  (a) Part 5.11(a) of the Company Disclosure Schedule contains a<br \/>\nlist of all employees of the Company as of the date of the Agreement and their<br \/>\nrespective titles and annualized compensation.<\/p>\n<p>                  (b) Part 5.11(b) of the Company Disclosure Schedule contains a<br \/>\nlist of Persons who are currently performing services for the Company business<br \/>\nand are classified as <\/p>\n<p>                                       17<\/p>\n<p>&#8220;consultants&#8221; or &#8220;independent contractors,&#8221; and the respective compensation<br \/>\nof each such &#8220;consultant&#8221; or &#8220;independent contractor.&#8221;<\/p>\n<p>                  (c) The Company has no collective bargaining agreements or<br \/>\nunion contracts with any of its employees. To the knowledge of the Company,<br \/>\nthere is no labor union organizing activity pending or threatened with respect<br \/>\nto the Company. The employment of each of the Company&#8217;s employees is terminable<br \/>\nby the Company at will; and, except as set forth in Part 5.11(c) of the Company<br \/>\nDisclosure Schedule, no employee has any agreement or contract, written or<br \/>\nverbal, regarding his or her continued employment.<\/p>\n<p>                  (d) To the Company&#8217;s knowledge, (i) no employee of the<br \/>\nCompany, nor any consultant with whom the Company has contracted, is in material<br \/>\nviolation of any term of any employment contract, proprietary information<br \/>\nagreement or any other agreement relating to the right of any such individual to<br \/>\nbe employed by, or to contract with, the Company because of the nature of the<br \/>\nbusiness to be conducted by the Company, and (ii) the continued employment by<br \/>\nthe Company of its present employees, and the performance of the Company&#8217;s<br \/>\ncontracts with its independent contractors, will not result in any such<br \/>\nviolation. The Company has not received any notice (written or otherwise)<br \/>\nalleging that any such violation has occurred. No employee of the Company has<br \/>\nbeen granted the right to continued employment by the Company or to any material<br \/>\ncompensation following termination of employment with the Company. To the<br \/>\nknowledge of the Company, no officer or key employee, or any group of employees,<br \/>\nhas given notice of his, her or their intent to terminate his, her or their<br \/>\nemployment with the Company, and no employee of the Company has received an<br \/>\noffer to join a business that is or likely would be competitive with the<br \/>\nCompany&#8217;s business.<\/p>\n<p>         5.12     COMPLIANCE WITH LEGAL REQUIREMENTS.<\/p>\n<p>                  (a) The Company is in full compliance with each legal<br \/>\nrequirement that is applicable to it or to the conduct of its business or the<br \/>\nownership or use of any of its assets, except where any noncompliance would not<br \/>\nhave a Material Adverse Effect.<\/p>\n<p>                  (b) The Company has not received, at any time, any notice from<br \/>\nany Governmental Body or any other Person regarding (i) any actual, alleged,<br \/>\npossible or potential violation of, or failure to comply with, any legal<br \/>\nrequirement by the Company, or (ii) any actual, alleged, possible or potential<br \/>\nobligation on the part of the Company to undertake, or to bear all or any<br \/>\nportion of the cost of, any cleanup or any remedial, corrective or response<br \/>\naction of any nature relating to Hazardous Materials, except to the extent<br \/>\nnoncompliance would not have a Material Adverse Effect.<\/p>\n<p>         5.13     GOVERNMENTAL AUTHORIZATIONS.<\/p>\n<p>                  (a) Part 5.13 of the Company Disclosure Schedule identifies<br \/>\neach Governmental Authorization held by the Company. The Company has delivered<br \/>\nto Purchaser accurate and complete copies of all such Governmental<br \/>\nAuthorizations, including all renewals thereof and all amendments thereto. Each<br \/>\nGovernmental Authorization identified or required to be identified in Part 5.13<br \/>\nof the Company Disclosure Schedule is valid and in full force and effect.<\/p>\n<p>                                       18<\/p>\n<p>                  (b) The Governmental Authorizations identified in Part 5.13 of<br \/>\nthe Company Disclosure Schedule constitute all the Governmental Authorizations<br \/>\nnecessary (i) to enable the Company to conduct its business in the manner in<br \/>\nwhich its business is currently being conducted, and (ii) to permit the Company<br \/>\nto own and use its assets in the manner in which they are currently owned and<br \/>\nused, except to the extent that any failure to obtain any Governmental<br \/>\nAuthorization would not have a Material Adverse Effect.<\/p>\n<p>         5.14     TAX MATTERS.<\/p>\n<p>                  (a) Except to the extent set forth in Part 5.14 of the Company<br \/>\nDisclosure Schedule, each Tax required to have been paid, or claimed by any<br \/>\nGovernmental Body to be payable, by the Company (whether pursuant to any Tax<br \/>\nReturn or otherwise) has been duly paid in full on a timely basis. Any Tax<br \/>\nrequired to have been withheld or collected by the Company has been duly<br \/>\nwithheld and collected, and (to the extent required) each such Tax has been paid<br \/>\nto the appropriate Governmental Body. The Company has complied with all<br \/>\ninformation reporting and backup withholding requirements, including maintenance<br \/>\nof required records with respect thereto, in connection with amounts paid or<br \/>\nowing to any employee, creditor, independent contractor, or other third party.<\/p>\n<p>                  (b) Part 5.14 of the Company Disclosure Schedule accurately<br \/>\nidentifies all Tax Returns required to be filed by or on behalf of the Company<br \/>\nwith any Governmental Body with respect to any taxable period ending on or<br \/>\nbefore the Closing Date (&#8220;COMPANY RETURNS&#8221;). All Company Returns (i) have been,<br \/>\nor will be, filed when due, and (ii) have been, or will be when filed,<br \/>\naccurately and completely prepared pursuant to applicable law. All amounts shown<br \/>\non the Company Returns to be due on or before the Closing Date, and all amounts<br \/>\notherwise payable in connection with the Company Returns on or before the<br \/>\nClosing Date, have been paid on or before the Closing Date. The Company has<br \/>\ndelivered to Purchaser copies of all Company Returns filed by or on behalf of<br \/>\nthe Company or any other entity acquired by or merged into the Company prior to<br \/>\nthe Closing Date.<\/p>\n<p>                  (c) The Company&#8217;s liability for unpaid Taxes for all periods<br \/>\nending on or before the date of the Financial Statements does not, in the<br \/>\naggregate, exceed the amount of the current liability accruals for Taxes<br \/>\n(excluding reserves for deferred taxes) reported in the Financial Statements.<br \/>\nThe Company has established, in the Ordinary Course of Business, reserves<br \/>\nadequate for the payment of all Taxes for the period from December 31, 1998<br \/>\nthrough the Closing Date, and the Company has disclosed the dollar amount of<br \/>\nsuch reserves to Purchaser on or prior to the Closing Date.<\/p>\n<p>                  (d) Part 5.14 of the Company Disclosure Schedule identifies<br \/>\neach examination or audit of any Company Return that has been conducted by any<br \/>\nGovernmental Body. The Company has delivered to Purchaser copies of all audit<br \/>\nreports and similar documents (to which the Company has access) relating to<br \/>\nCompany Returns. No extension or waiver of the limitation period applicable to<br \/>\nany of the Company Returns has been granted (by the Company or any other<br \/>\nPerson), and no such extension or waiver has been requested from the Company.<\/p>\n<p>                  (e) No claim or other Proceeding is pending or has been<br \/>\nthreatened in writing or orally (formally or informally) against or with respect<br \/>\nto the Company in respect of any Tax. <\/p>\n<p>                                       19<\/p>\n<p>The Company has not entered into or become bound by any agreement or consent<br \/>\npursuant to Section 341(f) of the Code. The Company has not been, and will<br \/>\nnot be, required to include any adjustment in taxable income for any tax<br \/>\nperiod (or portion thereof) pursuant to Section 481 or 263A of the Code or<br \/>\nany comparable provision under state or foreign Tax laws as a result of<br \/>\ntransactions or events occurring, or accounting methods employed, prior to<br \/>\nthe Closing. The Company has never been in a &#8220;consolidated group&#8221; within the<br \/>\nmeaning of Treasury Regulations Section 1.1502-1(h), and is not liable for<br \/>\nTaxes incurred by any individual, trust, corporation, partnership or any<br \/>\nother Entity either as a transferee, pursuant to Treasury Regulations Section<br \/>\n1.1502-6, or pursuant to any other provision of federal, territorial, state,<br \/>\nlocal or foreign law or regulations. Except as set forth in Part 5.14 of the<br \/>\nCompany Disclosure Schedule, the Company is not a party to any joint venture,<br \/>\npartnership or other arrangement or contract which could be treated as a<br \/>\npartnership for United States federal income tax purposes. None of the assets<br \/>\nof the Company (i) directly or indirectly secures any debt the interest on<br \/>\nwhich is tax exempt under Section 103(a) of the Code or (ii) is &#8220;tax exempt<br \/>\nuse property&#8221; within the meaning of Section 168(h) of the Code. The Company<br \/>\nhas not participated in an international boycott as defined in Code Section<br \/>\n999. The Company does not have a &#8220;permanent establishment,&#8221; as defined in any<br \/>\napplicable Tax treaty or convention of the United States of America, or fixed<br \/>\nplace of business in any foreign country. The Company is not, nor has it ever<br \/>\nbeen, an &#8220;S corporation,&#8221; within the meaning of Section 1361(a) of the Code.<\/p>\n<p>                  (f) The Company is not party to any agreement, plan,<br \/>\narrangement or other Contract covering any employee or independent contractor or<br \/>\nformer employee or independent contractor of the Company that, individually or<br \/>\ncollectively, could give rise directly or indirectly to the payment of any<br \/>\namount that would not be deductible pursuant to Section 280G of the Code. Except<br \/>\nas set forth in Part 5.14 of the Company Disclosure Schedule, the Company is<br \/>\nnot, and has never been, a party to or bound by any tax indemnity agreement,<br \/>\ntax-sharing agreement, tax allocation agreement or similar Contract, and has not<br \/>\notherwise assumed the tax liability of any other Person under contract.<\/p>\n<p>                  (g) The Company is not a United States real property holding<br \/>\ncorporation within the meaning of Section 897(c)(2) of the Code and has not been<br \/>\na United States real property holding corporation within the applicable period<br \/>\nspecified in Section 897(c)(1)(A)(ii) of the Code.<\/p>\n<p>                  (h) The Company has no net operating losses or other tax<br \/>\nattributes presently subject to limitation under Code Section 382, 383 or 384.<\/p>\n<p>                  (i) All of the Selling Stockholders are &#8220;United States<br \/>\npersons,&#8221; within the meaning of Section 7701(a)(30) of the Code.<\/p>\n<p>                  (j) The Company&#8217;s final 1999 U.S. income tax return to be<br \/>\nprepared pursuant to Section 12.4(b) will contain, in all material respects, an<br \/>\naccurate and complete description of the Company&#8217;s tax basis in its assets, its<br \/>\ncurrent and accumulated earnings and profits, its tax carryovers, and any tax<br \/>\nelections.<\/p>\n<p>                  (k) The Company has not and will not prior to the Merger<br \/>\nredeem or make any extraordinary distribution (within the meaning of Treasury<br \/>\nRegulations Section 1.368-<\/p>\n<p>                                       20<\/p>\n<p>1T(e)(1)(ii)(A)) with respect to any Company capital stock in connection with<br \/>\nthe Merger; no &#8220;related person&#8221; of the Company (within the meaning of<br \/>\nTreasury Regulations Section 1.368-1(e)(3)) has purchased or will purchase<br \/>\nprior to the Effective Time any Company capital stock in connection with the<br \/>\nMerger.<\/p>\n<p>                  (l) After the Merger, the Company will hold at least ninety<br \/>\npercent (90%) of the fair market value of its net assets and at least seventy<br \/>\npercent (70%) of the fair market value of its gross assets held immediately<br \/>\nprior to the Merger. For purposes hereof, amounts paid by the Company to<br \/>\ndissenters, amounts paid by the Company to shareholders who receive cash or<br \/>\nother property, amounts used by the Company to pay reorganization expenses, and<br \/>\nall redemptions and distributions (except for regular, normal dividends) made by<br \/>\nthe Company will be included as assets of the Company immediately prior to the<br \/>\nMerger.<\/p>\n<p>                  (m) The Liabilities of the Company, if any, and the<br \/>\nLiabilities to which the assets of the Company are subject, if any, were or will<br \/>\nbe incurred by the Company in the Ordinary Course of Business.<\/p>\n<p>                  (n) The Company and each of the Selling Stockholders will pay<br \/>\nany of their own expenses incurred in connection with the Merger.<\/p>\n<p>                  (o) The Company is not under the jurisdiction of a court in a<br \/>\n&#8220;title 11 or similar case,&#8221; within the meaning of Section 368(a)(3)(A) of the<br \/>\nCode.<\/p>\n<p>                  (p) The Company is not an investment company for purposes of<br \/>\nSection 368(a)(2)(F) of the Code.<\/p>\n<p>                  (q) The Company&#8217;s business conducted immediately before the<br \/>\nEffective Time will be its &#8220;historic business&#8221; and its assets held immediately<br \/>\nbefore the Effective Time will be its &#8220;historic business assets&#8221; for purposes of<br \/>\nSection 368 of the Code.<\/p>\n<p>         5.15     SECURITIES LAWS COMPLIANCE; REGISTRATION RIGHTS.<\/p>\n<p>         The Company has complied with all applicable federal and state<br \/>\nsecurities laws in connection with all offers and sales of securities issued<br \/>\nby the Company prior to the date of this Agreement. Except as set forth in<br \/>\nPart 5.15 of the Company Disclosure Schedule, the Company has not heretofore<br \/>\ngranted any other purchaser of its securities the right to require the<br \/>\nCompany to register any securities under the Securities Act or to qualify for<br \/>\nany exemption thereunder.<\/p>\n<p>         5.16     FINDERS AND BROKERS; FEES.<\/p>\n<p>                  (a) Neither the Company nor any person acting on behalf of the<br \/>\nCompany has engaged any finder, broker, intermediary or any similar person in<br \/>\nconnection with the Transactions.<\/p>\n<p>                  (b) The Company has not entered into a contract or other<br \/>\nagreement that provides that a fee shall be paid to any Person or Entity if the<br \/>\nTransactions are consummated.<\/p>\n<p>                                       21<\/p>\n<p>         5.17     ENVIRONMENTAL COMPLIANCE.<\/p>\n<p>         To the knowledge of the Company, the Company is and has been at all<br \/>\ntimes in compliance in all respects with all Environmental Laws, except where<br \/>\nthe failure to so comply would not have a Material Adverse Effect.<\/p>\n<p>         5.18     INSURANCE.<\/p>\n<p>                  (a) Part 5.18 of the Company Disclosure Schedule sets forth<br \/>\neach insurance policy maintained by or at the expense of, or for the benefit of,<br \/>\nthe Company:<\/p>\n<p>                  (b) The Company has delivered to Purchaser copies of all of<br \/>\nthe insurance policies identified in Part 5.18 of the Company Disclosure<br \/>\nSchedule (including all renewals thereof and endorsements thereto) and binders<br \/>\nrelating thereto.<\/p>\n<p>                  (c) Each of the policies identified in Part 5.18 of the<br \/>\nCompany Disclosure Schedule is in full force and effect. All of the information<br \/>\ncontained in the applications submitted in connection with said policies was (at<br \/>\nthe times said applications were submitted) accurate and complete, and all<br \/>\npremiums and other amounts owing with respect to said policies have been paid in<br \/>\nfull on a timely basis. Each of the policies identified in Part 5.18 of the<br \/>\nCompany Disclosure Schedule will continue in full force and effect following the<br \/>\nClosing, and the Company has paid all premiums due, and has otherwise performed<br \/>\nall of its obligations, under each policy to which it is a party or that<br \/>\nprovides coverage to it or any of its directors or officers in connection with<br \/>\ntheir performance of services to the Company.<\/p>\n<p>                  (d) There is no pending claim under or based upon any of the<br \/>\npolicies identified in Part 5.18 of the Company Disclosure Schedule, and, to the<br \/>\nCompany&#8217;s knowledge, no event has occurred, and no condition or circumstance<br \/>\nexists, that might (with or without notice or lapse of time) directly or<br \/>\nindirectly give rise to or serve as a basis for any such claim.<\/p>\n<p>                  (e) The Company has not received:<\/p>\n<p>                           (i)      any notice or other communication (in<br \/>\nwriting or otherwise) regarding the actual or possible cancellation or<br \/>\ninvalidation of any of the policies identified in Part 5.18 of the Company<br \/>\nDisclosure Schedule or regarding any actual or possible adjustment in the amount<br \/>\nof the premiums payable with respect to any of said policies; or<\/p>\n<p>                           (ii)     any notice or other communication (in<br \/>\nwriting or otherwise) regarding any actual or possible refusal of coverage<br \/>\nunder, or any actual or possible rejection of any claim under, any of the<br \/>\npolicies identified in Part 5.18 of the Company Disclosure Schedule.<\/p>\n<p>         5.19     RELATED PARTY TRANSACTIONS.<\/p>\n<p>                  (a) No Related Party has, and no Related Party has at any time<br \/>\nsince December 31, 1998, had, any direct or indirect material interest of any<br \/>\nnature in any material asset of the Company or any Company Contract, except in<br \/>\nsuch Related Party&#8217;s capacity as a director, employee, officer or stockholder of<br \/>\nthe Company.<\/p>\n<p>                                       22<\/p>\n<p>                  (b) No Related Party is, or has at any time since December 31,<br \/>\n1998, been, indebted to the Company for an amount, individually or in the<br \/>\naggregate, in excess of $25,000.<\/p>\n<p>                  (c) Since December 31, 1998, no Related Party has entered<br \/>\ninto, or has had any direct or indirect material financial interest in, any<br \/>\nCompany Contract, transaction or business dealing of any nature involving the<br \/>\nCompany, except in such Related Party&#8217;s capacity as a director, employee,<br \/>\nofficer or stockholder of the Company.<\/p>\n<p>                  (d) To the Company&#8217;s knowledge, no Related Party is competing,<br \/>\nor has at any time since December 31, 1998, competed, directly or indirectly,<br \/>\nwith the Company in any market served by the Company.<\/p>\n<p>         5.20     ABSENCE OF CHANGES.<\/p>\n<p>         Since March 31, 1999:<\/p>\n<p>                  (a) there has not been any Material Adverse Change, and, to<br \/>\nthe knowledge of the Company, no event has occurred that is reasonably likely to<br \/>\nhave a Material Adverse Effect;<\/p>\n<p>                  (b) the Company has not declared, accrued, set aside or paid<br \/>\nany dividend or made any other distribution in respect of any shares of capital<br \/>\nstock;<\/p>\n<p>                  (c) the Company has not amended its Certificate of<br \/>\nIncorporation or Bylaws and has not effected or been a party to any Acquisition<br \/>\nTransaction, recapitalization, reclassification of shares, stock split, reverse<br \/>\nstock split or similar transaction;<\/p>\n<p>                  (d) the Company has not made any individual capital<br \/>\nexpenditure in excess of $50,000<\/p>\n<p>                  (e) the Company has not pledged or hypothecated any of its<br \/>\nmaterial assets or otherwise permitted any of its material assets to become<br \/>\nsubject to any encumbrance;<\/p>\n<p>                  (f) the Company has not made any loan or advance in excess of<br \/>\n$25,000 to any Person;<\/p>\n<p>                  (g) the Company has not paid any bonus or made any<br \/>\nprofit-sharing or similar payment to, or increased the amount of the wages,<br \/>\nsalary, commissions, fringe benefits or other compensation or remuneration<br \/>\npayable to, any of its directors, officers or employees in excess of $5,000<br \/>\nindividually or $10,000 in the aggregate;<\/p>\n<p>                  (h) there has been no resignation or termination of employment<br \/>\nof any officer or Critical Employee of the Company;<\/p>\n<p>                  (i) there has been no borrowing or agreement to borrow by the<br \/>\nCompany or material change in the contingent obligations of the Company by way<br \/>\nof guaranty, endorsement, indemnity, warranty or otherwise or grant of a<br \/>\nmortgage or security interest in any property of the Company;<\/p>\n<p>                                       23<\/p>\n<p>                  (j) the Company has not discharged any encumbrance or<br \/>\ndischarged, paid or forgiven any indebtedness or other Liability in excess of<br \/>\n$25,000, individually or in the aggregate, except for accounts payable that (i)<br \/>\nare reflected as current liabilities in the &#8220;liabilities&#8221; column of the<br \/>\nUnaudited Interim Balance Sheet or have been incurred by the Company since the<br \/>\ndate of the Unaudited Interim Balance Sheet in the Ordinary Course of Business<br \/>\nand (ii) have been discharged or paid in the Ordinary Course of Business;<\/p>\n<p>                  (k) the Company has not released or waived any material right<br \/>\nor claim;<\/p>\n<p>                  (l) the Company has not changed any of its methods of<br \/>\naccounting or accounting practices in any material respect;<\/p>\n<p>                  (m) the Company has not received notice that there has been a<br \/>\nloss of, or cancellation of a material order by, any customer of the Company;<br \/>\nand<\/p>\n<p>                  (n) the Company has not agreed, committed or offered (in<br \/>\nwriting or otherwise), and has not attempted, to take any of the actions<br \/>\nreferred to in clauses (b) through (m) above.<\/p>\n<p>         5.21     POWERS OF ATTORNEY.<\/p>\n<p>         The Company has not given a power of attorney to any Person.<\/p>\n<p>         5.22     BENEFIT PLANS; ERISA.<\/p>\n<p>                  (a) Part 5.22 of the Company Disclosure Schedule lists (i) all<br \/>\n&#8220;employee benefit plans&#8221; within the meaning of Section 3(3) of ERISA, (ii) all<br \/>\nmaterial employment agreements, including, but not limited to, any individual<br \/>\nbenefit arrangement, policy or practice with respect to any current or former<br \/>\nemployee or director of the Company or Member of the Controlled Group, and (iii)<br \/>\nall other material employee benefit, bonus or other incentive compensation,<br \/>\nstock option, stock purchase, stock appreciation, severance pay, lay-off or<br \/>\nreduction in force, change in control, sick pay, vacation pay, salary<br \/>\ncontinuation, retainer, leave of absence, educational assistance, service award,<br \/>\nemployee discount, fringe benefit plans, arrangements, policies or practices,<br \/>\nwhether legally binding or not, which the Company or any Member of the<br \/>\nControlled Group maintains, contributes to or has any obligation to or liability<br \/>\nfor (collectively, the &#8220;PLANS&#8221;).<\/p>\n<p>                  (b) None of the Plans is a Defined Benefit Plan, and neither<br \/>\nthe Company nor any Member of the Controlled Group has ever sponsored,<br \/>\nmaintained or contributed to, or ever been obligated to contribute to, a Defined<br \/>\nBenefit Plan that could reasonably be expected to result in a material amount of<br \/>\nliability under Title IV of ERISA.<\/p>\n<p>                  (c) None of the Plans is a Multiemployer Plan, and neither the<br \/>\nCompany nor any Member of the Controlled Group has ever contributed to, or ever<br \/>\nbeen obligated to contribute to, a Multiemployer Plan that could reasonably be<br \/>\nexpected to result in a material amount of liability under Title IV of ERISA.<\/p>\n<p>                  (d) The Company does not maintain or contribute to any welfare<br \/>\nbenefit plan which provides health benefits to an employee after the employee&#8217;s<br \/>\ntermination of employment <\/p>\n<p>                                       24<\/p>\n<p>or retirement except as required under Section 4980B of the Code and Sections<br \/>\n601 through 608 of ERISA, or other applicable law.<\/p>\n<p>                  (e) Each Plan that is an &#8220;employee benefit plan,&#8221; as defined<br \/>\nin Section 3(3) of ERISA, complies in all material respects by its terms and in<br \/>\noperation with the requirements provided by any and all statutes, orders or<br \/>\ngovernmental rules or regulations currently in effect and applicable to the<br \/>\nPlan, including but not limited to ERISA and the Code.<\/p>\n<p>                  (f) All reports, forms and other documents required to be<br \/>\nfiled with any government entity with respect to any Plan (including, without<br \/>\nlimitation, summary plan descriptions, Forms 5500 and summary annual reports)<br \/>\nhave been timely filed and are accurate.<\/p>\n<p>                  (g) Each Plan intended to qualify under Section 401(a) of the<br \/>\nCode is the subject of a favorable determination letter issued by the Internal<br \/>\nRevenue Service that provides that it so qualifies through the last day of the<br \/>\n&#8220;TRA 86 Remedial Amendment Period,&#8221; as such term is defined in Section 3.02 or<br \/>\nRevenue Procedure 96-55. To the Company&#8217;s knowledge, nothing has occurred since<br \/>\nthe date of the Internal Revenue Service&#8217;s favorable determination letter that<br \/>\ncould adversely affect the qualification of the Plan and its related trust. The<br \/>\nCompany and each Member of the Controlled Group have timely and properly applied<br \/>\nfor a written determination by the Internal Revenue Service on the qualification<br \/>\nof each such Plan and its related trust under Section 401(a) of the Code, as<br \/>\namended by the Tax Reform Act of 1986 and subsequent legislation enacted through<br \/>\nthe date hereof, and Section 501 of the Code.<\/p>\n<p>                  (h) All contributions owed for all periods ending prior to the<br \/>\nClosing Date (including periods from the first day of the current plan year to<br \/>\nthe Closing Date) under any Plan have been or will be made prior to the Closing<br \/>\nDate by the Company in accordance with past practice and the recommended<br \/>\ncontribution in any applicable actuarial report.<\/p>\n<p>                  (i) All insurance premiums have been paid in full, subject<br \/>\nonly to normal retrospective adjustments in the ordinary course, with regard to<br \/>\nthe Plans for plan years ending on or before the Closing Date.<\/p>\n<p>                  (j) With respect to each Plan:<\/p>\n<p>                           (i)      no prohibited transactions (as defined in<br \/>\nSection 406 or 407 of ERISA or Section 4975 of the Code) have occurred for which<br \/>\nan exemption is not available that could reasonably be expected to result in a<br \/>\nmaterial amount of liability to the Company;<\/p>\n<p>                           (ii)     no actions or claims (other than routine<br \/>\nclaims for benefits made in the ordinary course of Plan administration for which<br \/>\nPlan administrative review procedures have not been exhausted) are pending,<br \/>\nthreatened or, to the knowledge of the Company, imminent against or with respect<br \/>\nto the Plan, any employer who is participating (or who has participated) in the<br \/>\nPlan or any fiduciary (as defined in Section 3(21) of ERISA) of the Plan that<br \/>\ncould reasonably be expected to result in a material amount of liability to the<br \/>\nCompany;<\/p>\n<p>                           (iii)    no facts exist which could give rise to any<br \/>\nsuch action or claim; and<\/p>\n<p>                                       25<\/p>\n<p>                           (iv)     the Plan provides that it may be amended or<br \/>\nterminated at any time and, except for benefits protected under Section 411(d)<br \/>\nof the Code, all benefits payable to current, terminated employees or any<br \/>\nbeneficiary may be amended or terminated by the Company at any time without a<br \/>\nmaterial amount of liability.<\/p>\n<p>                  (k) Neither the Company nor any Member of the Controlled Group<br \/>\nhas any Plan-related liability or is threatened with any liability (whether<br \/>\njoint or several) (i) for any excise tax imposed by Section 4971, 4975, 4976,<br \/>\n4977 or 4979 of the Code, or (ii) for a fine under Section 502 of ERISA that<br \/>\ncould reasonably be expected to result in a material amount of liability to the<br \/>\nCompany.<\/p>\n<p>                  (l) All the &#8220;group health plans&#8221; (as defined in Section 607(1)<br \/>\nor 733(a)(1) of ERISA or Section 4980B(g)(2) of the Code) that are part of the<br \/>\nPlans listed in the Company Disclosure Schedule are in material compliance with<br \/>\nthe continuation of group health coverage provisions contained in Section 4980B<br \/>\nof the Code and Sections 601 through 608 of ERISA.<\/p>\n<p>                  (m) Copies of all documents creating or evidencing any Plan<br \/>\nlisted in the Company Disclosure Schedule, and all reports, forms and other<br \/>\ndocuments required to be filed with any governmental entity (including, without<br \/>\nlimitation, summary plan descriptions, Forms 5500 and summary annual reports for<br \/>\nall plans subject to ERISA), have been delivered or made available to Purchaser.<br \/>\nThere are no negotiations, demands or proposals which are pending or have been<br \/>\nmade which concern matters now covered, or that would be covered, by any Plan<br \/>\nlisted in the Company Disclosure Schedule.<\/p>\n<p>                  (n) All expenses and liabilities relating to contributions<br \/>\nrequired by law and the terms of the Plans described in the Company Disclosure<br \/>\nSchedule have been, and on the Closing Date will be, fully and properly accrued<br \/>\non the Company&#8217;s books and records and disclosed in accordance with GAAP and in<br \/>\nPlan financial statements.<\/p>\n<p>         5.23     HSR ACT MATTERS.<\/p>\n<p>         The Company is its own &#8220;ultimate parent entity&#8221; as such term is defined<br \/>\nin 16 C.F.R. Section 801.1(a)(3). The Company, on a consolidated basis, does not<br \/>\nengage in manufacturing within the meaning of 16 C.F.R. Section 801.1(j). The<br \/>\nCompany, on a consolidated basis, does not have assets with an aggregate book<br \/>\nvalue of $10,000,000 or more based on its most recent regularly prepared balance<br \/>\nsheet. This representation is made solely for the purpose of determining the<br \/>\napplicability to the transactions contemplated by this Agreement of the<br \/>\nHart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.<\/p>\n<p>         5.24     FULL DISCLOSURE.<\/p>\n<p>                  (a) Neither this Agreement (including all Schedules and<br \/>\nExhibits hereto), nor any of the Transactional Agreements, contains any untrue<br \/>\nstatement of material fact; and none of such documents omits to state any<br \/>\nmaterial fact necessary to make any of the representations, warranties or other<br \/>\nstatements or information contained therein when read collectively not<br \/>\nmisleading.<\/p>\n<p>                                       26<\/p>\n<p>                  (b) There is no fact within the knowledge of the Company<br \/>\n(other than publicly known facts relating exclusively to political or economic<br \/>\nmatters of general applicability that will adversely affect all comparable<br \/>\nEntities) that may (i) have a Material Adverse Effect or (ii) affect the ability<br \/>\nof the Selling Stockholders or the Company to comply with or perform any<br \/>\ncovenant or obligation under this Agreement or any of the other Transactional<br \/>\nAgreements to which it is contemplated to be a party.<\/p>\n<p>                  (c) All the information set forth in the Company Disclosure<br \/>\nSchedule is accurate and complete in all material respects.<\/p>\n<p>         5.25     DUE DILIGENCE INFORMATION.<\/p>\n<p>         The Company has provided Purchaser and Purchaser&#8217;s representatives with<br \/>\nfull and complete access to all of the Company&#8217;s records and other documents and<br \/>\ndata, and has produced all documents and related materials in response to the<br \/>\nreasonable requests of Purchaser.<\/p>\n<p>6.       REPRESENTATIONS AND WARRANTIES OF PURCHASER AND MERGER SUB.<\/p>\n<p>         Except as set forth in the disclosure schedule provided by Purchaser<br \/>\nattached hereto at SCHEDULE IV (the &#8220;PURCHASER DISCLOSURE SCHEDULE&#8221;) Purchaser<br \/>\nand Merger Sub, jointly and severally, hereby represent and warrant to the<br \/>\nSelling Stockholders as follows:<\/p>\n<p>         6.1      ORGANIZATION, GOOD STANDING, AUTHORITY; BINDING NATURE OF<br \/>\nAGREEMENT.<\/p>\n<p>                  (a) Purchaser is a corporation duly organized, validly<br \/>\nexisting and in good standing under the laws of the State of Delaware, is<br \/>\nqualified to conduct business and is in both corporate and tax good standing<br \/>\nunder the laws of each jurisdiction in which the nature of its business or the<br \/>\nownership or leasing of its properties requires such qualification. Purchaser<br \/>\nhas the requisite corporate power and authority to own and operate its<br \/>\nproperties and assets and to carry on its business as currently conducted.<\/p>\n<p>                  (b) Merger Sub is a corporation duly organized, validly<br \/>\nexisting and in good standing under the laws of the State of Delaware, is<br \/>\nqualified to conduct business and is in both corporate and tax good standing<br \/>\nunder the laws of each jurisdiction in which the nature of its business or the<br \/>\nownership or leasing of its properties requires such qualification. Merger Sub<br \/>\nhas the requisite corporate power and authority to own and operate its<br \/>\nproperties and assets and to carry on its business as currently conducted.<br \/>\nMerger Sub was created solely to effect the Transactions.<\/p>\n<p>         6.2      INVESTMENT REPRESENTATIONS.<\/p>\n<p>                  (a) Purchaser understands that the Stock has not been<br \/>\nregistered under the Securities Act. Purchaser also understands that the Stock<br \/>\nis being offered and sold pursuant to an exemption from registration contained<br \/>\nin the Securities Act based in part upon Purchaser&#8217;s representations contained<br \/>\nin this Section 6.2.<\/p>\n<p>                  (b) Purchaser is entering into the Transactions for<br \/>\nPurchaser&#8217;s own account for investment only, and not with the current intention<br \/>\nof making a public distribution of the Stock.<\/p>\n<p>                                       27<\/p>\n<p>                  (c) Purchaser represents that by reason of its, or of its<br \/>\nmanagement&#8217;s business or financial experience, Purchaser has the capacity to<br \/>\nprotect its own interests in connection with the Transactions contemplated in<br \/>\nthis Agreement and the other Transactional Agreements. Purchaser is able to bear<br \/>\nthe loss of its entire investment in the Company. Purchaser is not a<br \/>\ncorporation, partnership or other entity specifically formed for the purpose of<br \/>\nconsummating this transaction.<\/p>\n<p>                  (d) Purchaser is an &#8220;accredited investor&#8221; as that term is<br \/>\ndefined in Rule 501(a) of Regulation D promulgated under to the Securities Act.<\/p>\n<p>         6.3      PURCHASER STOCK.<\/p>\n<p>         The Purchaser Stock to be issued to the Selling Stockholders and upon<br \/>\nexercise of the Company Options assumed by Purchaser, when issued in connection<br \/>\nwith this Agreement and the other Transactional Agreements, will be duly<br \/>\nauthorized, validly issued and nonassessable.<\/p>\n<p>         6.4      AUTHORITY; BINDING NATURE OF AGREEMENTS.<\/p>\n<p>                  (a) The execution, delivery and performance of this Agreement,<br \/>\nthe Transactional Agreements, and all other agreements and instruments<br \/>\ncontemplated to be executed and delivered by Purchaser or Merger Sub, as the<br \/>\ncase may be, in connection herewith have been duly authorized by all necessary<br \/>\naction on the part of Purchaser and Merger Sub and their respective board of<br \/>\ndirectors.<\/p>\n<p>                  (b) This Agreement, the Transactional Agreements, and all<br \/>\nother agreements and instruments contemplated to be executed and delivered by<br \/>\nPurchaser and Merger Sub each constitute the legal, valid and binding obligation<br \/>\nof Purchaser and Merger Sub, enforceable against Purchaser and Merger Sub in<br \/>\naccordance with their terms, except to the extent that enforceability may be<br \/>\nlimited by applicable bankruptcy, reorganization, insolvency, moratorium or<br \/>\nother laws affecting the enforcement of creditors&#8217; rights generally and by<br \/>\ngeneral principles of equity regardless of whether such enforceability is<br \/>\nconsidered in a proceeding in law or equity.<\/p>\n<p>         6.5      NON-CONTRAVENTION; CONSENTS.<\/p>\n<p>         The execution and delivery of this Agreement and the other<br \/>\nTransactional Agreements, and the consummation of the Transactions, by Purchaser<br \/>\nand Merger Sub will not, directly or indirectly (with or without notice or lapse<br \/>\nof time):<\/p>\n<p>                  (a) contravene, conflict with or result in a material<br \/>\nviolation of (i) Purchaser and Merger Sub&#8217;s Certificate of Incorporation or<br \/>\nbylaws, or (ii) any resolution adopted by Purchaser and Merger Sub Board or any<br \/>\ncommittee thereof or the stockholders of Purchaser and Merger Sub;<\/p>\n<p>                  (b) contravene, conflict with or result in a material<br \/>\nviolation of, or give any Governmental Body the right to challenge any of the<br \/>\nTransactions or to exercise any remedy or obtain any relief under, any legal<br \/>\nrequirement or any Order to which Purchaser and Merger Sub or any material<br \/>\nassets owned or used by it are subject;<\/p>\n<p>                                       28<\/p>\n<p>                  (c) cause any material assets owned or used by Purchaser and<br \/>\nMerger Sub to be reassessed or revalued by any taxing authority or other<br \/>\nGovernmental Body;<\/p>\n<p>                  (d) contravene, conflict with or result in a material<br \/>\nviolation of any of the terms or requirements of, or give any Governmental Body<br \/>\nthe right to revoke, withdraw, suspend, cancel, terminate or modify, any<br \/>\nGovernmental Authorization that is held by Purchaser or Merger Sub or any of<br \/>\ntheir respective employees or that otherwise relates to Purchaser and Merger<br \/>\nSub&#8217;s business or to any of the material assets owned or used by Purchaser and<br \/>\nMerger Sub;<\/p>\n<p>                  (e) contravene, conflict with or result in a material<br \/>\nviolation or material breach of, or material default under, any Purchaser<br \/>\nContract;<\/p>\n<p>                  (f) give any Person the right to any payment by Purchaser or<br \/>\nMerger Sub or give rise to any acceleration or change in the award, grant,<br \/>\nvesting or determination of options, warrants, rights, severance payments or<br \/>\nother contingent obligations of any nature whatsoever of Purchaser or Merger Sub<br \/>\nin favor of any Person, in any such case as a result of the change in control of<br \/>\nMerger Sub or otherwise resulting from the Transactions; or<\/p>\n<p>                  (g) result in the imposition or creation of any material<br \/>\nencumbrance upon or with respect to any material asset owned or used by<br \/>\nPurchaser and Merger Sub.<\/p>\n<p>Except as set forth in Part 6.5 of the Purchaser Disclosure Schedule and as<br \/>\ncontemplated in this Agreement and the other Transactional Agreements, Purchaser<br \/>\nand Merger Sub will not be required to make any filing with or give any notice<br \/>\nto, or obtain any Consent from, any Person in connection with the execution and<br \/>\ndelivery of this Agreement and the other Transactional Agreements or the<br \/>\nconsummation or performance of any of the Transactions.<\/p>\n<p>         6.6      FINDERS AND BROKERS.<\/p>\n<p>         Purchaser and Merger Sub will indemnify the Selling Stockholders and<br \/>\nthe Company and hold them harmless from any liability or expense arising from<br \/>\nany claim for brokerage commissions, finder&#8217;s fees or other similar compensation<br \/>\nbased upon any agreement, arrangement or understanding made by or on behalf of<br \/>\nPurchaser or Merger Sub.<\/p>\n<p>         6.7      REPORTS AND FINANCIAL STATEMENTS; ABSENCE OF CERTAIN CHANGES.<\/p>\n<p>                  (a) Purchaser has filed all reports required to be filed with<br \/>\nthe SEC pursuant to the Exchange Act, if any, since its initial public offering<br \/>\non December 9, 1998 (all such reports, including those to be filed prior to the<br \/>\nClosing Date, collectively, the &#8220;PURCHASER SEC REPORTS&#8221;), and has previously<br \/>\nfurnished or made available to the Company true and complete copies of all the<br \/>\nPurchaser SEC Reports filed, if any, with respect to periods ending after<br \/>\nDecember 9, 1998 (including any exhibits thereto) and will promptly deliver to<br \/>\nthe Company any Purchaser SEC Reports filed between the date hereof and the<br \/>\nEffective Time. All of such Purchaser SEC Reports complied at the time they were<br \/>\nfiled in all material respects with applicable requirements of the Securities<br \/>\nAct and the Exchange Act and the rules and regulations thereunder. None of such<br \/>\nPurchaser SEC Reports, as of their respective dates (as amended through the date<br \/>\nhereof), contained or, with respect to Purchaser SEC Reports filed after the<br \/>\ndate hereof, will contain any untrue statement of a material fact or omitted<br \/>\nor, with respect to Purchaser SEC Reports filed <\/p>\n<p>                                       29<\/p>\n<p>after the date hereof, will omit to state a material fact required to be<br \/>\nstated therein or necessary to make the statements therein, in light of the<br \/>\ncircumstances under which they were made, not misleading. The audited<br \/>\nfinancial statements of Purchaser included in the Purchaser SEC Reports<br \/>\ncomply in all material respects with the published rules and regulations of<br \/>\nthe SEC with respect thereto, and such audited financial statements (i) were<br \/>\nprepared from the books and records of Purchaser, (ii) were prepared in<br \/>\naccordance with GAAP applied on a consistent basis (except as may be<br \/>\nindicated therein or in the notes or schedules thereto) and (iii) present<br \/>\nfairly the financial position of Purchaser as of the dates thereof and the<br \/>\nresults of operations and cash flows for the periods then ended. The<br \/>\nunaudited financial statements included in the Purchaser SEC Reports comply<br \/>\nin all material respects with the published rules and regulations of the SEC<br \/>\nwith respect thereto; and such unaudited financial statements (i) were<br \/>\nprepared from the books and records of Purchaser, (ii) were prepared in<br \/>\naccordance with GAAP, except as otherwise permitted under the Exchange Act<br \/>\nand the rules and regulations thereunder, on a consistent basis (except as<br \/>\nmay be indicated therein or in the notes or schedules thereto) and (iii)<br \/>\npresent fairly the financial position of Purchaser as of the dates thereof<br \/>\nand the results of operations and cash flows (or changes in financial<br \/>\ncondition) for the periods then ended, subject to normal year-end adjustments<br \/>\nand any other adjustments described therein or in the notes or schedules<br \/>\nthereto. The foregoing representations and warranties shall also be deemed to<br \/>\nbe made with respect to all filings made with the SEC on or before the<br \/>\nEffective Time.<\/p>\n<p>                  (b) Except as specifically contemplated by this Agreement or<br \/>\nreflected in the Purchaser SEC Reports, since March 31, 1999 there has not been<br \/>\n(i) any change or event having a Purchaser Material Adverse Effect, (ii) any<br \/>\ndeclaration, setting aside or payment of any dividend or distribution with<br \/>\nrespect to the common stock of Purchaser other than consistent with past<br \/>\npractices, or (iii) any material change in Purchaser&#8217;s accounting principles,<br \/>\nprocedures or methods.<\/p>\n<p>         6.8      COMPLIANCE WITH APPLICABLE LAW.<\/p>\n<p>         Except as disclosed in the Purchaser SEC Reports filed prior to the<br \/>\ndate of this Agreement, Purchaser holds all licenses, franchises, permits,<br \/>\nvariances, exemptions, orders, approvals and authorizations necessary for the<br \/>\nlawful conduct of its business under and pursuant to, and the business of<br \/>\nPurchaser is not being conducted in violation of, any provision of any federal,<br \/>\nstate, local or foreign statute, law, ordinance, rule, regulation, judgment,<br \/>\ndecree, order, concession, grant, franchise, permit or license or other<br \/>\ngovernmental authorization or approval applicable to Purchaser, except to the<br \/>\nextent that the failure or violation would not in the aggregate have a Purchaser<br \/>\nMaterial Adverse Effect.<\/p>\n<p>         6.9      COMPLETE COPIES OF REQUESTED REPORTS.<\/p>\n<p>         Purchaser has delivered or made available (through public sources or<br \/>\ndirectly) true and complete copies of each document that has been reasonably<br \/>\nrequested by the Company or its counsel in connection with their legal and<br \/>\naccounting review of Purchaser.<\/p>\n<p>                                       30<\/p>\n<p>         6.10     CONTRACTS.<\/p>\n<p>                  (a) Except as set forth in Part 6.10 of the Purchaser<br \/>\nDisclosure Schedule, no Purchaser Contracts have come into existence since March<br \/>\n31, 1999, that have not previously been filed with the SEC, that will be<br \/>\nrequired to be filed as exhibits to Purchaser&#8217;s Quarterly Report on Form 10-Q<br \/>\nfor the quarter ended June 30, 1999.<\/p>\n<p>                  (b) Purchaser has previously made available for inspection and<br \/>\ncopying to the Company complete and correct copies (or, in the case of oral<br \/>\ncontracts, a complete and correct description) of each Purchaser Contract (and<br \/>\nany amendments or supplements thereto) listed on Part 6.10 of the Purchaser<br \/>\nDisclosure Schedule. Except as set forth on Part 6.10 of the Purchaser<br \/>\nDisclosure Schedule, (i) each Purchaser Contract (including any Purchaser<br \/>\nContract filed with the Purchaser SEC Reports) listed is in full force and<br \/>\neffect, (ii) neither Purchaser nor, to its knowledge, any other party is in<br \/>\nmaterial default under any such Purchaser Contract, and no event has occurred<br \/>\nwhich constitutes, or with the lapse of time or the giving of notice or both<br \/>\nwould constitute, a material default, (iii) to the knowledge of Purchaser, there<br \/>\nare no material disputes or disagreements between Purchaser and any other party<br \/>\nwith respect to any such Purchaser Contract and (iv) each other party to each<br \/>\nsuch Purchaser Contract has consented or been given notice (or prior to the<br \/>\nClosing Date shall have consented or been given notice), where such consent or<br \/>\nthe giving of such notice is necessary, sufficient that such Purchaser Contract<br \/>\nshall remain in full force and effect following the consummation of the<br \/>\nTransactions, without material modification in the rights or obligations of<br \/>\nPurchaser thereunder.<\/p>\n<p>         6.11     TAX MATTERS.<\/p>\n<p>                  (a) Except with respect to the NBC Transactions, Purchaser has<br \/>\nno plan or intention to cause the Company to issue additional shares of stock<br \/>\nafter the Merger, or take any other action, that would result in the Purchaser<br \/>\nlosing Control of the Company.<\/p>\n<p>                  (b) Purchaser has no plan or intention, following the Merger,<br \/>\nto liquidate the Company; to merge the Company with or into any other<br \/>\ncorporation; to sell, distribute or otherwise dispose of the capital stock of<br \/>\nthe Company; or to cause the Company to sell or otherwise dispose of any of its<br \/>\nassets (or of any of the assets acquired from Merger Sub) except for<br \/>\ndispositions made in the Ordinary Course of Business or transfers permitted<br \/>\nunder Section 368(a)(2)(C) of the Code or prescribed by Treasury Regulations<br \/>\nunder Section 368 of the Code.<\/p>\n<p>                  (c) Following the Merger, the historic business of the Company<br \/>\nwill be continued, or a significant portion of the Company&#8217;s historic business<br \/>\nassets will be used in a business.<\/p>\n<p>                  (d) Neither the Purchaser nor any &#8220;related person&#8221; with<br \/>\nrespect to Purchaser (within the meaning of Treasury Regulations Section<br \/>\n1.368-1(e)(3)) owns or has at any time during the past years owned any capital<br \/>\nstock of the Company.<\/p>\n<p>                  (e) Except for (I) repurchases or redemptions of Purchaser<br \/>\nStock that are consistent with past practices and purchase programs that were<br \/>\nnot created or modified in connection with the Merger, (II) possible repurchases<br \/>\nof unvested shares of employees or consultants in connection with the<br \/>\ntermination of their services, and (III) possible reacquisitions <\/p>\n<p>                                       31<\/p>\n<p>of Purchaser Stock pursuant to the Escrow Agreement, neither the Purchaser or<br \/>\nany &#8220;related person&#8221; with respect to the Purchaser (within the meaning of<br \/>\nTreasury Regulations Section 1.368-1(e)(3)) has any plan or intention to<br \/>\nrepurchase or redeem any of the Purchaser Stock to be issued in the Merger in<br \/>\nexchange for shares of Company capital stock.<\/p>\n<p>                  (f) Purchaser is not an investment company for purposes of<br \/>\nSection 368(a)(2)(F) of the Code.<\/p>\n<p>7.       PRE-CLOSING COVENANTS OF THE COMPANY AND THE SELLING STOCKHOLDERS.<\/p>\n<p>         7.1      CORPORATE PROCEEDINGS; STOCKHOLDER APPROVAL.<\/p>\n<p>         The Company shall (i) ensure that resolutions (in form satisfactory to<br \/>\nPurchaser) of the Company Board approving or adopting, as applicable, all<br \/>\nnecessary further action of the Company Board, this Agreement, the other<br \/>\nTransactional Agreements and the Transactions and recommending approval by the<br \/>\nCompany&#8217;s stockholders of the Agreement, the other Transactional Agreements and<br \/>\nthe Transactions, are passed as necessary pursuant to applicable law, and (ii)<br \/>\nuse Best Efforts to ensure that the stockholders of the Company take all<br \/>\nnecessary action to approve or adopt, as applicable, the Merger. In furtherance,<br \/>\nand not in limitation of the foregoing:<\/p>\n<p>                  (a) the Company, acting through the Company Board, shall, in<br \/>\naccordance with all applicable legal requirements and its Certificate of<br \/>\nIncorporation and Bylaws (i) promptly and duly call, give notice of, convene and<br \/>\nhold as soon as practicable a meeting (or solicit an action by written consent<br \/>\nin lieu thereof) of its stockholders for the purpose of voting to approve and<br \/>\nadopt the Merger and this Agreement and the other Transactional Agreements to<br \/>\nwhich the Company is a party, and (ii) recommend approval and adoption of the<br \/>\nMerger and this Agreement and the other Transactional Agreements to which the<br \/>\nCompany is a party by the Company&#8217;s stockholders and include in the Information<br \/>\nStatement such recommendation, and take all lawful action to solicit such<br \/>\napproval. The Company shall consult with Purchaser as to the timing and<br \/>\nprocedures of such meeting (or consent solicitation); and<\/p>\n<p>                  (b) the Company will cooperate fully with respect to all<br \/>\nrequests by Purchaser to facilitate the preparation and mailing of the<br \/>\nInformation Statement. The Company shall furnish Purchaser with all information<br \/>\nconcerning the Company, its capital stock, the Selling Stockholders, the holders<br \/>\nof the Company Options and other matters, and shall take all other actions, as<br \/>\nPurchaser may reasonably request in connection with the Information Statement.<br \/>\nSuch information provided by the Company shall not contain any untrue statement<br \/>\nof a material fact or omit to state any material fact required to be stated<br \/>\ntherein or necessary to make the statements therein not misleading. Whenever the<br \/>\nCompany obtains any knowledge of any event which should be set forth in an<br \/>\namendment or a supplement to the Information Statement, the Company will<br \/>\npromptly inform Purchaser and will cooperate in mailing to the Selling<br \/>\nStockholders such amendment or supplement.<\/p>\n<p>                                       32<\/p>\n<p>         7.2      ACCESS AND INVESTIGATION.<\/p>\n<p>         The Company shall ensure that, at all times during the Pre-Closing<br \/>\nPeriod:<\/p>\n<p>                  (a) The Company and its representatives provide Purchaser and<br \/>\nits representatives with such copies of existing books, records, Tax Returns,<br \/>\nwork papers and other documents and information relating to the Company as<br \/>\nPurchaser may reasonably request in good faith; and<\/p>\n<p>                  (b) The Company and its representatives compile and provide<br \/>\nPurchaser and its representatives with such additional financial, operating and<br \/>\nother data and information regarding the Company as Purchaser may reasonably<br \/>\nrequest in good faith.<\/p>\n<p>         7.3      OPERATION OF BUSINESS.<\/p>\n<p>         Except as otherwise contemplated by this Agreement and Section 5.3(b)<br \/>\nof the Company Disclosure Schedule, the Company shall ensure that, during the<br \/>\nPre-Closing Period:<\/p>\n<p>                  (a) the Company conducts its operations in the Ordinary Course<br \/>\nof Business and in the same manner as such operations have been conducted prior<br \/>\nto the date of this Agreement;<\/p>\n<p>                  (b) the Company preserves intact its current business<br \/>\norganization, keeps available the services of its current officers and employees<br \/>\nand maintains its relations and goodwill with all suppliers, customers,<br \/>\nlandlords, creditors, licensors, licensees, employees and other Persons having<br \/>\nbusiness relationships with the Company;<\/p>\n<p>                  (c) the Company keeps in full force all insurance policies<br \/>\nidentified in Part 5.18 of the Company Disclosure Schedule;<\/p>\n<p>                  (d) the Company&#8217;s officers confer regularly with Purchaser<br \/>\nconcerning operational matters and otherwise report regularly to Purchaser<br \/>\nconcerning the status of the Company&#8217;s business, condition, assets, liabilities,<br \/>\noperations, financial performance and prospects;<\/p>\n<p>                  (e) the Company immediately notifies Purchaser of any inquiry,<br \/>\nproposal or offer from any Person relating to any Acquisition Transaction;<\/p>\n<p>                  (f) the Company does not declare, accrue, set aside or pay any<br \/>\ndividend or make any other distribution in respect of any shares of capital<br \/>\nstock, and does not repurchase, redeem or otherwise reacquire any shares of<br \/>\ncapital stock or other securities, except for shares for which the Company has a<br \/>\nrepurchase right under the Option Plan;<\/p>\n<p>                  (g) the Company does not sell or otherwise issue (or grant any<br \/>\nwarrants, options or other rights to purchase) any shares of capital stock or<br \/>\nany other securities, other than options to purchase up to the number of shares<br \/>\nof Common Stock pursuant to the Option Plan set forth on SCHEDULE II attached<br \/>\nhereto, or unless approved in advance in writing by Purchaser;<\/p>\n<p>                  (h) the Company does not amend its Certificate of<br \/>\nIncorporation or Bylaws, and does not effect or become a party to any<br \/>\nAcquisition Transaction, recapitalization, <\/p>\n<p>                                       33<\/p>\n<p>reclassification of shares, stock split, reverse stock split or similar<br \/>\ntransaction, or enter into any transaction or take any other action of the<br \/>\ntype referred to in Section 5.20(c) through (n);<\/p>\n<p>                  (i) the Company does not form any subsidiary or acquire any<br \/>\nequity interest or other interest in any other Entity;<\/p>\n<p>                  (j) the Company does not make any capital expenditure, except<br \/>\nfor capital expenditures made in the Ordinary Course of Business that, when<br \/>\nadded to all other capital expenditures made on behalf of the Company during the<br \/>\nPre-Closing Period, do not exceed $25,000, unless approved in advance in writing<br \/>\nby Purchaser;<\/p>\n<p>                  (k) the Company does not enter into, or permit any of the<br \/>\nmaterial assets owned or used by the Company to become bound by, any Contract;<\/p>\n<p>                  (l) the Company does not incur, assume or otherwise become<br \/>\nsubject to any Liability, except for current liabilities incurred in the<br \/>\nOrdinary Course of Business, unless approved in advance in writing by Purchaser;<\/p>\n<p>                  (m) the Company does not establish or adopt any Employee<br \/>\nBenefit Plan, and does not pay any bonus or make any profit-sharing or similar<br \/>\npayment to, or materially increase the amount of the wages, salary, commissions,<br \/>\nfringe benefits or other compensation or remuneration payable to, any of its<br \/>\ndirectors, officers or employees;<\/p>\n<p>                  (n) the Company does not change any of its methods of<br \/>\naccounting or accounting practices in any respect;<\/p>\n<p>                  (o) the Company does not make any Tax election;<\/p>\n<p>                  (p) the Company does not commence any Proceeding without the<br \/>\nprior written consent of Purchaser; and<\/p>\n<p>                  (q) the Company does not agree, commit or offer (in writing or<br \/>\notherwise) or attempt to take any of the actions described in the preceding<br \/>\nclauses of this Section 7.3.<\/p>\n<p>         7.4      FILINGS AND CONSENTS.<\/p>\n<p>         The Company and the Holder Representative shall ensure that:<\/p>\n<p>                  (a) each filing or notice required to be made or given<br \/>\n(pursuant to any applicable legal requirement, Order or Contract, or otherwise)<br \/>\nby the Company or the Selling Stockholders in connection with the execution and<br \/>\ndelivery of any of the Transactional Agreements or in connection with the<br \/>\nconsummation or performance of any of the Transactions (including each of the<br \/>\nfilings and notices identified in Part 5.5 of the Company Disclosure Schedule)<br \/>\nis made or given as soon as possible after the date of this Agreement;<\/p>\n<p>                  (b) each Consent required to be obtained (pursuant to any<br \/>\napplicable legal requirement, Order or Contract, or otherwise) by the Company or<br \/>\nthe Selling Stockholders in connection with the execution and delivery of any of<br \/>\nthe Transactional Agreements or in <\/p>\n<p>                                       34<\/p>\n<p>connection with the consummation or performance of any of the Transactions<br \/>\n(including each of the Consents identified in Part 5.5 of the Company<br \/>\nDisclosure Schedule) is obtained as soon as possible after the date of this<br \/>\nAgreement and remains in full force and effect through the Closing Date;<\/p>\n<p>                  (c) the Company promptly delivers to Purchaser a copy of each<br \/>\nfiling made, each notice given and each Consent obtained by the Company or the<br \/>\nSelling Stockholders during the Pre-Closing Period; and<\/p>\n<p>                  (d) during the Pre-Closing Period, the Company and its<br \/>\nrepresentatives cooperate with Purchaser and with Purchaser&#8217;s representatives,<br \/>\nand prepare and make available such documents and take such other actions as<br \/>\nPurchaser may request in good faith, in connection with any filing, notice or<br \/>\nConsent that Purchaser or Merger Sub is required or elects to make, give or<br \/>\nobtain.<\/p>\n<p>         7.5      NOTIFICATION; UPDATES TO COMPANY DISCLOSURE SCHEDULE.<\/p>\n<p>                  (a) During the Pre-Closing Period, the Company and the Holder<br \/>\nRepresentative shall promptly notify Purchaser in writing of:<\/p>\n<p>                           (i)      the discovery by the Company or the Selling<br \/>\nStockholders of any event, condition, fact or circumstance that constitutes a<br \/>\nmaterial breach of any representation or warranty made by the Company or the<br \/>\nSelling Stockholders in this Agreement or in any of the other Transactional<br \/>\nAgreements; and<\/p>\n<p>                           (ii)     any event, condition, fact or circumstance<br \/>\nthat may make the timely satisfaction of any of the conditions set forth in<br \/>\nSection 4.1 impossible or unlikely.<\/p>\n<p>                  (b) If any event, condition, fact or circumstance that is<br \/>\nrequired to be disclosed pursuant to Section 7.5(a) requires any change in the<br \/>\nCompany Disclosure Schedule or Information Statement, or if any such event,<br \/>\ncondition, fact or circumstance would require such a change assuming the Company<br \/>\nDisclosure Schedule were dated as of the date of the occurrence, existence or<br \/>\ndiscovery of such event, condition, fact or circumstance, then the Company and<br \/>\nthe Selling Stockholders shall promptly deliver to Purchaser an update to the<br \/>\nCompany Disclosure Schedule (a &#8220;COMPANY DISCLOSURE SCHEDULE UPDATE&#8221;) or to the<br \/>\nInformation Statement (an &#8220;INFORMATION STATEMENT UPDATE&#8221;) specifying such<br \/>\nchange. Such Company Disclosure Schedule Update or Information Statement Update<br \/>\nshall be deemed to supplement or amend the Company Disclosure Schedule or<br \/>\nInformation Statement for the purpose of (i) determining the accuracy of any of<br \/>\nthe representations and warranties made by the Company or the Selling<br \/>\nStockholders in this Agreement or any of the Transactional Agreements as of the<br \/>\nClosing or (ii) determining whether the conditions set forth in Section 4.1 have<br \/>\nbeen satisfied, unless objected to in writing by Purchaser.<\/p>\n<p>         7.6      NO NEGOTIATION.<\/p>\n<p>         Neither the Company nor the Selling Stockholders nor any of their<br \/>\nrespective employees, directors, representatives, affiliates or advisors<br \/>\n(including, without limitation, legal, accounting, <\/p>\n<p>                                       35<\/p>\n<p>financial and investment banking advisors) will directly or indirectly on<br \/>\nbehalf of the Company or the Selling Stockholders:<\/p>\n<p>                  (a) enter into any agreement (or grant any option or right) to<br \/>\nsell, transfer or otherwise dispose of the shares of capital stock or the assets<br \/>\nof the Company or issue any controlling interest in shares of capital stock of<br \/>\nthe Company, directly or indirectly, to any person other than Company Options<br \/>\nand shares issuable upon exercise of the Company Options in the ordinary course;<\/p>\n<p>                  (b) hold any discussion with, or provide any information to,<br \/>\nany person concerning the Company in connection therewith or provide any<br \/>\ninformation to, any person concerning the Company in connection therewith; or<\/p>\n<p>                  (c) respond to any inquiry made by any person concerning a<br \/>\nproposed acquisition of any assets or capital stock of the Company, except to<br \/>\nadvise such person that the Company has entered into this Agreement. The Company<br \/>\nand the Holder Representative, on behalf of the Selling Stockholders, further<br \/>\nagree to advise Purchaser immediately upon receiving any inquiry from any such<br \/>\nperson. If the Company receives a bona fide offer concerning a proposed<br \/>\nacquisition of any assets or capital stock of the Company, the Company shall, in<br \/>\naddition to notifying Purchaser of the receipt of such offer, identify the<br \/>\nidentity of the proposed buyer.<\/p>\n<p>         7.7      BEST EFFORTS.<\/p>\n<p>         During the Pre-Closing Period, the Company and the Selling Stockholders<br \/>\nshall (i) use their Best Efforts to (i) cause the conditions set forth in<br \/>\nSection 4.1 to be satisfied on a timely basis and (ii) complete the unaudited<br \/>\nbalance sheet of the Company as of June 30, 1999, and the related unaudited<br \/>\nstatement of operations, changes in stockholders&#8217; equity and cash flows of the<br \/>\nCompany for the three (3) and six (6) months then ended, and shall not take any<br \/>\naction or omit to take any action, the taking or omission of which would or<br \/>\ncould reasonably be expected to result in any of the representations and<br \/>\nwarranties set forth in Section 5 of this Agreement becoming untrue, in any of<br \/>\nthe conditions of Closing set forth in Section 4.1 not being satisfied or in the<br \/>\nbusiness of the Company becoming materially less valuable.<\/p>\n<p>8.       PRE-CLOSING COVENANTS OF PURCHASER.<\/p>\n<p>         8.1      CORPORATE PROCEEDINGS.<\/p>\n<p>                  (a) Purchaser shall ensure that resolutions (in form<br \/>\nsatisfactory to Purchaser) of the Purchaser Board approving or adopting, as<br \/>\napplicable, all necessary further action of the Purchaser Board, this Agreement,<br \/>\nthe other Transactional Agreements and the Transactions and, if required,<br \/>\nrecommending approval by Purchaser&#8217;s stockholders of the Agreement, the other<br \/>\nTransactional Agreements and the Transactions.<\/p>\n<p>                  (b) Prior to or after the signing of this Agreement, Purchaser<br \/>\nwill prepare an Information Statement (the &#8220;INFORMATION STATEMENT&#8221;), subject to<br \/>\nSection 7.1(b), and use its Best Efforts to cause the Information Statement and<br \/>\nany other disclosure documents deemed appropriate by Purchaser to be mailed to<br \/>\nSelling Stockholders in connection with obtaining the <\/p>\n<p>                                       36<\/p>\n<p>approval of such Selling Stockholders of the Merger and this Agreement and<br \/>\nthe other Transactional Agreements to which Purchaser is a party.<\/p>\n<p>         8.2      ACCESS AND INVESTIGATION.<\/p>\n<p>         Purchaser shall ensure that, at all times during the Pre-Closing<br \/>\nPeriod:<\/p>\n<p>                  (a) Purchaser and its representatives provide the Company and<br \/>\nits representatives with free and complete access at reasonable times to<br \/>\nPurchaser&#8217;s premises and assets and to all existing books, records, Tax Returns,<br \/>\nwork papers and other documents and information relating to Purchaser;<\/p>\n<p>                  (b) Purchaser and its representatives provide the Company and<br \/>\nits representatives with such copies of existing books, records, Tax Returns,<br \/>\nwork papers and other documents and information relating to Purchaser as the<br \/>\nCompany may request in good faith; and<\/p>\n<p>                  (c) Purchaser and its representatives compile and provide the<br \/>\nCompany and its representatives with such additional financial, operating and<br \/>\nother data and information regarding Purchaser as the Company may request in<br \/>\ngood faith.<\/p>\n<p>         8.3      FILINGS AND CONSENTS.<\/p>\n<p>         Purchaser shall ensure that:<\/p>\n<p>                  (a) each filing or notice required to be made or given<br \/>\n(pursuant to any applicable legal requirement, Order or Contract, or otherwise)<br \/>\nby Purchaser or Merger Sub in connection with the execution and delivery of any<br \/>\nof the Transactional Agreements or in connection with the consummation or<br \/>\nperformance of any of the Transactions is made or given as soon as possible<br \/>\nafter the date of this Agreement;<\/p>\n<p>                  (b) each Consent required to be obtained (pursuant to any<br \/>\napplicable legal requirement, Order or Contract, or otherwise) by Purchaser or<br \/>\nMerger Sub in connection with the execution and delivery of any of the<br \/>\nTransactional Agreements or in connection with the consummation or performance<br \/>\nof any of the Transactions is obtained as soon as possible after the date of<br \/>\nthis Agreement and remains in full force and effect through the Closing Date;<\/p>\n<p>                  (c) Purchaser promptly delivers to the Company a copy of each<br \/>\nfiling made, each material notice given and each material Consent obtained by<br \/>\nPurchaser or Merger Sub during the Pre-Closing Period; and<\/p>\n<p>                  (d) during the Pre-Closing Period, Purchaser or Merger Sub and<br \/>\nthe representatives of either cooperate with the Company and its<br \/>\nrepresentatives, and prepare and make available such documents and take such<br \/>\nother actions as the Company may request in good faith, in connection with any<br \/>\nfiling, notice or Consent that the Company is required or elects to make, give<br \/>\nor obtain.<\/p>\n<p>                                       37<\/p>\n<p>         8.4      NOTIFICATION.<\/p>\n<p>         During the Pre-Closing Period, Purchaser or Merger Sub shall promptly<br \/>\nnotify the Company in writing of:<\/p>\n<p>                  (a) the discovery by Purchaser of any event, condition, fact<br \/>\nor circumstance that constitutes a breach of any representation or warranty made<br \/>\nby Purchaser or Merger Sub in this Agreement or in any of the other<br \/>\nTransactional Agreements;<\/p>\n<p>                  (b) any breach of any covenant or obligation of Purchaser or<br \/>\nMerger Sub; and<\/p>\n<p>                  (c) any event, condition, fact or circumstance that may make<br \/>\nthe timely satisfaction of any of the conditions set forth in Section 4.2,<br \/>\nimpossible or unlikely.<\/p>\n<p>         8.5      BEST EFFORTS.<\/p>\n<p>         During the Pre-Closing Period, each of Purchaser or Merger Sub shall<br \/>\nuse its Best Efforts to cause the conditions set forth in Section 4.2 to be<br \/>\nsatisfied on a timely basis, and shall not take any action or omit to take any<br \/>\naction, the taking or omission of which would or could reasonably be expected to<br \/>\nresult in any of the representations and warranties set forth in Section 6 of<br \/>\nthis Agreement becoming untrue or in any of the conditions of Closing set forth<br \/>\nin Section 4.2 not being satisfied.<\/p>\n<p>9.       OTHER AGREEMENTS.<\/p>\n<p>         9.1      REGISTRATION OF COMPANY OPTIONS.<\/p>\n<p>         Purchaser agrees that as soon as reasonably practicable after the<br \/>\nClosing Date, but in no event later than fifteen (15) days following the Closing<br \/>\nDate, it will cause to be filed one or more registration statements on Form S-8<br \/>\nunder the Securities Act, or amendments to its existing registration statements<br \/>\non Form S-8, in order to register, if necessary, the shares of Common Stock of<br \/>\nPurchaser issuable upon exercise of the aforesaid converted Company Options.<\/p>\n<p>9.2      CONFIDENTIALITY.<\/p>\n<p>         Each of the parties hereto hereby agrees to and reaffirms the terms and<br \/>\nprovisions of the Mutual Nondisclosure Agreement by and between Purchaser and<br \/>\nthe Company, dated as of June 15, 1999 (the &#8220;NONDISCLOSURE AGREEMENT&#8221;).<\/p>\n<p>9.3      PUBLIC DISCLOSURE.<\/p>\n<p>         Unless otherwise required by law (including, without limitation,<br \/>\nsecurities laws) or, as to Purchaser, by the rules and regulations of the<br \/>\nNational Association of Securities Dealers, Inc., prior to the Effective Time,<br \/>\nno disclosure (whether or not in response to an inquiry) of the subject matter<br \/>\nof this Agreement or any Transactional Agreement shall be made by any party<br \/>\nhereto unless approved by Purchaser and the Company prior to release; PROVIDED,<br \/>\nthat such approval shall not be unreasonably withheld, PROVIDED, FURTHER, that<br \/>\nthe parties agree and understand that certain disclosures regarding the<br \/>\nTransactions may be made to (i) employees of <\/p>\n<p>                                       38<\/p>\n<p>Purchaser and the Company, (ii) third parties whose consent or approval may<br \/>\nbe required in connection with the Transactions, and (iii) the professional<br \/>\nadvisors of Purchaser, the Company and the Selling Stockholders, in each case<br \/>\nwithout any prior written consent.<\/p>\n<p>         9.4      VALUATION REPORT.<\/p>\n<p>         The Company shall cooperate with Purchaser to prepare a report relating<br \/>\nto the valuation of the Company.<\/p>\n<p>         9.5      NO INCONSISTENT ACTION.<\/p>\n<p>         None of Purchaser, the Company or the Selling Stockholders shall take<br \/>\nany action inconsistent with the treatment of the Merger as a reorganization<br \/>\nunder Section 368(a) of the Code. Notwithstanding any other provision of this<br \/>\nAgreement, the undertaking set forth in this Section 9.5 shall not expire.<\/p>\n<p>         9.6      TERMS OF EMPLOYMENT OF CRITICAL EMPLOYEES.<\/p>\n<p>         Purchaser and the Critical Employees shall agree to the employment<br \/>\nterms set forth in the forms of Employment and Non-Competition Agreement<br \/>\nattached hereto as EXHIBIT D.<\/p>\n<p>         9.7      PATENT OPINIONS.<\/p>\n<p>         The Company and the Holder Representative shall ensure that: (i) within<br \/>\nten (10) days of the Closing Date, a request will have been made to the United<br \/>\nStates Patent and Trademark Office for the prosecution history relating to the<br \/>\npatents specified in Exhibit A to the Escrow Agreement; and (ii) within thirty<br \/>\n(30) days of the Closing Date, the Supplemental Technology Description specified<br \/>\nin the same Exhibit A will have been delivered to the Company&#8217;s patent counsel.<\/p>\n<p>         9.8      EFFECT OF PRE-CLOSING COVENANTS.<\/p>\n<p>         The pre-closing covenants of the Company, the Selling Stockholders and<br \/>\nPurchaser contained in Sections 7 and 8 shall be of no force or effect unless<br \/>\nthe date hereof is not the Closing Date.<\/p>\n<p>10.      TERMINATION.<\/p>\n<p>         10.1     TERMINATION EVENTS.<\/p>\n<p>         This Agreement may be terminated prior to Closing:<\/p>\n<p>                  (a) by Purchaser if there is a material breach of any covenant<br \/>\nor obligation of the Company or the Selling Stockholders under this Agreement or<br \/>\nany of the Transactional Agreements and such breach has not been cured within<br \/>\nten (10) business days of after written notice of such breach is given to the<br \/>\nCompany or the Holder Representative, as appropriate;<\/p>\n<p>                                       39<\/p>\n<p>                  (b) by the Company if there is a material breach of any<br \/>\ncovenant or obligation of Purchaser and such breach has not been cured within<br \/>\nten (10) business days of after written notice of such breach is given to<br \/>\nPurchaser;<\/p>\n<p>                  (c) by the Company pursuant to the provisions specified in<br \/>\nSection 1.3(b)(iii);<\/p>\n<p>                  (d) by either Purchaser or the Company if the Closing has not<br \/>\ntaken place on or before July 31, 1999; or<\/p>\n<p>                  (e) by the mutual consent of Purchaser and the Company.<\/p>\n<p>         10.2     TERMINATION PROCEDURES.<\/p>\n<p>         If Purchaser wishes to terminate this Agreement pursuant to Section<br \/>\n10.1(a) or Section 10.1(d), Purchaser shall deliver to the Selling Stockholders<br \/>\na written notice stating that Purchaser is terminating this Agreement and<br \/>\nsetting forth a brief description of the basis on which Purchaser is terminating<br \/>\nthis Agreement. If the Company wishes to terminate this Agreement pursuant to<br \/>\nSection 10.1(b), Section 10.1(c) or Section 10.1(d), the Company shall deliver<br \/>\nto Purchaser a written notice stating that the Company is terminating this<br \/>\nAgreement and setting forth a brief description of the basis on which the<br \/>\nCompany is terminating this Agreement.<\/p>\n<p>         10.3     EFFECT OF TERMINATION.<\/p>\n<p>         If this Agreement is terminated pursuant to Section 10.1, all further<br \/>\nobligations of the parties under this Agreement shall terminate; PROVIDED, that<br \/>\neach party shall remain liable for any breaches of this Agreement prior to its<br \/>\ntermination and PROVIDED, FURTHER, that Sections 9.2, 9.3, 10, 12.2, 12.3 and<br \/>\n12.11 shall survive the termination of this Agreement.<\/p>\n<p>         10.4     EXCLUSIVITY OF TERMINATION RIGHTS.<\/p>\n<p>         Except to the extent termination occurs due to the bad faith of the<br \/>\nother party, the termination rights and obligations provided in this Section 10<br \/>\nshall be deemed to be exclusive. Subject to the provisions of Section 10.3, the<br \/>\nparties shall not have any other or further Liabilities to or with respect to<br \/>\none another by reason of this Agreement or its termination.<\/p>\n<p>11.      INDEMNIFICATION, ETC.<\/p>\n<p>         11.1     SURVIVAL OF REPRESENTATIONS AND COVENANTS.<\/p>\n<p>                  (a) The representations, warranties, covenants and obligations<br \/>\nof each party (including the Selling Stockholders) set forth in this Agreement,<br \/>\nthe Escrow Agreement, the Investment Agreement and the Registration Rights<br \/>\nAgreement shall survive the Closing Date, and any subsequent Acquisition<br \/>\nTransaction effected by or otherwise involving the Purchaser or the Company, to<br \/>\nthe extent provided in this Section 11.1(a). All representations and warranties<br \/>\n(as well as covenants and obligations to be performed prior to the Closing Date)<br \/>\nof the parties in this Agreement, the Escrow Agreement, the Investment Agreement<br \/>\nand the Registration Rights Agreement shall terminate and have no further force<br \/>\nor effect on the Indemnification <\/p>\n<p>                                       40<\/p>\n<p>Termination Date, unless earlier terminated pursuant to Section 10.1;<br \/>\nPROVIDED, HOWEVER, that any representation or warranty made herein or in the<br \/>\nEscrow Agreement, the Investment Agreement or the Registration Rights<br \/>\nAgreement, (i) the breach of which resulted from the commission of fraud or<br \/>\nan intentional misrepresentation or omission by a Selling Stockholder or (ii)<br \/>\nwhich a Selling Stockholder knew was false when made (each such Selling<br \/>\nStockholder referred to in clause (i) and (ii) above, shall be referred to<br \/>\nherein as a &#8220;RESPONSIBLE STOCKHOLDER&#8221;), shall, solely with respect to such<br \/>\nResponsible Stockholder and in connection with such Responsible Stockholder&#8217;s<br \/>\nindemnification obligations under Section 11 hereof, terminate and have no<br \/>\nfurther force or effect on the second anniversary of the Closing Date, and<br \/>\nany covenants or obligations under this Agreement or any of the other<br \/>\nTransactional Agreements to be performed after the Closing shall survive the<br \/>\nClosing as required for the completion of such covenants or obligations.<\/p>\n<p>                  (b) The representations, warranties, covenants and obligations<br \/>\nof the respective parties, and the rights and remedies that may be exercised by<br \/>\nany of them, shall not be limited or otherwise affected by or as a result of any<br \/>\ninformation furnished to, or any investigation made by, or the knowledge of, any<br \/>\nof the parties or any of their respective representatives.<\/p>\n<p>                  (c) For purposes of this Agreement, although each statement or<br \/>\nother item of information set forth in the Company Disclosure Schedule qualifies<br \/>\nthe specific representation and warranty to which such information refers, all<br \/>\nsuch statements and other items of information set forth in the Company<br \/>\nDisclosure Schedule shall be deemed to be a representation and warranty made by<br \/>\nthe Company in this Agreement.<\/p>\n<p>                  (d) The representations, warranties, covenants and obligations<br \/>\nof the Company or the Selling Stockholders in this Agreement or any other<br \/>\nTransactional Agreement (other than the Employment and Non-Competition<br \/>\nAgreements) are made to Purchaser and for the benefit of each Indemnitee (as<br \/>\ndefined in Section 11.2(a) below).<\/p>\n<p>         11.2     INDEMNIFICATION BY THE SELLING STOCKHOLDERS.<\/p>\n<p>                  (a) Subject to the remainder of this Section 11.2 and Section<br \/>\n11.7, and to the extent of each Selling Stockholder&#8217;s pro rata share of the<br \/>\nIndemnification Portion, the Selling Stockholders covenant and agree to defend,<br \/>\nindemnify and hold harmless Purchaser, and each of its officers, directors,<br \/>\nemployees, agents and representatives (collectively, the &#8220;INDEMNITEES&#8221; and<br \/>\nindividually each an &#8220;INDEMNITEE&#8221;) from and against, and shall compensate and<br \/>\nreimburse each of the Indemnitees for, any Damages which are suffered or<br \/>\nincurred by any of the Indemnitees (regardless of whether or not such Damages<br \/>\nrelate to any third party claim) directly or indirectly arising or resulting<br \/>\nfrom or connected with any breach of any representation or warranty made by the<br \/>\nCompany or the Selling Stockholders in this Agreement, the Escrow Agreement, the<br \/>\nInvestment Agreement or the Registration Rights Agreement. Notwithstanding the<br \/>\nforegoing, each Responsible Stockholder shall be liable up to such Responsible<br \/>\nStockholder&#8217;s pro rata share of the Merger Consideration for Damages resulting<br \/>\nfrom (i) the commission of fraud or an intentional misrepresentation or omission<br \/>\nby such Responsible Stockholder in connection with the representations and<br \/>\nwarranties contained in this Agreement, the Escrow Agreement, the Investment<br \/>\nAgreement or the Registration Rights Agreement or (ii) the breach of any<br \/>\nrepresentation or warranty contained in this Agreement, the Escrow Agreement,<br \/>\nthe Investment <\/p>\n<p>                                       41<\/p>\n<p>Agreement or the Registration Rights Agreement which such Responsible<br \/>\nStockholder knew was false when made.<\/p>\n<p>                  (b) From and after the Closing Date, the Selling Stockholders<br \/>\nshall protect, defend, indemnify and hold harmless the Indemnitees from any and<br \/>\nall Taxes (including without limitation any obligation to contribute to the<br \/>\npayment of any Taxes determined on a consolidated, combined or unitary basis<br \/>\nwith respect to a group of corporations that includes or included the Company)<br \/>\nthat are (i) imposed on Purchaser or any member (other than the Company) of any<br \/>\nconsolidated, unitary or combined group that includes or included the Company<br \/>\nand (ii) imposed on the Company in respect of its income, business, property or<br \/>\noperations or for which the Company may otherwise be liable (A) for any<br \/>\nPre-Closing Period, (B) resulting by reason of the several liability of the<br \/>\nCompany pursuant to Treasury Regulations Section 1.1502-6 or any analogous<br \/>\nstate, local or foreign law or regulation or by reason of the Company having<br \/>\nbeen a member of any consolidated, combined or unitary group on or prior to the<br \/>\nClosing Date, (C) in respect of any taxable income included by the Company in a<br \/>\nPost-Closing Period that is attributable to income that is realized in a<br \/>\nPre-Closing Period, including, in each case, the appropriate portion of a<br \/>\nStraddle Period, or (D) in respect of any Post-Closing Period, attributable to<br \/>\nany mandatory change in accounting method employed by the Company during any of<br \/>\nits previous taxable years, or (E) in respect of any Post-Closing Period,<br \/>\nattributable to any items of income or gain of a partnership reporting the<br \/>\nCompany as a partner, to the extent such items are properly attributable to<br \/>\nperiods of the partnership ending on or before the Closing Date; provided,<br \/>\nhowever, that the Selling Stockholder&#8217;s liability under the foregoing provisions<br \/>\nof this paragraph shall be reduced as to any item to the extent that such item<br \/>\nwas either (x) specifically reserved for in the Unaudited Interim Balance Sheet<br \/>\nor (y) satisfied through an estimated Tax payment by the Company after the date<br \/>\nof the Unaudited Interim Balance Sheet, provided that such payment is<br \/>\nattributable to a Post-Closing Period and, on or before the Closing, the Company<br \/>\nprovides satisfactory evidence of such payment to Purchaser. Notwithstanding<br \/>\nanything to the contrary contained in this Agreement, (i) the representations,<br \/>\nwarranties and covenants of the Company and the Selling Stockholders set forth<br \/>\nin Sections 5.14 and 12.4 hereof shall survive the execution and delivery hereof<br \/>\nand the Closing and continue until the expiration of the applicable statute of<br \/>\nlimitations date (or any extensions thereof) and (ii) the aggregate liability of<br \/>\neach Selling Stockholder under this Section 11.2(b) shall not exceed such<br \/>\nSelling Stockholder&#8217;s pro rata share of the Merger Consideration.<\/p>\n<p>                  (c) After Closing, no Person shall be required to indemnify<br \/>\nany Indemnitee with respect to any claim for indemnification pursuant to Section<br \/>\n11.2(a) and 11.2(b) unless and until the aggregate amount of indemnifiable<br \/>\nDamages suffered by all Indemnitees subject to indemnification pursuant to this<br \/>\nAgreement exceeds $100,000 (the &#8220;BASKET&#8221;), and only to the extent such amount<br \/>\nexceeds the Basket. The aggregation of claims must reach the Basket only once,<br \/>\nand after such point the Indemnitees may seek indemnification for all claims in<br \/>\nexcess of the Basket that may arise under this Section 11.2.<\/p>\n<p>                  (d) Claims for indemnification under this Section 11.2 shall<br \/>\nbe made first from the Indemnification Portion Escrow Account. The number of<br \/>\nshares of Purchaser Stock to be released to Purchaser pursuant to the terms of<br \/>\nthe Escrow Agreement shall be calculated by dividing the dollar amount of the<br \/>\nDamages incurred by the Indemnitee by the Average Purchaser Stock Price.<\/p>\n<p>                                       42<\/p>\n<p>                  (e) The Selling Stockholders are not required to make any<br \/>\nindemnification payment hereunder unless a claim is initiated in the manner set<br \/>\nforth in the Escrow Agreement prior to the termination date of such Selling<br \/>\nStockholders&#8217; indemnification obligations specified in Section 11.2(a).<\/p>\n<p>         11.3     TAX INDEMNIFICATION BY PURCHASER.<\/p>\n<p>         Purchaser shall indemnify and hold the Selling Stockholders harmless<br \/>\nfrom and against the following Taxes with respect to the Company: (a) except as<br \/>\ndescribed in Section 11.2(b), any and all Taxes for any taxable period beginning<br \/>\nor deemed to begin after the Closing Date, due or payable by the Company or<br \/>\nPurchaser (except to the extent such Taxes arise or result from a breach of<br \/>\nrepresentations or warranties provided for in Section 5.14 or in Section 3.1 of<br \/>\nthe Investment Agreement); or (b) any and all Taxes attributable to acts or<br \/>\ntransactions of the Company occurring on the Closing Date but after the Closing<br \/>\nand not in the Ordinary Course of Business.<\/p>\n<p>         11.4     NO CONTRIBUTION.<\/p>\n<p>         It is the intention of the parties that after the Closing the remedy<br \/>\nfor Purchaser or any Indemnitee seeking indemnification from the Selling<br \/>\nStockholders hereunder shall be a remedy solely against the Selling Stockholders<br \/>\nand not against the Company; accordingly, the Selling Stockholders agree to<br \/>\nwaive any right of contribution or right of indemnity between the Company and<br \/>\nsuch Selling Stockholder in connection with any indemnification obligation of<br \/>\nsuch Selling Stockholder to any Indemnitee arising under the Transactional<br \/>\nAgreements or otherwise in connection with any of the Transactions. The Selling<br \/>\nStockholders further acknowledge that the waivers, acknowledgments and<br \/>\nagreements of such Selling Stockholders contained in this Section are an<br \/>\nessential inducement to Purchaser in entering into this Agreement and agreeing<br \/>\nto consummate the Transactions.<\/p>\n<p>         11.5     SETOFF.<\/p>\n<p>         In addition to any rights of setoff or other rights that any Person may<br \/>\nhave at common law or otherwise, each Person shall have the right to set off any<br \/>\namount that may be owed to it by the other under this Section 11 against any<br \/>\namount otherwise specifically payable by such Person by the terms of this<br \/>\nAgreement.<\/p>\n<p>         11.6     DEFENSE OF THIRD PARTY CLAIMS.<\/p>\n<p>         In the event of the assertion or commencement by any Person of any<br \/>\nclaim or Proceeding (whether against Purchaser, the Company, the Selling<br \/>\nStockholders, any other Indemnitee or any other Person) with respect to which a<br \/>\nparty hereto may become obligated hereunder to indemnify, hold harmless,<br \/>\ncompensate or reimburse any Indemnitee pursuant to this Section 11, the party to<br \/>\nbe indemnified (the &#8220;INDEMNIFIED PARTY&#8221;) shall reasonably promptly, but in any<br \/>\nevent within thirty (30) days following the Indemnified Party&#8217;s actual knowledge<br \/>\nthereof, notify the Person providing the indemnification hereunder (the<br \/>\n&#8220;INDEMNIFYING PARTY&#8221;) of such claim or Proceeding by providing notice to the<br \/>\nHolder Representative. In any such event, the Indemnified Party may proceed with<br \/>\nthe defense of such claim or Proceeding and the Indemnifying Party shall bear<br \/>\nand pay all reasonable costs and expenses (including attorneys fees and costs)<br \/>\nin <\/p>\n<p>                                       43<\/p>\n<p>connection with the Indemnified Party&#8217;s defense of any such claim or<br \/>\nProceeding (whether or not incurred by the Indemnified Party); PROVIDED, that<br \/>\nall such expenses paid by the Selling Stockholders, combined with any other<br \/>\nindemnification, will in no event exceed the respective indemnification<br \/>\nlimitations set forth in Section 11.2(a).<\/p>\n<p>         If the Indemnified Party so proceeds with the defense of any such claim<br \/>\nor Proceeding:<\/p>\n<p>                  (a) all expenses reasonably incurred and relating to the<br \/>\ndefense of such claim or Proceeding (whether or not incurred by the Indemnified<br \/>\nParty) shall be borne and paid exclusively by the Indemnifying Party;<\/p>\n<p>                  (b) the Indemnifying Party shall make available to the<br \/>\nIndemnified Party any documents and materials in the possession or control of<br \/>\nthe Indemnifying Party that may be necessary to the defense of such claim or<br \/>\nProceeding;<\/p>\n<p>                  (c) the Indemnified Party shall keep the Holder Representative<br \/>\ninformed of all material developments and events relating to such claim or<br \/>\nProceeding;<\/p>\n<p>                  (d) the Selling Stockholders shall have the right to<br \/>\nparticipate in the defense of such claim or Proceeding at their own expense; and<\/p>\n<p>                  (e) the Indemnified Party shall not settle, adjust or<br \/>\ncompromise such claim or Proceeding without the prior written consent of the<br \/>\nSelling Stockholders or the Holder Representative, which consent shall not be<br \/>\nunreasonably withheld.<\/p>\n<p>         Notwithstanding the foregoing, the Selling Shareholders shall have the<br \/>\nright (but not the obligation), at their own expense, to control, defend,<br \/>\nsettle, compromise or prosecute in any manner any audit, examination,<br \/>\ninvestigation, hearing or other proceeding with respect to any Company Return<br \/>\ninvolving only periods ending on or before the Closing Date; PROVIDED, HOWEVER,<br \/>\nthat the Selling Shareholders shall not settle, or compromise any such audit,<br \/>\netc. without the Purchaser&#8217;s timely and reasonable prior written consent.<\/p>\n<p>         11.7     SOLE REMEDY.<\/p>\n<p>         Other than rights to equitable relief, the sole remedy available to any<br \/>\nIndemnitee or other Person for breaches of this Agreement or the other<br \/>\nTransactional Agreements shall be limited to the rights set forth in this<br \/>\nSection 11. The maximum aggregate amounts payable by the Company or the Selling<br \/>\nStockholders, as the case may be, to any and all Indemnitees for any and all<br \/>\nDamages arising out of, or in connection with, this Agreement, any Transactional<br \/>\nAgreement, any certificate, any other document delivered, or any of the<br \/>\nTransactions, are the amounts specified as limitations in Section 11.2(a)<br \/>\nhereof. In no event will any other Person except the named Indemnitees have any<br \/>\nrights to any payments whatsoever.<\/p>\n<p>         11.8     EXERCISE OF REMEDIES BY INDEMNITEES OTHER THAN PURCHASER AND<br \/>\n                  BY SELLING STOCKHOLDERS.<\/p>\n<p>         Except with respect to the indemnification rights of the Selling<br \/>\nStockholders set forth in Section 11.3, no Person other than an Indemnitee (or<br \/>\nany successor or assignee thereof) shall be <\/p>\n<p>                                       44<\/p>\n<p>permitted to assert any indemnification claim or exercise any other remedy<br \/>\nunder this Agreement unless Purchaser, the Company and the Selling<br \/>\nStockholders (or any successor assignee thereof) shall have consented to the<br \/>\nassertion of such indemnification claim or the exercising of such other<br \/>\nremedy.<\/p>\n<p>12.      MISCELLANEOUS.<\/p>\n<p>         12.1     FURTHER ASSURANCES.<\/p>\n<p>         Each party hereto shall execute and\/or cause to be delivered to each<br \/>\nother party hereto such instruments and other documents, and shall take such<br \/>\nother actions, as such other party may reasonably request (prior to, at or after<br \/>\nthe Closing) for the purpose of carrying out or evidencing any of the<br \/>\nTransactions.<\/p>\n<p>         12.2     FEES AND EXPENSES.<\/p>\n<p>         Subject to the provisions of this Agreement (including the<br \/>\nindemnification and other obligations of the Selling Stockholders pursuant to<br \/>\nSection 11), each party shall bear and pay all fees, costs and expenses that<br \/>\nhave been incurred or that are in the future incurred by or on behalf of such<br \/>\nparty in connection with the Transactions; PROVIDED, that, the Selling<br \/>\nStockholders shall bear and pay all fees, costs and expenses incurred on behalf<br \/>\nof the Company in connection with the negotiation of this Agreement and the<br \/>\nTransactional Agreements in excess of $160,000, and any such excess shall be<br \/>\npaid out of the Indemnification Portion.<\/p>\n<p>         12.3     ATTORNEYS&#8217; FEES.<\/p>\n<p>         If any legal action or other legal proceeding (including arbitration)<br \/>\nrelating to the Transactions or the enforcement of any provision of any of the<br \/>\nTransactional Agreements is brought against any party hereto, the prevailing<br \/>\nparty shall be entitled to recover reasonable attorneys&#8217; fees, costs and<br \/>\ndisbursements (in addition to any other relief to which the prevailing party may<br \/>\nbe entitled), including any fees incurred with respect to the production of a<br \/>\nPatent Opinion.<\/p>\n<p>         12.4     TAXES.<\/p>\n<p>                  (a) The Selling Stockholders shall be responsible for sales,<br \/>\nuse and transfer taxes, including but not limited to any value added, stock<br \/>\ntransfer, gross receipts, stamp duty and real, personal or intangible property<br \/>\ntransfer taxes, due by reason of the consummation of the Merger, including but<br \/>\nnot limited to any interest or penalties in respect thereof.<\/p>\n<p>                  (b) The Selling Stockholders shall cause the Company&#8217;s<br \/>\naccountants to prepare and the Company to timely file and pay amounts owed with<br \/>\nrespect to all Company Returns not already filed for the Company for all tax<br \/>\nperiods ended or ending on or before the Closing Date (the &#8220;Final Returns&#8221;), and<br \/>\nshall pay the Company&#8217;s accountants for such preparation and filing. The Final<br \/>\nReturns shall be prepared in a manner consistent with previously filed Company<br \/>\nReturns. The Selling Stockholders (or their authorized representative) shall<br \/>\nsend a copy of all Final Returns to Purchaser for its review and comment and, if<br \/>\nrequired, appropriate execution, at least fifteen (15) days prior to the filing<br \/>\nthereof.<\/p>\n<p>                                       45<\/p>\n<p>                  (c) Purchaser shall prepare and timely file or shall cause to<br \/>\nbe prepared and timely filed all other Tax Returns with respect to the Company<br \/>\nand any of its businesses, assets, or operations, provided that any Tax Return<br \/>\nto be prepared and filed by Purchaser for a Straddle Period shall be prepared on<br \/>\na basis consistent with the last previous similar Tax Return (&#8220;STRADDLE<br \/>\nRETURNS&#8221;). Prior to filing any Straddle Return, at the written request of a<br \/>\nSelling Stockholder (or its authorized representative), Purchaser shall make the<br \/>\nStraddle Return available to a Selling Stockholder for its review and comment at<br \/>\nthe offices of Purchaser or such other office designated by Purchaser.<\/p>\n<p>                  (d) The parties agree that if the Company is permitted but not<br \/>\nrequired under applicable Tax laws to treat the Closing Date as the last day of<br \/>\na taxable period, they shall treat such day as the last day of a taxable period.<br \/>\nAny Taxes for a Straddle Period with respect to the Company shall be apportioned<br \/>\nfor purposes of Sections 11.3 and 12.4 between the portion of the period ending<br \/>\non the Closing Date and the portion of the period commencing on the day<br \/>\nimmediately following the Closing Date based on the actual operations of the<br \/>\nCompany during such portions of the periods, and each such portion of such<br \/>\nperiod shall be deemed to be a taxable period (whether or not it is in fact a<br \/>\ntaxable period).<\/p>\n<p>         12.5     GOVERNING LAW.<\/p>\n<p>                  (a) This Agreement is to be construed in accordance with and<br \/>\ngoverned by the laws of the State of California (as permitted by Section 1646.5<br \/>\nof the California Civil Code or any similar successor provision), without giving<br \/>\neffect to any choice of law rule that would cause the application of the laws of<br \/>\nany jurisdiction other than the State of California to the rights and duties of<br \/>\nthe parties.<\/p>\n<p>                  (b) Any legal action or other legal proceeding relating to<br \/>\nthis Agreement or any other Transactional Agreement or the enforcement of any<br \/>\nprovision of this Agreement or any other Transactional Agreement may be brought<br \/>\nor otherwise commenced in any state or federal court located in the County of<br \/>\nSan Francisco, California. Each Selling Stockholder and each party to this<br \/>\nAgreement:<\/p>\n<p>                           (i)      expressly and irrevocably consents and<br \/>\nsubmits to the jurisdiction of each state and federal court located in the<br \/>\nCounty of San Francisco, California (and each appellate court located in the<br \/>\nState of California) in connection with any such legal proceeding;<\/p>\n<p>                           (ii)     agrees that each state and federal court<br \/>\nlocated in the County of San Francisco, California shall be deemed to be a<br \/>\nconvenient forum; and<\/p>\n<p>                           (iii)    agrees not to assert (by way of motion, as a<br \/>\ndefense or otherwise), in any such legal proceeding commenced in any state or<br \/>\nfederal court located in the County of San Francisco, any claim that such party<br \/>\nis not subject personally to the jurisdiction of such court, that such legal<br \/>\nproceeding has been brought in an inconvenient forum, that the venue of such<br \/>\nproceeding is improper or that this Agreement or any other Transactional<br \/>\nAgreement or the subject matter of this Agreement or any Transactional Agreement<br \/>\nmay not be enforced in or by such court.<\/p>\n<p>                                       46<\/p>\n<p>                  (c) Notwithstanding the foregoing, if any Proceeding is<br \/>\ncommenced against any Indemnitee by any Person in or before any court or other<br \/>\ntribunal anywhere in the world, then such Indemnitee may proceed against each<br \/>\nSelling Stockholder in such court or other tribunal with respect to any<br \/>\nindemnification claim or other claim arising directly or indirectly from or<br \/>\nrelating directly or indirectly to such Proceeding or any of the matters alleged<br \/>\ntherein or any of the circumstances giving rise thereto.<\/p>\n<p>                  (d) Nothing contained in Section 12.5(b) or (c) shall be<br \/>\ndeemed to limit or otherwise affect the right of any Indemnitee to commence any<br \/>\nlegal proceeding or otherwise proceed against the Company or any Selling<br \/>\nStockholder in any other forum or jurisdiction.<\/p>\n<p>         12.6     SUCCESSORS AND ASSIGNS.<\/p>\n<p>         Except as otherwise expressly provided herein, the provisions hereof<br \/>\nshall inure to the benefit of, and be binding upon, the successors, assigns,<br \/>\nheirs, executors and administrators of the parties hereto and the Indemnitees<br \/>\nand shall inure to the benefit of and be enforceable by each person who shall be<br \/>\na holder of the Stock from time to time. None of the parties hereto may assign<br \/>\nany of its or their rights or obligations hereunder to any other party (by<br \/>\ncontract, operation of law or otherwise) without the prior written consent of<br \/>\nthe other, which consent shall not be unreasonably withheld, and any attempted<br \/>\nassignment in violation thereof shall be void and of no effect.<\/p>\n<p>         12.7     ENTIRE AGREEMENT.<\/p>\n<p>         The Transactional Agreements, the Nondisclosure Agreement, the<br \/>\nSchedules and the Exhibits thereto and the other documents contemplated<br \/>\nexpressly thereby constitute the full and entire understanding and agreement<br \/>\namong the parties thereto with regard to the subjects hereof and thereof and<br \/>\nsupersede all prior agreements and understandings among or between any of the<br \/>\nParties relating to the subject matter hereof and thereof.<\/p>\n<p>         12.8     SEPARABILITY.<\/p>\n<p>         In case any provision of this Agreement shall be invalid, illegal or<br \/>\nunenforceable, the validity, legality and enforceability of the remaining<br \/>\nprovisions shall not in any way be affected or impaired thereby.<\/p>\n<p>         12.9     AMENDMENTS.<\/p>\n<p>         This Agreement may be amended or modified only upon the mutual written<br \/>\nconsent of the Holder Representative, the Company and Purchaser. Any amendment<br \/>\nor modification effected pursuant to this Section 12.9 shall be binding upon the<br \/>\nSelling Stockholders, the Company, Purchaser and Merger Sub.<\/p>\n<p>         12.10    NOTICES.<\/p>\n<p>         Any notice or other communication required or permitted to be delivered<br \/>\nto any party under this Agreement shall be in writing and shall be deemed<br \/>\nproperly delivered, given and received when delivered (by hand, by registered<br \/>\nmail, by courier or express delivery service or <\/p>\n<p>                                       47<\/p>\n<p>by telecopier during business hours) to the address or telecopier number set<br \/>\nforth beneath the name of such party below (or to such other address or<br \/>\ntelecopier number as such party shall have specified in a written notice<br \/>\ngiven to the other parties hereto), with a confirming copy of any notice by<br \/>\ntelecopier sent promptly by hand, registered mail, courier or express<br \/>\ndelivery service:<\/p>\n<p>if to the Company:<\/p>\n<p>         LiquidMarket, Inc.<br \/>\n         5757 W. Century Boulevard, Suite 465<br \/>\n         Los Angeles, CA 90045<br \/>\n         Attention:  Gauthier Groult<br \/>\n         Telecopier:  310-670-4598<\/p>\n<p>         with a copy to:<\/p>\n<p>         Hale &amp; Dorr, LLP<br \/>\n         60 State Street<br \/>\n         Boston, MA 02109<br \/>\n         Attention:  Christopher Umana, Esq.<br \/>\n         Telecopier:  617-526-5000<\/p>\n<p>if to the Holder Representative, to its address set forth on the signature page<br \/>\nhereof;<\/p>\n<p>if to Purchaser:<\/p>\n<p>         XOOM.com, Inc.<br \/>\n         300 Montgomery Street<br \/>\n         Third Floor<br \/>\n         San Francisco, California  94104<br \/>\n         Attention:  Rajesh A. Aji, Esq.<br \/>\n         Telecopier:  415-445-2526<\/p>\n<p>         with a copy to:<\/p>\n<p>         Morrison &amp; Foerster LLP<br \/>\n         425 Market Street<br \/>\n         San Francisco, California 94105<br \/>\n         Attention:  Bruce Alan Mann, Esq.<br \/>\n         Telecopier:  415-268-7522<\/p>\n<p>         SNAP! LLC<br \/>\n         One Beach Street<br \/>\n         San Francisco, California 94133<br \/>\n         Attention:  Chief Financial Officer<br \/>\n         Telecopier:  415-392-9088<\/p>\n<p>                                       48<\/p>\n<p>         National Broadcasting Company, Inc.<br \/>\n         30 Rockefeller Plaza<br \/>\n         New York, NY 10012<br \/>\n         Attention:  Vice President, Corporate Law<br \/>\n         Telecopier:  212-977-7165<\/p>\n<p>         12.11    PUBLICITY AND USE OF CONFIDENTIAL INFORMATION.<\/p>\n<p>                  (a) Notwithstanding anything to the contrary contained in any<br \/>\nagreement among the parties hereto, Purchaser shall have the right to disclose<br \/>\nthe Company&#8217;s financial statements and related information, the terms of this<br \/>\nAgreement and the identity of the Company to potential investors of Purchaser,<br \/>\nthrough the use of printed offering materials or otherwise or as otherwise<br \/>\nrequired by applicable legal requirements.<\/p>\n<p>                  (b) The Company and the Selling Stockholders, on the one hand,<br \/>\nand Purchaser, on the other, shall keep strictly confidential, and shall not<br \/>\nuse, or disclose to any other Person, any non-public document or other<br \/>\ninformation in the Company&#8217;s or the Selling Stockholders&#8217; possession, on the one<br \/>\nhand, and in Purchaser&#8217;s possession, on the other, that relates directly or<br \/>\nindirectly to the business of the Company, Purchaser or any affiliate of<br \/>\nPurchaser; PROVIDED, THAT Purchaser or the Selling Stockholders may disclose<br \/>\nsuch non-public information as required by any applicable law or rule to which<br \/>\nPurchaser or the Selling Stockholders is subject, including the Exchange Act and<br \/>\nthe rules of the National Association of Securities Dealers, Inc.<\/p>\n<p>                  (c) Neither the Company nor the Selling Stockholders shall<br \/>\nissue or disseminate any press release or other publicity concerning any of the<br \/>\nTransactions, or permit any press release or other publicity concerning any of<br \/>\nthe Transactions to be issued or otherwise disseminated by or on behalf of the<br \/>\nCompany or the Selling Stockholders without Purchaser&#8217;s prior written consent,<br \/>\nand the Company and the Selling Stockholders shall continue to keep the terms of<br \/>\nthis Agreement and the other Transactional Agreements strictly confidential.<\/p>\n<p>         12.12    COUNTERPARTS.<\/p>\n<p>         This Agreement may be executed in any number of counterparts, each of<br \/>\nwhich shall be an original, but all of which together shall constitute one<br \/>\ninstrument.<\/p>\n<p>         12.13    DELAYS OR OMISSIONS; WAIVERS.<\/p>\n<p>                  (a) No failure on the part of any Person to exercise any<br \/>\npower, right, privilege or remedy under this Agreement, and no delay on the part<br \/>\nof any Person in exercising any power, right, privilege or remedy under this<br \/>\nAgreement, shall operate as a waiver of such power, right, privilege or remedy;<br \/>\nand no single or partial exercise or waiver of any such power, right, privilege<br \/>\nor remedy shall preclude any other or further exercise thereof or of any other<br \/>\npower, right, privilege or remedy.<\/p>\n<p>                  (b) No Person shall be deemed to have waived any claim arising<br \/>\nout of this Agreement, or any power, right, privilege or remedy under this<br \/>\nAgreement, unless the waiver of such claim, power, right, privilege or remedy is<br \/>\nexpressly set forth in a written instrument duly <\/p>\n<p>                                       49<\/p>\n<p>executed and delivered on behalf of such Person; and any such waiver shall<br \/>\nnot be applicable or have any effect except in the specific instance in which<br \/>\nit is given.<\/p>\n<p>         12.14    REMEDIES CUMULATIVE; SPECIFIC PERFORMANCE.<\/p>\n<p>         All remedies, either under this Agreement or by law or otherwise<br \/>\nafforded to the parties hereto, shall be cumulative and not alternative. Each of<br \/>\nthe parties agrees that:<\/p>\n<p>                  (a) in the event of any breach or threatened breach by a party<br \/>\nof any covenant, obligation or other provision set forth in this Agreement, the<br \/>\nother party shall be entitled (in addition to any other remedy that may be<br \/>\navailable to it) to (i) a decree or order of specific performance or mandamus to<br \/>\nenforce the observance and performance of such covenant, obligation or other<br \/>\nprovision, and (ii) an injunction restraining such breach or threatened breach;<br \/>\nand<\/p>\n<p>                  (b) neither Purchaser nor any other Indemnitee, on the one<br \/>\nhand, nor the Selling Stockholders, on the other, shall be required to provide<br \/>\nany bond or other security in connection with any such decree, order or<br \/>\ninjunction or in connection with any related action or Proceeding.<\/p>\n<p>         12.15    HEADINGS.<\/p>\n<p>         The underlined headings contained in this Agreement are for convenience<br \/>\nof reference only, shall not be deemed to be a part of this Agreement and shall<br \/>\nnot be referred to in connection with the construction or interpretation of this<br \/>\nAgreement.<\/p>\n<p>         12.16    CONSTRUCTION.<\/p>\n<p>                  (a) For purposes of this Agreement, whenever the context<br \/>\nrequires: the singular number shall include the plural, and vice versa; the<br \/>\nmasculine gender shall include the feminine and neuter genders; the feminine<br \/>\ngender shall include the masculine and neuter genders; and the neuter gender<br \/>\nshall include the masculine and feminine genders.<\/p>\n<p>                  (b) The parties hereto agree that any rule of construction to<br \/>\nthe effect that ambiguities are to be resolved against the drafting party shall<br \/>\nnot be applied in the construction or interpretation of this Agreement.<\/p>\n<p>                  (c) As used in this Agreement, the words &#8220;include&#8221; and<br \/>\n&#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of<br \/>\nlimitation, but rather shall be deemed to be followed by the words &#8220;without<br \/>\nlimitation.&#8221;<\/p>\n<p>                  (d) Except as otherwise specified, all references in this<br \/>\nAgreement to &#8220;Sections,&#8221; &#8220;Exhibits&#8221; and &#8220;Schedules&#8221; are intended to refer to<br \/>\nSections of this Agreement and Exhibits and Schedules to this Agreement.<\/p>\n<p>                                       50<\/p>\n<p>         IN WITNESS WHEREOF, the parties hereto have executed this AGREEMENT AND<br \/>\nPLAN OF MERGER as of the date set forth in the first paragraph hereof.<\/p>\n<p>COMPANY:                                LIQUIDMARKET, INC.<br \/>\n                                        a Delaware corporation<\/p>\n<p>                                        By: \/s\/ Gauthier H. Groult<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Name: Gauthier H. Groult<br \/>\n                                               Title:    Chief Executive Officer<\/p>\n<p>PURCHASER:                              XOOM.COM, INC.<br \/>\n                                        a Delaware corporation<\/p>\n<p>                                        By: \/s\/ John Harbottle<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Name:  John Harbottle<br \/>\n                                               Title: Chief Financial Officer<\/p>\n<p>MERGER SUB:                             XOOM ACQUISITION SUB II, INC.<br \/>\n                                        a Delaware corporation<\/p>\n<p>                                        By: \/s\/ John Harbottle<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Name:  John Harbottle<br \/>\n                                               Title:  Chief Financial Officer<\/p>\n<p>HOLDER REPRESENTATIVE:<\/p>\n<p>ADDRESS:<br \/>\n                                        By: \/s\/ Rajesh Parekh<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n151 Bridgton Court                             Rajesh Parekh<br \/>\nLos Altos, CA 94022<\/p>\n<p>                                       51<\/p>\n<table>\n<caption>\n<p>                         INDEX OF SCHEDULES AND EXHIBITS<\/p>\n<p><s>                       <c><br \/>\nSchedule I                Schedule of Selling Stockholders<\/p>\n<p>Schedule II               Schedule of Company Options<\/p>\n<p>Schedule III              Company Disclosure Schedule<\/p>\n<p>Schedule IV               Purchaser Disclosure Schedule<\/p>\n<p>Exhibit A                 Certain Definitions<\/p>\n<p>Exhibit B                 Form of Escrow Agreement<\/p>\n<p>Exhibit C                 Form of Registration Rights Agreement<\/p>\n<p>Exhibit D                 Forms of Employment and Non-Competition Agreement<\/p>\n<p>Exhibit E                 Form of Investment Agreement<\/p>\n<p>Exhibit F                 Form of Stockholder Questionnaire<\/p>\n<p>Exhibit G                 Form of Legal Opinion of Hale and Dorr, LLP, counsel to the<br \/>\n                          Selling Stockholders and the Company<\/p>\n<p>Exhibit H                 Form of Legal Opinion of Morrison &amp; Foerster LLP, counsel to<br \/>\n                          Purchaser<\/p>\n<p>Exhibit I                 Financial Statements of the Company<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       52<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                   SCHEDULE I<\/p>\n<p>                        SCHEDULE OF SELLING STOCKHOLDERS<\/p>\n<p>                                       53<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                   SCHEDULE II<\/p>\n<p>                               SCHEDULE OF OPTIONS<\/p>\n<p>                                       54<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                  SCHEDULE III<\/p>\n<p>                           COMPANY DISCLOSURE SCHEDULE<\/p>\n<p>                                       55<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                   SCHEDULE IV<\/p>\n<p>                          PURCHASER DISCLOSURE SCHEDULE<\/p>\n<p>                                       56<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                    EXHIBIT A<\/p>\n<p>                               CERTAIN DEFINITIONS<\/p>\n<p>         For purposes of this Agreement:<\/p>\n<p>         ACQUISITION TRANSACTION. &#8220;Acquisition Transaction&#8221; shall mean any<br \/>\ntransaction involving:<\/p>\n<p>         (a)      the sale or other disposition of all or any portion of the<br \/>\n                  Company&#8217;s business or assets (other than in the Ordinary<br \/>\n                  Course of Business);<\/p>\n<p>         (b)      the issuance, sale or other disposition of (i) any capital<br \/>\n                  stock of the Company, (ii) any option, call, warrant or<br \/>\n                  right (whether or not immediately exercisable) to acquire<br \/>\n                  any capital stock of the Company, or (iii) any security,<br \/>\n                  instrument or obligation that is or may become convertible<br \/>\n                  into or exchangeable for any capital stock of the Company; or<\/p>\n<p>         (c)      any merger, consolidation, business combination, share<br \/>\n                  exchange, reorganization or similar transaction involving<br \/>\n                  the Company.<\/p>\n<p>         ADDITIONAL EMPLOYEE OPTION GRANTS. &#8220;Additional Employee Option<br \/>\nGrants&#8221; shall have the meaning specified in Section 3.1(c)(ii).<\/p>\n<p>         AGREEMENT. &#8220;Agreement&#8221; shall mean the Agreement and Plan of Merger<br \/>\nto which this EXHIBIT A is attached (including the Disclosure Schedule and<br \/>\nall other schedules and exhibits attached thereto), as it may be amended from<br \/>\ntime to time.<\/p>\n<p>         AVERAGE PURCHASER STOCK PRICE. &#8220;Average Purchaser Stock Price&#8221; shall<br \/>\nmean (a) $47.125, in the event that the Merger Consideration is calculated in<br \/>\naccordance with Section 1.3(a) or (b) the lesser of (i) the average closing<br \/>\nprice of Purchaser Stock on the Nasdaq National Stock Market for the<br \/>\ntwenty-seven (27) trading days ending on the last trading day prior to the<br \/>\nClosing Date or (ii) the average closing price of Purchaser Stock on the<br \/>\nNasdaq National Stock Market for the five (5) trading days ending on the last<br \/>\ntrading day prior to the Closing Date, for purposes of the calculations in<br \/>\nSection 1.3(b)(i) or 1.3(b)(ii), and in the event that, as a result of such<br \/>\ncalculations, the Merger Consideration is determined pursuant to Section<br \/>\n1.3(b)(i), (ii) or (iii).<\/p>\n<p>         BASKET. &#8220;Basket&#8221; shall have the meaning specified in Section 11.2(b).<\/p>\n<p>         BEST EFFORTS. &#8220;Best Efforts&#8221; shall mean the efforts that a prudent<br \/>\nPerson desiring to achieve a particular result would use in order to ensure<br \/>\nthat such result is achieved as expeditiously as possible.<\/p>\n<p>         CERTIFICATE OF MERGER. &#8220;Certificate of Merger&#8221; shall have the<br \/>\nmeaning specified in Section 1.2.<\/p>\n<p>                                       57<\/p>\n<p>         CERTIFICATES. &#8220;Certificates&#8221; shall have the meaning specified in<br \/>\nSection 3.2(a).<\/p>\n<p>         CLOSING. &#8220;Closing&#8221; shall have the meaning specified in Section 3.4.<\/p>\n<p>         CLOSING DATE. &#8220;Closing Date&#8221; shall have the meaning specified in<br \/>\nSection 3.4.<\/p>\n<p>         CODE. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as<br \/>\namended.<\/p>\n<p>         COMMON STOCK. &#8220;Common Stock&#8221; shall have the meaning specified in<br \/>\nSection 3.1(b).<\/p>\n<p>         COMPANY. &#8220;Company&#8221; shall mean LiquidMarket, Inc., a Delaware<br \/>\ncorporation.<\/p>\n<p>         COMPANY BOARD. &#8220;Company Board&#8221; shall mean the members of the board<br \/>\nof directors of the Company.<\/p>\n<p>         COMPANY CLOSING CERTIFICATE. &#8220;Company Closing Certificate&#8221; shall<br \/>\nhave the meaning specified in Section 4.1(c)(vii).<\/p>\n<p>         COMPANY CONTRACT. &#8220;Company Contract&#8221; shall mean any contract listed<br \/>\non the Disclosure Schedule.<\/p>\n<p>         COMPANY DISCLOSURE SCHEDULE. &#8220;Company Disclosure Schedule&#8221; shall<br \/>\nhave the meaning specified in the introductory paragraph to Section 5.<\/p>\n<p>         COMPANY DISCLOSURE SCHEDULE UPDATE. &#8220;Company Disclosure Schedule<br \/>\nUpdate&#8221; shall have the meaning specified in Section 7.5(b).<\/p>\n<p>         COMPANY OPTIONS. &#8220;Company Options&#8221; shall refer to those options<br \/>\ngranted by the Company, or proposed to be granted prior to the Closing Date,<br \/>\nto purchase shares of the Common Stock of the Company as set forth on<br \/>\nSCHEDULE II attached hereto.<\/p>\n<p>         COMPANY PREFERRED STOCK. &#8220;Company Preferred Stock&#8221; shall have the<br \/>\nmeaning specified in Section 5.3(a).<\/p>\n<p>         COMPANY RETURNS. &#8220;Company Returns&#8221; shall have the meaning specified<br \/>\nin Section 5.14(b).<\/p>\n<p>         CONSENT. &#8220;Consent&#8221; shall mean any approval, consent, ratification,<br \/>\npermission, waiver or authorization (including any Governmental<br \/>\nAuthorization).<\/p>\n<p>         CONSTITUENT CORPORATIONS. &#8220;Constituent Corporations&#8221; shall refer to<br \/>\nthe Company and Merger Sub.<\/p>\n<p>         CONTRACT. &#8220;Contract&#8221; shall mean, with respect to any Person, any<br \/>\nwritten or oral or other contract, arrangement or other agreement to which<br \/>\nsuch Person is a party or by which its properties or assets may be bound or<br \/>\naffected or under which it or its respective business, properties or assets<br \/>\nreceive benefits.<\/p>\n<p>                                       58<\/p>\n<p>         CONTROL. &#8220;Control&#8221; shall consist of direct ownership of stock<br \/>\npossessing at least eighty percent (80%) of the total combined voting power<br \/>\nof all classIes of stock entitled to vote and at least eighty percent (80%)<br \/>\nof the total number of shares of each other class of stock of the corporation.<\/p>\n<p>         CRITICAL EMPLOYEES. &#8220;Critical Employees&#8221; shall refer to Gauthier<br \/>\nGroult and Francois Rouaix, each of whom are considered by Purchaser to be<br \/>\ncritical to success of the Company&#8217;s business operations.<\/p>\n<p>         DAMAGES. &#8220;Damages&#8221; shall include any loss, damage, injury, decline<br \/>\nin value, lost opportunity, Liability, settlement, judgment, award, fine,<br \/>\npenalty, Tax, fee (including any legal fee resulting from, but not limited<br \/>\nto, the defense of third party claims pursuant to Section 11.5 of this<br \/>\nAgreement, expert fee, accounting fee or advisory fee), charge, cost<br \/>\n(including any cost of investigation) or expense of any nature.<\/p>\n<p>         DEFINED BENEFIT PLAN. &#8220;Defined Benefit Plan&#8221; shall mean either a<br \/>\nplan described in Section 3(35) of ERISA or a plan subject to the minimum<br \/>\nfunding standards set forth in Section 302 of ERISA and Section 412 of the<br \/>\nCode.<\/p>\n<p>         DISSENTING HOLDER. &#8220;Dissenting Holder&#8221; shall have the meaning<br \/>\nspecified in Section 3.6(a).<\/p>\n<p>         DISSENTING SHARES. &#8220;Dissenting Shares&#8221; shall have the meaning<br \/>\nspecified in Section 3.6(a).<\/p>\n<p>         EFFECTIVE TIME. &#8220;Effective Time&#8221; shall have the meaning specified in<br \/>\nSection 1.2.<\/p>\n<p>         EMPLOYMENT AND NON-COMPETITION AGREEMENT. &#8220;Employment and<br \/>\nNon-Competition Agreement&#8221; shall refer to the employment contract by and<br \/>\nbetween Purchaser and each of the Critical Employees substantially in the<br \/>\nforms attached at EXHIBIT D.<\/p>\n<p>         END-USER LICENSES. &#8220;End-User Licenses&#8221; shall have the meaning<br \/>\nspecified in Section 5.6.<\/p>\n<p>         ENTITY. &#8220;Entity&#8221; shall mean any corporation (including any non<br \/>\nprofit corporation), general partnership, limited partnership, limited<br \/>\nliability partnership, joint venture, estate, trust or company (including any<br \/>\nlimited liability company or joint stock company).<\/p>\n<p>         ENVIRONMENTAL LAW. &#8220;Environmental Law&#8221; shall mean any federal,<br \/>\nstate, local or foreign legal requirement relating to pollution or protection<br \/>\nof human health or the environment.<\/p>\n<p>         ERISA. &#8220;ERISA&#8221; shall mean the Employee Retirement Income Security<br \/>\nAct of 1974, as amended.<\/p>\n<p>         ESCROW ACCOUNT. &#8220;Escrow Account&#8221; shall have the mean the account<br \/>\ninto which the Holdback Amount is deposited.<\/p>\n<p>         ESCROW AGENT.  &#8220;Escrow Agent&#8221; shall refer to USBank Trust, N.A. <\/p>\n<p>                                       59<\/p>\n<p>         ESCROW AGREEMENT. &#8220;Escrow Agreement&#8221; shall have the meaning<br \/>\nspecified in Section 1.4.<\/p>\n<p>         EXCHANGE ACT. &#8220;Exchange Act&#8221; shall mean the Securities Exchange Act<br \/>\nof 1934, as amended.<\/p>\n<p>         EXCHANGE RATIO. &#8220;Exchange Ratio&#8221; shall have the meaning specified in<br \/>\nSection 3.1(b).<\/p>\n<p>         FINAL RETURNS. &#8220;Final Returns&#8221; shall have the meaning specified in<br \/>\nSection 12.4(b).<\/p>\n<p>         FINANCIAL STATEMENTS. &#8220;Financial Statements&#8221; shall have the meaning<br \/>\nspecified in Section 5.8(a).<\/p>\n<p>         GAAP. &#8220;GAAP&#8221; shall mean generally accepted accounting principles.<\/p>\n<p>         GOVERNMENTAL AUTHORIZATION. &#8220;Governmental Authorization&#8221; shall mean<br \/>\nany:<\/p>\n<p>         (a)      permit, license, certificate, franchise, approval, consent,<br \/>\n                  permission, clearance, waiver, certification, designation,<br \/>\n                  registration, qualification or authorization issued,<br \/>\n                  granted, given or otherwise made available by or under the<br \/>\n                  authority of any Governmental Body or pursuant to any legal<br \/>\n                  requirement; or<\/p>\n<p>         (b)      right under any Contract with any Governmental Body.<\/p>\n<p>         GOVERNMENTAL BODY. &#8220;Governmental Body&#8221; shall mean any:<\/p>\n<p>         (a)      nation, principality, state, province, territory, county,<br \/>\n                  municipality, district or other jurisdiction of any nature;<\/p>\n<p>         (b)      federal, state, local, municipal, foreign or other<br \/>\n                  government; or<\/p>\n<p>         (c)      individual, Entity or body exercising, or entitled to<br \/>\n                  exercise, any executive, legislative, judicial,<br \/>\n                  administrative, regulatory, police, military or taxing<br \/>\n                  authority or power of any nature.<\/p>\n<p>         HAZARDOUS MATERIALS. &#8220;Hazardous Materials&#8221; shall mean any substance,<br \/>\nchemical, waste or other material which is listed, defined or otherwise<br \/>\nidentified as hazardous or toxic, or which is otherwise regulated, under any<br \/>\nlegal requirement, as well as any asbestos, polychlorinated biphenyls<br \/>\n(&#8220;PCBs&#8221;), petroleum, petroleum product or by-product, crude oil, natural gas,<br \/>\nnatural gas liquids, liquefied natural gas, or synthetic gas useable for<br \/>\nfuel, and &#8220;source,&#8221; &#8220;special nuclear,&#8221; and &#8220;by-product&#8221; material as defined<br \/>\nin the Atomic Energy Act of 1954, 42 U.S.C. Sections 2011 et seq.<\/p>\n<p>         HOLDBACK AMOUNT. &#8220;Holdback Amount&#8221; shall have the meaning specified<br \/>\nin Section 1.4.<\/p>\n<p>         HOLDER REPRESENTATIVE. &#8220;Holder Representative&#8221; shall have the<br \/>\nmeaning specified in the first paragraph hereof.<\/p>\n<p>                                       60<\/p>\n<p>         INDEMNIFICATION PORTION. &#8220;Indemnification Portion&#8221; shall have the<br \/>\nmeaning specified in Section 1.1 of the Escrow Agreement.<\/p>\n<p>         INDEMNIFICATION PORTION ESCROW ACCOUNT. &#8220;Indemnification Portion<br \/>\nEscrow Account&#8221; shall have the meaning specified in Section 1.1 of the Escrow<br \/>\nAgreement.<\/p>\n<p>         INDEMNIFICATION TERMINATION DATE. &#8220;Indemnification Termination Date&#8221;<br \/>\nshall have the meaning specified in Section 3.2 of the Escrow Agreement.<\/p>\n<p>         INDEMNIFIED PARTY. &#8220;Indemnified Party&#8221; shall have the meaning<br \/>\nspecified in Section 11.6.<\/p>\n<p>         INDEMNIFYING PARTY. &#8220;Indemnifying Party&#8221; shall have the meaning<br \/>\nspecified in Section 11.6.<\/p>\n<p>         INDEMNITEE. &#8220;Indemnitee&#8221; shall have the meaning specified in Section<br \/>\n11.2(a).<\/p>\n<p>         INFORMATION STATEMENT. &#8220;Information Statement&#8221; shall have the<br \/>\nmeaning specified in Section 8.1(b).<\/p>\n<p>         INFORMATION STATEMENT UPDATE. &#8220;Information Statement Update&#8221; shall<br \/>\nhave the meaning specified in Section 7.5(b).<\/p>\n<p>         INVESTMENT AGREEMENT. &#8220;Investment Agreement&#8221; shall have the meaning<br \/>\nspecified in Section 4.1(c)(iv).<\/p>\n<p>         LEASED PREMISES. &#8220;Leased Premises&#8221; shall mean the premises and<br \/>\nfacilities identified in Part 5.9(d) of the Disclosure Schedule.<\/p>\n<p>         LIABILITY. &#8220;Liability&#8221; shall mean any debt, obligation, duty or<br \/>\nliability of any nature (including any contingent or indirect liability),<br \/>\nregardless of whether such debt, obligation, duty or liability would be<br \/>\nrequired to be disclosed on a balance sheet prepared in accordance with<br \/>\ngenerally accepted accounting principles and regardless of whether such debt,<br \/>\nobligation, duty or liability is immediately due and payable.<\/p>\n<p>         MATERIAL ADVERSE CHANGE. &#8220;Material Adverse Change&#8221; shall have the<br \/>\nmeaning specified in Section 4.1(j).<\/p>\n<p>         MATERIAL ADVERSE EFFECT. &#8220;Material Adverse Effect&#8221; shall have the<br \/>\nmeaning specified in Section 4.1(j).<\/p>\n<p>         MEMBER OF THE CONTROLLED GROUP. &#8220;Member of the Controlled Group&#8221;<br \/>\nshall mean each trade or business, whether or not incorporated, which would<br \/>\nbe treated as a single employer with the Company under Section 4001 of ERISA<br \/>\nor Section 414(b), (c), (m) or (o) of the Code.<\/p>\n<p>         MERGER.  &#8220;Merger&#8221; shall have the meaning specified in Recital A.<\/p>\n<p>                                       61<\/p>\n<p>         MERGER CONSIDERATION. &#8220;Merger Consideration&#8221; shall have the meaning<br \/>\nspecified in Section 1.3.<\/p>\n<p>         MERGER SUB. &#8220;Merger Sub&#8221; shall refer to XOOM Acquisition Sub II,<br \/>\nInc., a Delaware corporation.<\/p>\n<p>         MERGER SUB BOARD. &#8220;Merger Sub Board&#8221; shall refer to the board of<br \/>\ndirectors of Merger Sub.<\/p>\n<p>         MILESTONES. &#8220;Milestones&#8221; shall have the meaning specified in Section<br \/>\n1.1 of the Escrow Agreement.<\/p>\n<p>         MULTIEMPLOYER PLAN. &#8220;Multiemployer Plan&#8221; shall mean a plan described<br \/>\nin Section 3(37) of ERISA.<\/p>\n<p>         NBC. &#8220;NBC&#8221; shall mean the National Broadcasting Company, Inc.<\/p>\n<p>         NBC AGREEMENTS. &#8220;NBC Agreements&#8221; shall mean the Agreement and Plan<br \/>\nof Contribution and Merger, dated as of May 9, 1999, as amended and restated<br \/>\nthrough the date hereof, with the Purchaser and others, and an Agreement and<br \/>\nPlan of Contribution, Investment and Merger dated as of May 9, 1999, as<br \/>\namended and restated through date hereof, with NBC and others pursuant to<br \/>\nwhich the existing businesses of Purchaser and certain assets of NBC and<br \/>\nothers will be combined.<\/p>\n<p>         NBC TRANSACTIONS. &#8220;NBC Transactions&#8221; shall mean those transactions<br \/>\ncontemplated by the NBC Agreements.<\/p>\n<p>         NONDISCLOSURE AGREEMENT. &#8220;Nondisclosure Agreement&#8221; shall have the<br \/>\nmeaning specified in Section 9.2.<\/p>\n<p>         OPTION PLAN. &#8220;Option Plan&#8221; shall have the meaning specified in<br \/>\nSection 3.1(c)(i).<\/p>\n<p>         OPTION POOL. &#8220;Option Pool&#8221; shall mean the number of shares of Common<br \/>\nStock reserved for the grant of options (whether or not such options are then<br \/>\noutstanding) under the Option Plan as of the Closing Date.<\/p>\n<p>         ORDER.  &#8220;Order&#8221; shall mean any:<\/p>\n<p>         (a)      order, judgment, injunction, edict, decree, ruling,<br \/>\n                  subpoena, writ or award that is or has been issued, made,<br \/>\n                  entered, rendered or otherwise put into effect by or under<br \/>\n                  the authority of any court, administrative agency or other<br \/>\n                  Governmental Body or any arbitrator or arbitration panel; or<\/p>\n<p>         (b)      Contract with any Governmental Body that is or has been<br \/>\n                  entered into in connection with any Proceeding.<\/p>\n<p>                                       62<\/p>\n<p>         ORDINARY COURSE OF BUSINESS. An action taken by or on behalf of the<br \/>\nCompany shall not be deemed to have been taken in the &#8220;Ordinary Course of<br \/>\nBusiness&#8221; unless:<\/p>\n<p>         (a)      such action is recurring in nature, is consistent with the<br \/>\n                  Company&#8217;s past practices and is taken in the ordinary course<br \/>\n                  of the Company&#8217;s normal day to day operations;<\/p>\n<p>         (b)      such action is taken in accordance with sound and prudent<br \/>\n                  business practices;<\/p>\n<p>         (c)      such action is not required to be authorized by the<br \/>\n                  Company&#8217;s stockholders, the Company Board or any committee<br \/>\n                  of the Company Board and does not require any other separate<br \/>\n                  or special authorization of any nature; and<\/p>\n<p>         (d)      such action is similar in nature and magnitude to actions<br \/>\n                  customarily taken, without any separate or special<br \/>\n                  authorization, in the ordinary course of the normal day to<br \/>\n                  day operations of other Entities that are engaged in<br \/>\n                  businesses similar to the Company&#8217;s business.<\/p>\n<p>         PATENT OPINION. &#8220;Patent Opinion&#8221; shall have the meaning specified in<br \/>\nthe Milestones attached at Exhibit A to the Escrow Agreement.<\/p>\n<p>         PERSON. &#8220;Person&#8221; shall mean any individual, Entity or Governmental<br \/>\nBody.<\/p>\n<p>         PLANS. &#8220;Plans&#8221; shall have the meaning specified in Section 5.22(a).<\/p>\n<p>         POST-CLOSING PERIOD. &#8220;Post-Closing Period&#8221; means any taxable period<br \/>\n(or portion thereof) beginning after the close of business on the Closing<br \/>\nDate.<\/p>\n<p>         PRE-CLOSING PERIOD. &#8220;Pre-Closing Period&#8221; shall mean the period from<br \/>\nthe date of this Agreement until the Closing Date.<\/p>\n<p>         PROCEEDING. &#8220;Proceeding&#8221; shall mean any action, suit, litigation,<br \/>\narbitration, proceeding (including any civil, criminal, administrative,<br \/>\ninvestigative or appellate proceeding and any informal proceeding), hearing,<br \/>\ninquiry, audit or investigation that is or has been commenced, brought,<br \/>\nconducted or heard by or before, or that otherwise has involved or would<br \/>\nreasonably be expected to involve, any Governmental Body or any arbitrator or<br \/>\narbitration panel.<\/p>\n<p>         PROPRIETARY ASSET. &#8220;Proprietary Asset&#8221; shall mean any patent, patent<br \/>\napplication, trademark (whether registered or unregistered and whether or not<br \/>\nrelating to a published work), trademark application, trade name, fictitious<br \/>\nbusiness name, service mark (whether registered or unregistered), service<br \/>\nmark application, copyright (whether registered or unregistered), copyright<br \/>\napplication, maskwork, maskwork application, trade secret, know how,<br \/>\nfranchise, system, computer software, invention, design, blueprint,<br \/>\nproprietary product, technology, proprietary right or other intellectual<br \/>\nproperty right or intangible asset.<\/p>\n<p>         PURCHASER. &#8220;Purchaser&#8221; shall mean XOOM.com, Inc., a Delaware<br \/>\ncorporation.<\/p>\n<p>         PURCHASER BOARD. &#8220;Purchaser Board&#8221; shall refer to the board of<br \/>\ndirectors of Purchaser.<\/p>\n<p>                                       63<\/p>\n<p>         PURCHASER CLOSING CERTIFICATE. &#8220;Purchaser Closing Certificate&#8221; hall<br \/>\nhave the meaning specified in Section 4.2(c)(v).<\/p>\n<p>         PURCHASER CONTRACT. &#8220;Purchaser Contract&#8221; shall refer to those<br \/>\ncontracts required by Regulation S-K to be filed in connection with the<br \/>\nPurchaser SEC Reports.<\/p>\n<p>         PURCHASER DISCLOSURE SCHEDULE. &#8220;Purchaser Disclosure Schedule&#8221; shall<br \/>\nhave the meaning specified in the introductory paragraph to Section 6.<\/p>\n<p>         PURCHASER MATERIAL ADVERSE CHANGE. &#8220;Purchaser Material Adverse<br \/>\nChange&#8221; shall have the meaning specified in Section 4.2(e).<\/p>\n<p>         PURCHASER MATERIAL ADVERSE EFFECT. &#8220;Purchaser Material Adverse<br \/>\nEffect&#8221; shall have the meaning specified in Section 4.2(e).<\/p>\n<p>         PURCHASER OPTIONS. &#8220;Purchaser Options&#8221; shall refer to those options<br \/>\ngranted by Purchaser, or proposed to be granted by Purchaser, to purchase<br \/>\nshares of Purchaser Stock under the Purchaser Option Plan.<\/p>\n<p>         PURCHASER OPTION PLAN. &#8220;Purchaser Option Plan&#8221; shall refer to the<br \/>\n1998 Stock Incentive Plan of Purchaser.<\/p>\n<p>         PURCHASER SEC REPORTS. &#8220;Purchaser SEC Reports&#8221; shall have the<br \/>\nmeaning specified in Section 6.7(a).<\/p>\n<p>         PURCHASER STOCK. &#8220;Purchaser Stock&#8221; shall refer to the Common Stock<br \/>\nof Purchaser, par value $.0001 per share, to be issued in connection with the<br \/>\nTransactions.<\/p>\n<p>         RELATED PARTY. Each of the following shall be deemed to be a<br \/>\n&#8220;Related Party&#8221;:<\/p>\n<p>         (a)      the Selling Stockholders;<\/p>\n<p>         (b)      each individual who is, or who has at any time been, an<br \/>\n                  officer of the Selling Stockholders or the Company;<\/p>\n<p>         (c)      each member of the family of each of the individuals<br \/>\n                  referred to in clause (b) above; and<\/p>\n<p>         (d)      any Entity (other than the Selling Stockholders or the<br \/>\n                  Company) in which any one of the Persons referred to in<br \/>\n                  clause (a), (b) or (c) above holds (or in which more than<br \/>\n                  one of such individuals collectively hold), beneficially or<br \/>\n                  otherwise, a material voting, proprietary or equity interest.<\/p>\n<p>         RESPONSIBLE STOCKHOLDER. &#8220;Responsible Stockholder&#8221; shall have the<br \/>\nmeaning specified in Section 11.1(a).<\/p>\n<p>                                       64<\/p>\n<p>         RIGHTS AGREEMENT. &#8220;Rights Agreement&#8221; shall refer to that certain<br \/>\nRegistration Rights Agreement by and among Purchaser and the Selling<br \/>\nStockholders substantially in the form of EXHIBIT C attached hereto.<\/p>\n<p>         SEC. &#8220;SEC&#8221; shall mean the Securities and Exchange Commission.<\/p>\n<p>         SECURITIES ACT. &#8220;Securities Act&#8221; shall mean the Securities Act of<br \/>\n1933, as amended.<\/p>\n<p>         SELLING STOCKHOLDERS. &#8220;Selling Stockholders&#8221; shall refer to those<br \/>\nindividuals and Entities listed on SCHEDULE I hereto.<\/p>\n<p>         SELLING STOCKHOLDERS CLOSING CERTIFICATE. &#8220;Selling Stockholders<br \/>\nClosing Certificate&#8221; shall have the meaning specified in Section 4.1(c)(vii).<\/p>\n<p>         STOCKHOLDER QUESTIONNAIRE. &#8220;Stockholder Questionnaire&#8221; shall have<br \/>\nthe meaning specified in Section 4.1(c)(iv).<\/p>\n<p>         STRADDLE PERIOD. &#8220;Straddle Period&#8221; means any taxable period that<br \/>\nincludes (but does not end on) the Closing Date.<\/p>\n<p>         STRADDLE RETURNS. &#8220;Straddle Returns&#8221; shall have the meaning<br \/>\nspecified in Section 12.4(c).<\/p>\n<p>         STOCK. &#8220;Stock&#8221; shall have the meaning specified in Section 3.1(b).<\/p>\n<p>         SURVIVING CORPORAITION. &#8220;Surviving Corporation&#8221; shall have the<br \/>\nmeaning specified in Section 1.1.<\/p>\n<p>         TAX. &#8220;Tax&#8221; shall mean any tax (including any income tax, franchise<br \/>\ntax, capital gains tax, estimated tax, gross receipts tax, value added tax,<br \/>\nsurtax, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use<br \/>\ntax, property tax, business tax, occupation tax, inventory tax, occupancy<br \/>\ntax, withholding tax or payroll tax), levy, assessment, tariff, impost,<br \/>\nimposition, toll, duty (including any customs duty), deficiency or fee, and<br \/>\nany related charge or amount (including any fine, penalty or interest), that<br \/>\nis, has been or in the future may be (a) imposed, assessed or collected by or<br \/>\nunder the authority of any Governmental Body, or (b) payable pursuant to any<br \/>\ntax sharing agreement or similar Contract.<\/p>\n<p>         TAX RETURN. &#8220;Tax Return&#8221; shall mean any return (including any<br \/>\ninformation return), report, statement, declaration, estimate, schedule,<br \/>\nnotice, notification, form, election, certificate or other document or<br \/>\ninformation that is, has been or in the future may be filed with or submitted<br \/>\nto, or required to be filed with or submitted to, any Governmental Body in<br \/>\nconnection with the determination, assessment, collection or payment of any<br \/>\nTax or in connection with the administration, implementation or enforcement<br \/>\nof or compliance with any legal requirement relating to any Tax.<\/p>\n<p>         TRANSACTION EXPENSES. &#8220;Transaction Expenses&#8221; shall mean all fees,<br \/>\ncosts and expenses including, without limitation all attorneys&#8217; fees, that<br \/>\nhave been incurred or that are in the future <\/p>\n<p>                                       65<\/p>\n<p>incurred by or on behalf of the Company or the Selling Stockholders in<br \/>\nconnection with the sale of the Stock and the preparation, execution and<br \/>\ndelivery of the Transactional Agreements.<\/p>\n<p>         TRANSACTIONAL AGREEMENTS. &#8220;Transactional Agreements&#8221; shall mean the<br \/>\nAgreement, the Rights Agreement, the Employment and Non-Competition<br \/>\nAgreement, the Escrow Agreement, the Investment Agreement, the Voting<br \/>\nAgreement, the Selling Stockholders and Company Closing Certificates, the<br \/>\nPurchaser Closing Certificate, and all other agreements, certificates and<br \/>\ninstruments executed or contemplated to be executed by any of the parties<br \/>\nhereto in connection with the Transactions.<\/p>\n<p>         TRANSACTIONS. &#8220;Transactions&#8221; shall mean (a) the execution and<br \/>\ndelivery of this Agreement and the other Transactional Agreements and (b) all<br \/>\nthe transactions contemplated by this Agreement and the other Transactional<br \/>\nAgreements.<\/p>\n<p>         UNAUDITED INTERIM BALANCE SHEET. &#8220;Unaudited Interim Balance Sheet&#8221;<br \/>\nshall have the meaning specified in Section 5.8(a)(ii).<\/p>\n<p>         VOTING AGREEMENT. &#8220;Voting Agreement&#8221; shall have the meaning<br \/>\nspecified in Section 4.1(c)(v).<\/p>\n<p>                                       66<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[9374],"corporate_contracts_industries":[9510],"corporate_contracts_types":[9622,9626],"class_list":["post-43155","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-xoom-inc","corporate_contracts_industries-technology__programming","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43155"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43155"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43155"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}